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Abstract 
The poultry industry has successfully applied breeding and production 
programmes to meet growing consumer demands for chicken meat and eggs. Over 
the last four decades, poultry breeders have selected birds not only for productivity, 
but also for improved health, welfare, fitness and environmental robustness. 
Intensive production settings contribute to faster spread of diseases and greater 
losses in production due to increased morbidity and mortality of the flock. 
Traditional methods of disease treatment and prevention have played a critical role 
in control of disease. However, growing resistance of pathogens to therapeutic 
measures and consumer concerns led to the withdrawal of antibiotics as growth 
promoting additives in chicken feed. In addition, some vaccines have been 
overcome by increasing variation and virulence of pathogens and are no longer 
successful in disease prevention. The emergence of virulent and drug resistant 
pathogens have emphasised the need to focus on other solutions to disease, 
particularly natural genetic resistance. Genetic loci or gene expression patterns 
associated with the differential resistance of lines to specific pathogens have been 
identified, providing valuable markers for selective breeding. However, to date 
relatively few of these have been successfully incorporated into commercial lines. 
An ability to suppress or resist multiple pathogens, by selection for improved innate 
immune robustness has also been studied but it has not been introduced in 
commercial production, partly as the phenotype is ill-defined. Previous studies that 
focused on pro-inflammatory cytokines and their mRNA levels expressed by innate 
immune effector cells (heterophils and macrophages) identified differences 
between resistant and susceptible chicken lines, with the former producing stronger 
responses, supporting efforts to select poultry with an efficient early innate 
response. Here, small-scale qPCR screening and cellular techniques were evaluated 
with the conclusion that a more rapid, cheaper and reproducible method needs to 
be applied.  
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The main objective of this project was therefore to design and validate a 
diagnostic tool that could be used to phenotype the immune responses of chickens 
at the level of innate immunity. For this purpose, a panel of 89 genes was selected 
based on previously published infection studies and on RNA-seq results obtained 
from stimulation of heterophils, macrophages and dendritic cells with 
lipopolysaccharide (LPS). Target genes were cloned and sequenced to optimise the 
design of qPCR reactions and primers. A multiplex qPCR platform, the Fluidigm 
96.96 Dynamic Array, was selected as the tool of choice with the capacity to 
measure transcription of 96 genes of interest in 96 samples simultaneously. The 
preamplification reaction was optimised and the platform validated using a 
commercial line of chickens housed in clean or pathogen-challenged environments. 
Lymphoid tissues, including bursa of Fabricius, spleen, ileum with Peyer’s patches, 
caecal tonsils, and blood leukocytes were isolated and transcript levels for immune-
related genes defined between organs, birds and farms. For qPCR analysis, a panel 
of reference genes was normalised and TBP, ACTB and GAPDH genes were selected 
and validated as the most stable. The high-throughput qPCR analysis identified 
peripheral blood leukocytes as a potentially reliable indicator of immune responses 
among all the tissues tested with the highest number of genes significantly 
differentially expressed between birds housed in varying hygienic environments.  
The research described here could potentially aid the selection of poultry for 
improved immune robustness. The technical optimisation and validation of a new 
tool to simultaneously quantify expression of tens of relevant immune-related 
genes will prime research in many areas of avian biology, especially to define 
baseline immune gene expression for selection, the basis of differential resistance, 




Over the last four decades poultry breeders have selected birds not only for 
productivity, but also for improved health, welfare, fitness and environmental 
robustness. However, with the intensification of production some traits have been 
compromised. Traditional methods of disease treatment and prevention have 
played a critical role in control of disease. However, growing resistance of 
pathogens to therapeutic measures and consumer concerns led to the withdrawal 
of antibiotics as growth promoting additives in chicken feed. The emergence of 
virulent and drug resistant pathogens have emphasised the need to focus on other 
solutions to disease, particularly natural genetic resistance. 
Previous attempts to describe immune robustness in poultry have focused on early 
responses in chicken immune cells (heterophils and macrophages) and found 
stronger responses in resistant lines compared to susceptible ones. These 
experiments suggest that selection of chickens that are characterised with early and 
efficient immune responses is possible. Popular techniques that are commonly used 
to characterise immune responses at the level of gene expression were evaluated in 
this thesis with a conclusion that more rapid, reproducible and cheaper methods 
need to be applied.  
The main objective of this thesis was to design and test a tool that would allow us to 
assess the levels of expression of many immune-related genes in many samples at 
once. This would allow for easier and faster characterisation of the ability of 
chickens to mount immune responses. A group of 89 genes was selected based on 
previous studies and analysis of genes induced in chicken immune cells upon 
stimulation with a bacterial agonist of early responses. To confirm the existence of 
selected genes in chicken genome they were cloned and sequenced. The Fluidigm 
96.96 Dynamic Array platform was chosen as the diagnostic tool. This platform can 
run 9,216 reactions at once. Chicken organs involved in immune responses (spleen, 
bursa of Fabricius, caecal tonsils, ileum and blood) were sampled from birds raised 
on two farms that differed in levels of hygiene. To normalise the results from 
iv 
Fluidigm platform a set of reference genes that show stable expression across a 
range of conditions was selected. Among all the different tissues tested, blood cells 
showed the highest number of genes that were differentially expressed between 
birds from clean and pathogen-challenged farms, suggesting that blood tests to 
analyse expression of immune-related genes may be useful. The research described 
here could potentially aid the selection of poultry for improved immune robustness. 
The technical optimisation and validation of a new tool to simultaneously quantify 
expression of tens of relevant immune-related genes will prime research in many 
areas of avian biology, especially to define baseline immune gene expression for 
selection, the basis of differential resistance, and host responses to infection, 
vaccination or immuno-modulatory substances.  
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 Introduction Chapter 1
 Background 1.1
Poultry are reared in most parts of the world and are vital to global food 
security. Since domestication around 4000 years ago, chickens were first bred in 
Europe by the Romans around 500 B.C. (Parkhurst and Mountney, 2012; page 3). 
Nowadays the poultry industry is the dominant and fastest growing supplier of high 
quality and inexpensive animal protein worldwide. Many aspects have contributed 
to the intensification of chicken farming, for example affordable feed, efficiency of 
feed conversion relative to other farmed animals, changes in housing and better 
disease control. In the period of 12 years, between 2000 and 2012, the number of 
slaughtered chickens increased from 40,635 million to 59,861 million, and the meat 
weight per bird increased from 1.44kg to 1.55kg (Global Poultry Trends, 2014). It is 
estimated that these numbers will increase substantially due to global population 
growth and rising affluence. By the end of this decade, 124 million tons of poultry 
will be consumed worldwide, with Asia and Africa as the leaders (Meat Atlas; 
Heinrich Böell Foundation and Friends of the Earth).  
To sustain market requirements, most poultry are raised in large operations, 
which can lead to rapid transmission of diseases and zoonotic pathogens among the 
flock. Intensive rearing conditions may also lead to stress and injury, making birds 
more vulnerable to diseases. The chicken immune system is challenged by diverse 
viral, prokaryotic and eukaryotic pathogens. Some of these microbes can infect both 
chickens and humans, for example, Gram-negative bacteria such as Salmonella and 
Campylobacter and avian influenza. Such agents are sometimes carried in the 
absence of symptoms, making carriers difficult to identify and enabling agents to 
spread undetected in flocks and through the food chain. The spread of pathogens is 
affected not only by host factors but environment and housing. Changes from caged 
to enriched cages and non-cage system housing regulations for laying hens in EU 
countries were implemented in 2012. Reports from countries that introduced new 
housing systems earlier showed an increase in the incidence of bacterial infections 
(Fossum et al., 2009; Kaufmann-Bart and Hoop, 2009). Conventional battery cages 
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limited the contact of hens with their faeces and provided less opportunity for 
stress or injury associated with formation of a social hierarchy.  
The most prevalent foodborne pathogens are Campylobacter and 
Salmonella species. According to a UK Government report on zoonotic diseases 
during 2013, Salmonella was responsible for 8,459 laboratory-confirmed cases of 
gastrointestinal infections in humans, whereas Campylobacter caused 66,575 cases 
in United Kingdom in 2013. The increase in the number of reported enteric and non-
enteric infections related to Campylobacter in part can be attributed to better 
outbreak surveillance systems, which have resulted in infections being more readily 
identified. National-scale genotyping was used to quantify the contributions of 
different sources of human Campylobacter infection. The study revealed that the 
main source of campylobacteriosis in Scotland in 2005-2006 was contaminated 
chicken meat (Sheppard et al., 2009). Also many Salmonella serovars, such as 
Heidelberg, Enteritidis, Infantis, Typhimurium, linked to human infections have 
been isolated from poultry, eggs and egg-containing products (Dutil et al., 2010; Yim 
et al., 2010; Cloeckaert et al., 2007). These pathogens are the main bacterial agents 
causing food-borne illnesses in developed countries.  
Losses in poultry production can be caused by diverse pathogens, some of 
which cause serious outbreaks with high mortality. In some cases it is necessary to 
slaughter entire flocks to prevent the infectious agents from spreading. Low 
pathogenic avian influenza virus (AIV), high pathogenic AIV and Newcastle Disease 
Virus (NDV) are the most common viruses, which have reservoirs in wild birds, and 
hence are difficult to control. Despite Infectious Bronchitis Virus (IBV) not having 
other hosts apart from the chicken, it can cause significant losses in production due 
to poor weight gain, mortality and reduced egg production. Avian pathogenic 
Escherichia coli (APEC) causes diverse respiratory and systemic diseases (collectively 
termed colibacillosis) in chickens and other avian species. Infected birds often show 
lower growth rates and feed conversion efficiency and have inflammation 
associated with one or more visceral organs. Colibacillosis also leads to higher 
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mortality causing losses to the industry. Outbreaks of parasitic infections with 
Eimeria species can cause high morbidity and mortality and can persist in chicken’s 
environment in faeces and litter as oocysts. Infected birds often exhibit increased 
intestinal colonisation by Clostridium perfringens leading to necrotic enteritis and 
with Salmonella species, which intensifies the risk to food security and spread of 
foodborne pathogens (Qin et al., 1996; Collier et al., 2008). 
Good husbandry practices together with support from vaccines and 
coccidiostats make poultry production on industrial scale achievable (Blake and 
Tomley, 2014). There are vaccines available against many pathogens, for example 
NDV, IBV, AIV, infectious bursal disease virus (IBDV), Marek’s Disease Virus (MDV), 
fowl pox, Infectious Laryngotracheitis (ILTV), Salmonella Enteritidis, S. Typhimurium 
and Eimeria species. However, such vaccines can be expensive and time-consuming 
to administer and in some cases require updating to cover circulating strains. 
In the past, the role of genetic disease resistance was limited due to 
extensive application of antibiotics (Zekarias et al., 2002). The prophylactic 
administration of antibiotics, as well as the use of in-feed antibiotics at sub-
therapeutic doses as growth-promoters, was prohibited in the European Union 
from 2006 (reviewed in Castanon, 2007) in the light of increasing antibiotic 
resistance of many pathogens and understandable concerns from consumers . 
Therapeutic use is still allowed, but is increasingly hindered by transmissible drug 
resistance and restrictions on antibiotic residues entering the food chain. Despite 
the availability of vaccines for most of the common poultry diseases, there are still 
regular breaks where disease can cause devastating problems for the commercial 
production flock. Numerous factors can contribute to these disease outbreaks. The 
factors include failure of vaccines to protect against a new or highly virulent form of 
the pathogen. A recent report by Read et al. (2015) established that imperfect viral 
vaccines that do not result in clearance might select for the occurrence of escape 
mutants and more virulent strains by allowing a longer period for virus to mutate in 
the host. In addition, loss of vaccine function due to incorrect storage or use, or the 
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disease challenge itself may be so high that it overwhelms vaccine-induced 
immunity (Fulton, 2004). Although recovery after such outbreaks can be observed, 
production efficiency rarely achieves the levels before the disease occurred.  
Given the diversity of infectious threats to poultry health and challenge of 
preventing and treating diseases, improved immune function would be 
advantageous for chicken breeders. In this context, selection of more resistant 
chicken lines offers much potential. The first selection experiments happened in 
1935 and were aimed to decrease disease occurrence, which was mainly caused by 
Salmonella enterica serovars Pullorum and Gallinarum that cause severe systemic 
disease in birds (reviewed in Jie and Liu, 2011). For many decades, poultry breeders 
focused their breeding schemes on phenotypic traits, which led to production of 
chickens with increased body weight. The last 60 years of selective breeding in 
broilers led to decrease in days required to reach processing weight. Nowadays it 
takes 42 days compared to 84 days in the 1950s. In 1957, a 42-day-old broiler 
weighed on average 591 g (Havenstein et al., 2003) whereas the avergage slaughter 
weight of modern broilers is approximately 2672 g. Breeding programs directed 
towards accelerated growth and feed conversion efficiency may unintentionally 
reduce the responsiveness to the plethora of immune challenges (Swaggerty et al., 
2009).  
While it has been possible to improve poultry by genetic selection for 
resistance to specific diseases (Star et al., 2008), achieving a general increase in 
immunological competence is considered challenging because of low heritability 
and the difficulty of measuring this trait. In addition, progress in vaccination and use 
of antibiotics repressed the requirement to generate immune protection through 
breeding programs. Although the heritability estimates of disease resistance are 
reported to be low, phenotypic variation is high in populations and genetic selection 
can be used to complement improvements in vaccination practices to support 
poultry in the “arms race” between pathogens and their host (reviewed in Hocking, 
2010). The selection based on immune function has no effect on growth promotion, 
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therefore it could be possible to select for immune responsiveness without causing 
a decline in weight gain abilities (van der Most et al., 2011). Selection for host 
responses to individual pathogens is achievable and has been used in breeding 
programmes (Zekarias et al., 2002) but it is not desirable.  
Few lines selected for resistance to specific pathogen have been tested for 
susceptibility to other pathogens. Hartmann et al. (1984) showed correlation of ALV 
resistance with MD resistance in two pairs of strain, where a third pair presented 
lower MD mortality rate. This demonstrates that the susceptibility spectrum to 
pathogens other than the one used for selection has different outcomes in different 
populations. Approaches to directly select for a single trait by creating divergent 
populations have been performed in the past. Multi-determinant and non-
pathogenic antigen – sheep red blood cells (SRBC), was first used in mice (Biozzi et 
al., 1979) and resulted in great differences in the magnitude of antibody responses. 
The application of selection for SRBC responses in chickens led to a long-term 
experiment using a White Leghorn population. The offspring of divergent lines (high 
antibody – HA, low antibody – LA) differed in antibody titer to Newcastle Disease 
Virus, mites, Mycoplasma gallisepticum, Eimeria necatrix and splenomeglia virus, 
with HA chickens characterised by better humoral responses. On the other hand, LA 
chickens were shown to be less susceptible to Escherichia coli and Staphylococcus 
aureus (Gross et al., 1980; Dunnington et al., 1991). Resistance of high antibody 
chickens to parasitic and viral pathogens was confirmed in experiments with 
Eimeria tenella (Martin et al., 1986) and Marek’s Disease (Dunnington et al., 1986). 
The susceptibility of the HA line to bacterial infections may lie in differential genetic 
regulation and negative correlation between immune responses to wide spectra of 
pathogens (Lamont et al., 2003). 
Genes involved in adaptive immune responses control resistance to specific 
pathogens. Therefore, selection based on adaptive immunity may be highly specific 
against one particular pathogen and unlikely to give resistance to even closely 
related pathogens. In addition, it can lead to susceptibility to other pathogens. 
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Breeding chickens for growth traits revealed its negative association with some 
aspects of immune system performance. Another problem associated with this 
approach is the difficulty to predict the specific types of microbes that may be 
present in the commercial poultry environment and thus genetic selection for 
resistance to a particular pathogen will not ensure infection-free chicken stocks 
(Lamont et al., 2008).  
A well-developed immune system that responds adequately to pathogens is 
necessary to reduce disease occurrence. The generation of more robust lines of 
birds with improved liveability would prevent major economic losses or 
contamination of food products (Swaggerty et al., 2009). In order to do this there is 
a demand for diagnostic tools that could rapidly and precisely evaluate avian 
immune responses associated with innate immunity and disease resistance. The 
innate immune response directs the adaptive response. Before this discovery, 
immunological research had been focused on clonal expansion of T and B cells by 
specific antigens (Parish and O’Neill, 1997). Since then many laboratories focused 
their research on evaluating various aspects of the innate immune response in 
poultry (Ferro et al., 2004; Wigley et al., 2006; Swaggerty et al., 2008). Kramer et al. 
(2003) performed experiments with various breeds of chickens and their abilities to 
fight the infection with innate or adaptive immune responses. The study showed 
that Old Dutch breeds were characterised by higher production of nitric oxide (NO), 
lower Salmonella survival in splenic leukocytes and higher total IgM and IgY 
antibody concentrations compared to a commercial broiler group. These 
experiments concluded that many aspects of the immune system should be 
included in the selective breeding program. Focusing on only one branch of immune 
system does not reliably indicate general responsiveness or immunocompetence. 
Therefore, better understanding of avian immunology is crucial in determining 
disease robustness in chickens. 
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 The immune system 1.2
All living organisms have evolved defence mechanisms against invading 
pathogens. Apart from commensal microflora that reaches homeostasis, the 
immune system is constantly challenged with a broad spectrum of microorganisms. 
Similar to mammalian species, chicken have developed two arms of defence: innate 
and adaptive immune responses (Figure 1.1). 
 
Figure 1.1. The components of innate and adaptive immune system in mammals. The cells 
(granulocytes, dendritic cells, macrophages, natural killer cells, mast cells) and soluble molecules 
(complement proteins) of the innate immune response act as the first line of defence against 
infection. The adaptive immune response is triggered by innate components, and it is highly 
characterised with high antigenic specificity and memory. The components of adaptive immune 
system include antibodies, B cells, and CD4+ and CD8+ T lymphocytes. Natural killer T cells and γδ T 
cells are cytotoxic lymphocytes that interact and bridge the innate and adaptive immunity (Adapted 
from Dranoff, 2004). 
 
The innate immune component generates responses immediately after the 
recognition of pathogen-associated molecular patterns (PAMPs). Adaptive 
immunity starts as a second line of defence and is highly specific to the invading 
organism(s). It requires time to design responses against invaders and to avoid 
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damaging of host tissues. The establishment of immunological memory by the 
adaptive branch of the immune system allows responses to be generated faster 
when the infection reoccurs. An important aspect of activation of adaptive immune 
responses is the presentation of foreign antigen to the T cell or B cell receptor by 
cells from the innate immune system that encountered pathogens via phagocytosis. 
The Major Histocompatibility Complex (MHC) is essential for such antigen 
presentation. The genes involved in MHC encode for glycoproteins that, after 
antigen processing and degradation, present small peptides to the cell surface and 
present them to the T or B lymphocytes. Naïve B cells can be activated by follicular 
dendritic cells (FDCs) after presentation of unprocessed antigen in secondary 
lymphoid organs (Batista and Harwood, 2009). B and T cells have major roles in the 
development and organisation of adaptive immunity, respectively producing 
antibody or targeting infected cells for killing. In the adaptive immune response, 
antigen is recognised by two distinct sets of highly variable receptors, the B cell 
receptor (BCR) and the T cell receptor (TCR). To protect against pathogens, the host 
needs to generate a diverse pool of BCR that will recognise a broad range of 
antigens and initiate the antibody production. TCR diversity has evolved as a result 
of the arms race with emerging pathogens to cover most of the antigen diversity 
(Nikolich-Zugich et al., 2004). In the chicken, mechanisms of somatic DNA 
recombination to create variability in the TCR are identical as in mammals (Jung et 
al., 2006). A vital part of immunity and control of infections with extracellular and 
intracellular pathogens are the T helper 1 (Th1) and T helper 2 (Th2) cells. The 
components of Th1 and Th2 responses required in mammals, including signature 
cytokines and transcription factors, have been identified in the chicken genome 
(Kaiser et al., 2005).  
The avian immune system differs from those of mammalian species at the 
genetic, molecular, cellular and organ level. Birds have different repertoires of Toll-
like receptors (TLRs) involved in pattern recognition, as well as different antibodies. 
They also lack draining lymph nodes and the sites of antigen uptake, processing and 
immunological priming are relatively poorly defined (reviewed in Kaiser, 2010). 
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Birds have an avian-specific primary lymphoid organ, the bursa of Fabricius, which is 
the site of development of the B-cell repertoire (Glick et al., 1956). At the cellular 
level, the avian functional equivalents of mammalian neutrophils are heterophils 
(Kogut et al., 2005). The chicken eosinophils appear to be non-functional (Maxwell, 
1987) and the components that control migration of eosinophils, for example 
eotaxins, eotaxin receptor and chemokines, are missing in the chicken genome 
(Kaiser, 2012). Similar to eosinophils, the numbers of basophils and mast cells, all 
typical cells of Th2 responses, are much lower compared to mammalian species 
(Schijns et al., 2014). The chicken Major Histocompatibility Complex (MHC) genes 
differ in the structure, function and architecture from the mammalian MHC 
(Kaufman et al., 2013). The chicken MHC is more compact, containing only 19 genes 
within the 92 kb region of the B locus on the chromosome 16. The 20-fold smaller 
size compared to human MHC has been termed “the minimal essential” MHC 
(Kaufman et al., 1995). 
 Avian Pattern Recognition Receptors (PRRs) 1.2.1
Similar to mammals, the chicken innate immune system depends on the 
recognition of pathogens or pathogen-associated molecular patterns through 
Pattern Recognition Receptors (PRRs) including TLRs, retinoic acid-inducible gene-1 
(RIG-I) like receptors (RLRs), nucleotide-binding oligomerisation domain (NOD)-like 
receptors (NLRs) and C-type lectin receptors (CLRs) family members. A RIG-I 
orthologue is present in both the duck and goose genomes (Barber et al., 2010; Sun 
et al., 2013) but it has not been identified in the chicken (Karpala et al., 2011). The 
most studied family are TLRs. This family consists of transmembrane glycoproteins, 
expressed on the cell membrane or intracellularly. The extracellular domain consists 
of leucine-rich repeats (LRR) responsible for pathogen recognition. The 
transmembrane domain and intracellular region containing Toll/interleukin (IL)-1R 
homology domains (TIR) recruits adaptor proteins, which then activate signal 
transduction cascades. A core signalling pathway is engaged by surface TLRs and 
leads to activation of transcription factors involved in pro-inflammatory gene 
expression (O’Neill and Bowie, 2007). 
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Avian TLR family members comprise mammalian orthologues and avian 
specific TLRs and their ligands, where known, are listed in (Table 1.1). The 
mammalian TLR1 family can form heterodimers with TLR2, which increases the 
capacity to detect PAMPs (Ozinsky et al., 2000). Tandemly duplicated genes, TLR1A, 
TLR1B and TLR2A, TLR2B represent the chicken TLR1 family (Boyd et al., 2001; Fukui 
et al., 2001). Similar to mammalian TLR2, chicken TLR1 and TLR2 families can form 
heterodimers and detect PAMPs (Higuchi et al., 2008). Orthologues for TLR3 
(Schwarz et al., 2007), TLR4 (Leveque et al., 2003), TLR5 (Iqbal et al., 2005) and TLR7 
(Philbin et al., 2005) are present in the chicken genome. TLR4 detects 
lipopolysaccharide and is associated with early regulation of Salmonella infection 
(Leveque et al., 2003). TLR5 detects flagellated Salmonella serovars (Iqbal et al., 
2005). Detection of viral RNA is mediated by intracellular TLR3 and TLR7 (Schwarz et 
al., 2007; Philbin et al., 2005). Chicken TLR8 is a pseudogene disrupted by a chicken 
repeat-1 (CR1) retrovirus-like element (Philbin et al., 2005). Although TLR9 gene is 
absent from the chicken genome, chickens are able to detect CpG motifs via TLR21 
(Brownlie et al., 2009; Keestra et al., 2010). Avian-specific TLR15 have been shown 
to detect range of PAMPs from various pathogens, for example Salmonella 
Typhimurium, S. Enteritidis, Escherichia coli, B- and C-type CpG oligonucleotides 
(ODN), tripalmitoylated lipopeptide (PAM3CSK4), LPS, virulence-associated fungal 
and bacterial proteases, yeast-derived agonist and Eimeria tenella sporozoites  
(Higgs et al., 2006; Shaughnessy et al., 2009; Nerren et al., 2010; Ciraci and Lamont, 
2011; De Zoete et al., 2011, Boyd et al., 2013, Zhou et al., 2013). 
11 
Table 1.1. TLR family members and their agonists in humans and chickens  
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 Non-cellular components of innate immune system 1.2.2
Cytokines and chemokines play an essential role in the immune response. 
These small regulatory molecules act as extracellular signals between cells during 
the course of an immune response. Knowledge of the cytokine repertoire in the 
chicken radically changed after the chicken genome sequence became available 
(Hiller et al., 2004). Due to very low (25-35%) identity with their mammalian 
orthologues there are only few cross-reactive monoclonal antibodies or bioassays 
(reviewed in Kaiser and Staeheli, 2008). The repertoire of chicken cytokines includes 
interferons (IFNs), interleukins (ILs), transforming growth factors (TGFs), tumour 
necrosis factors (TNFs), colony stimulating factors (CSFs) and chemokines (Kaiser et 
al., 2005). Many studies focus now on expression of pro-inflammatory cytokines in 
effector cells upon stimulation with TLR agonists. Pro-inflammatory cytokines and 
chemokines are involved in responses to various pathogens challenges and 
increased resistance against disease have been shown to be associated with strong 
pro-inflammatory cytokine and chemokine responses (Coussens et al., 2004, Ferro 
et al., 2004). 
12 
 Role of the effector cells 1.2.3
Various cells of both arms of the immune system have been described in the 
chicken. The activity of dendritic cells, macrophages, heterophils, natural killer cells  
(NKT), γδ T cells against invading microbes is considered a part of the innate 
immune response. In the context of this study, dendritic cells (DCs), macrophages 
and heterophils will be reviewed. Dendritic cells and macrophages phagocytose the 
encountered pathogen and present degraded peptides in the context of MHC 
molecules. MHC molecules play crucial role as a restriction element presenting 
antigens to T cells. MHC class I and II molecules have similar functions, both present 
the antigens to T cells, CD8+ and CD4+, respectively. The difference lies in the origin 
of the antigen. Generally, MHC class I molecules present peptides originated from 
intracellular pathogens whereas MHC class II molecules present exogenous peptides 
(reviewed in Vyas et al., 2008). In some circumstances, extracellular-derived 
antigens can be presented via MHC class I molecules to CD8+ T cells. The 
phenomenon of cross presentation has been described 30 years ago (Bevan, 1976) 
and is still a “hot topic” as it is not yet fully elucidated. The migratory CD103+ DCs 
have been shown to be most efficient in cross-presentation in mammals (Joffre et 
al., 2012). It is now known that the immune system uses this mechanism to monitor 
tissues and phagocytic cells for the presence of antigens.  
Since Metchnikoff first used the “macrophage” term to describe phagocytic 
leukocytes in 1884, the knowledge about these cells has grown hugely. Their role in 
innate and adaptive immunity, inflammation as well as in tissues homeostasis is 
well established in mammals (reviewed in Gordon, 2003). The macrophage 
repertoire consists of heterogeneous cells located in different tissues throughout 
the body in both vertebrates and invertebrates (Gordon and Taylor, 2005). They 
function as phagocytes and stimulate immune responses of other cells by 
expression of cytokines and chemokines, and therefore play primary roles in both 
innate and adaptive immunity. Carrell and Ebeling first described the isolation of 
macrophages from chicken blood in 1922. The adherence abilities of macrophages 
have been used to develop a protocol of selecting monocyte-derived macrophages 
13 
from peripheral blood (Peck et al., 1982). It is now possible to culture chicken bone 
marrow-derived macrophages with colony-stimulating factor 1 (Garceau et al., 
2010). Mammalian dendritic cells (DCs) have been identified over 30 years ago 
(Steinman et al., 1975) and have become the basis of immune responses studies in 
mammalian species since. Unlike macrophages or B cells, DCs are much more 
effective at inducing a primary immune response in resting naive T lymphocytes, 
and are called professional antigen-presenting cells (APCs) (Nakayama, 2015). Apart 
from phagocytosis and antigen processing, macrophages and dendritic cells also 
produce cytokines and chemokines and express MHC Class II molecules on their 
surface after recognition of PAMPs. The level of knowledge and availability of 
diagnostic tools to study avian effector cells is limited compared to the mammalian 
field. The populations of both types of effector cells are heterogeneous. Several 
different subtypes of dendritic cells have been identified and characterised in the 
chicken – bursal secretory DCs, follicular DCs, thymic DCs, Langerhans cells and 
bone marrow-derived DCs (Igyarto et al., 2006; Igyarto et al., 2007; del Cacho et al., 
2008; Wu et al., 2010, Olah and Nagy, 2013). Recent studies have characterised 
bone marrow-derived DC during viral infections with AIV and IBDV (Vervelde et al., 
2013; Liang et al., 2015). The advent of transgenic chickens in which all cells of the 
myeloid lineage express a fluorescent protein under the control of the CSF-1 
receptor promoter has begun to shed light on the spatial organisation and function 
of macrophages in the chicken (Garceau et al., 2015).  
Heterophils, the avian equivalent of mammalian neutrophils, have not been 
reported as APCs. However, several genes involved in the MHC class II system 
(CD80, MHC II β chain, c-KIT) were reported to be upregulated in Salmonella 
Enteritidis-stimulated heterophils derived from a resistant line of chickens (Chiang 
et al., 2008). Heterophils are useful biomarkers for measuring the innate immune 
response as they act early (within an hour) to engulf and destroy pathogens via 
phagocytosis (Swaggerty et al., 2003). Pathogens are then entrapped inside 
phagosomes that begin to fuse with cytoplasmic granules with microbicidal 
substances. Similarly to neutrophils, heterophils have evolved specific tools to 
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prevent pathogens from spreading. They are capable of producing reactive oxygen 
species (ROS) but the process of oxidative burst differs from the process observed in 
human neutrophils. The lack of myeloperoxidase, catalase and alkaline phosphatase 
enzymes distinguish them from neutrophils (Brune et al., 1972).  
Apart from intracellular phagocytic killing, heterophils are equipped with 
extracellular killing mechanisms. Heterophils have granules whose contents are 
released into the external environment upon contact with pathogens . The release 
of networked extracellular fibres made up of DNA, histones and granular enzymes 
has been shown in chicken heterophils stimulated with pathogens or their products . 
These heterophil extracellular traps (HET) are independent of phagocytosis, making 
heterophils the most equipped effector cells (Chuammitri et al., 2008). Association 
of HET production with variation at the locus associated with salmonellosis and 
SLC11A1 gene has been revealed in studies on two intercross lines of chickens 
challenged with S. Enteritidis (Redmond et al., 2011), indicating that it may be 
under genetic control. Antimicrobial proteins, peptides, enzymes and adhesion 
molecules are among the potentially toxic substances found in chicken heterophil 
granules. An antimicrobial cationic peptide, cathelicidin-2, has been shown to be 
released from heterophil granules upon stimulation with S. Enteritidis (van Dijk et 
al., 2009). Heterophils are able to release the granule contents at the infection site 
in a controlled manner to avoid damaging surrounding tissues (Genovese et al., 
2013). Phagocytosis has been shown to be associated with degranulation processes. 
Similar to phagocytosis, various microbial substances were found to stimulate 
degranulation (Kogut et al., 2005).  
 Adaptive immune response 1.2.4
The adaptive immune response is activated after the presentation of antigen 
to lymphocytes (Medzhitov and Janeway, 1998), in the context of the MHC, by 
antigen-presenting cells, especially DCs. CD8+ T cells and/or CD4+ T cells are 
stimulated and activated depending on the nature of the pathogen. Stimulation of 
naive T helper cells, expressing CD4 molecules, with IFN-γ, IL-12 or IL-18 secreted by 
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innate immune system effector cells initiates the differentiation of Th1 cells . In 
contrast, IL-4 and IL-13 trigger the differentiation of Th2 cells (Figure 1.2).  
Th1 cells enhance cell-mediated immunity against intracellular pathogens, 
whereas Th2 cells are important for control of extracellular pathogens via humoral 
responses. They are also responsible for activation of B cells (Lebman and Coffman, 
1988). Markers of these Th cell subsets are the transcription factor Tbet, the cell 
surface marker TRANCE and the signature cytokine IFN-γ for Th1 cells and, for Th2 
cells, GATA-3, Tim1 and IL-4 and IL-13 (reviewed by Zhu and Paul, 2008).  
Until recently, the Th1/Th2 paradigm (Mosmann and Coffman, 1989) has 
been used to describe the different adaptive responses triggered by various 
pathogens. Evidences of Th1/Th2 polarisation in the chicken have been shown 
based on infection studies with viruses and helminths (Eldaghayes et al., 2006; 
Degen et al., 2005). The Th1/Th2 paradigm does not explain many complicated 
pathological situations. The discovery of a third subset of Th cells (Th17) has 
expanded the Th1/Th2 paradigm (Ouyang et al., 2008). The primary function of 
Th17 cells is to handle pathogens that have not been cleared by Th1 or Th2 cells . 
Differentiation of Th17 cells is triggered by a combination of TGF-β, IL-6 and IL-23 
(reviewed in Korn et al., 2009). Th17 cells express the transcription factor RORγt, 
the receptor IL-23R on their surface and the signature cytokines IL-17A and IL-17F 
(Ivanov et al., 2006). The chicken IL-17 family consists of five members that have 
been identified in the genome: IL-17A, IL-17B, IL-17C, IL-17D and IL-17F (Kaiser et 
al., 2005). After successful clearance of the pathogen, some T cells, which 
previously encountered antigen, remain in the system as memory cells (reviewed in 
Korn et al., 2009). The immune system developed a mechanism that control the 
damage caused by immune responses. Regulatory T cells (Treg) are a subset of T 
cells that specialises in immune suppression. The disruption of regulatory function 
of immune system causes the autoimmune diseases. One of the unique markers of 
Treg is Foxp3 (Li et al., 2008b) which has not yet been identified in the chicken. The 
Treg family consists of Th3 cells, CD8+Foxp3+ cells, γδT cells, NKT cells and CD4-CD8-
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TCRαβ+ cells. Chicken CD4+CD25+ cells have been shown to have similar suppressive 
functions as mammalian Treg cells (Shanmugasundaram and Selvaraj, 2011).  
 
Figure 1.2. Differentiation of helper T cell subset in mammals.  Antigen –activated dendritic cells 
(DCs) interact with naïve CD4+  T cells which leads to polarisation into different effector T cell 
subsets — T helper 1 (Th1), Th2, Th17 and regulatory T (Treg) cells.Distinct sets of transcription 
factors control differentiation of each effect T cell type. Naïve T cells can differentiate into Th17 cells 
in the presence of interleukin-6 (IL-6) and transforming growth factor-β (TGFβ). Th17 cells express 
the transcription factors retinoic acid receptor-related orphan receptor-γt (RORγt) and signal 
transducer and activator of transcription 3 (STAT3). FOXP3 - forkhead box P3; GATA3 - GATA-binding 
protein 3; IFNγ - interferon-γ; TCR - T cell receptor (Adapted from Zou and Restifo, 2010). 
The humoral response is a part of the adaptive branch of immunity and 
involves activity of B lymphocytes. In mammals B cells develop in bone marrow 
from pluripotent haematopoietic stem cells that give rise to common lymphoid 
progenitor cells. Progenitor B cells undergo rearrangement of the immunoglobulin 
(Ig)-heavy chain and light chain genes. This process results in immature B cel l 
population that express the membrane-bound IgM. B cells migrate to lymphoid 
organs as naïve cells, meaning they have not yet been exposed to antigen. Activated 
B cells differentiate to plasma cells, express and secrete different classes of Ig. The 
switch between IgG, IgA, IgD, IgE and IgM is orchestrated by cytokines. In contrast 
to bone marrow B cell development in mammals, chickens unique lymphoid organ, 
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the Bursa of Fabricius is the site where B cells originate and differentiate (Barnes, 
2001; Glick, 1988). The B cells mature inside the bursa’s follicles and develop 
antigenic diversity after exposure to antigens by APCs (Glick, 1977; Ratcliffe, 1989). 
Humoral responses are maintained by matured B cells that migrate from bursa to 
spleen and lymphoid tissues (Pope, 2001).  
Avian immunoglobulins are classified into three groups: IgA, IgG and IgM 
(Hodek and Stiborova, 2003). Because of the structural differences between 
mammalian IgG and avian IgG, it was suggested to rename it to IgY (from yolk) 
(Leslie and Clem, 1969). Activation of mature B cells occurs when it recognises 
antigen in conjunction with signals from Th2 cells, which triggers proliferation and 
differentiation of B cells into a plasma cells. Plasma cells can be classified as 
antibody-producing cells or memory cells that survive for many years with the 
ability to produce antibody against specific antigen. Immunoglobulins consist of 
dimerised heavy and light chain with constant (C) and variable (V) regions. Somatic 
recombination of families of gene segments – V and joining (J) genes, produce light 
chains, and diversity (D) genes in case of heavy chain. The V(D)J recombination 
leads to great diversity in antigen recognition. Further changes in antigen 
recognition are manipulated by mutations occurring in the V, D, J genes, called 
somatic hypermutation. The Ig genes in avian species undergo rearrangement like 
their mammalian counterparts, but antibody diversity is primarily generated by 
gene conversion, which usually occurs after initial recombination of the single VJ or 
VH genes and surface expression of the B cell receptor. Single copies of VL and JL 
genes encode light chain and VH and JH genes encode heavy chain, which limits the 
diversity and the V(D)J rearrangements occurrence (Ratcliffe and Jacobsen, 1994; 
Reynaud et al., 1985). The recombination with clusters of pseudogenes upstream of 
the heavy and light chains loci increases the diversity of the Ig V region (Reynaud et 
al., 1987; Reynaud et al., 1989).  
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 Chicken breeding for improved immune robustness 1.3
Improvements in the poultry industry can be achieved by development of 
chicken lines with better immune responsiveness. To accomplish this, improved 
understanding of chicken immunology is necessary. Every aspect of the acquired 
immune response has its beginning in the innate response of effector cells. Stronger 
and more rapid innate responses to infection lead to higher resistance in particular 
chicken lines (Swaggerty et al., 2009). Over the years, many studies have shown 
that commercial broiler lines have distinct immune function parameters, due to 
differences in their genetic make-up, which results in disease resistance and/or 
susceptibility. Poultry breeders and producers should co-select for both immune 
competence and growth traits (Cheema et al., 2003). Disease resistance is generally 
a polygenic trait (Cavero et al., 2009). Before the chicken genome became available, 
the genetics of complex traits had been studied without identifying the genes 
involved. The basis for selection was estimated breeding values calculated from 
phenotypic records and pedigrees, and knowledge of the heritability of each trait. 
However, this process is slow and, in the case of disease resistance, measuring the 
trait is expensive. Identification of genes controlling this trait would be 
advantageous in selection of animals carrying the desirable alleles (Goddard and 
Hayes, 2009). Early studies of immunological traits were limited to measurements 
of antibody levels to a defined antigen. These biomarkers are still relevant because 
they are easy to assess and relatively cheap. However, over the past 20 years, the 
methods available for identification of DNA variation have changed and costs of 
these assays decreased (reviewed in Lamont et al., 2008). The early methods used 
to discover the genes were a candidate gene approach and gene mapping to a 
chromosomal location (reviewed in Jie and Liu, 2011).  
 Inbred lines 1.3.1
Toward the genetic improvement of poultry, a number of inbred lines of 
varying phenotypes have been created in the chicken from a selection of breed 
stocks (Crawford, 1990). First experiments with inbreeding started in 1939 at the 
Regional Poultry Disease Laboratory, now known as the Avian Disease and Oncology 
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Laboratory (ADOL). The natural variability inherent in a chicken population was 
explored with the use of individual cages, artificial insemination and brother-sister 
mating. Families with inherent high resistance or susceptibility to avian leukosis 
were formed with carefully selected source stocks. This resulted in production of 
several specific lines (Stone, 1975). Using inbred lines to identify sources of 
variation is advantageous, as the level of biological variance of the trait is very low 
compared to outbred lines. The phenotypic variance decreases in backcross 
populations. This allows the mapping of genomic regions associated with the trait of 
interest, termed quantitative trait loci (QTL) by association of the genotype of the 
backcross progeny with the phenotype under study. In addition, backcrossed 
populations maintain the non-random association of alleles at different loci, 
therefore the power to identify a QTL is maintained (Soller et al., 2006). The 
identification of QTL associated with a trait could lead to greater examination in 
order to find the causative gene or linked marker that can be used for marker-
assisted selection (MAS) in breeding programmes. 
 Microsatellites markers and QTL mapping 1.3.2
With the development of the polymerase chain reaction, amplification of DNA 
in a rapid inexpensive manner became available to detect variation. PCR techniques 
were used to identify short repetitive sequence length variations – microsatellites. 
Their many characteristics, such as codominance, high polymorphism and 
multiallele dispersion in the genome were used as DNA-based markers for breeding 
selection. This approach produced microsatellite-based genomic maps, which were 
then applied in studies on experimental crosses for identification of genomic 
regions influencing commercially important traits. With the use of genomic maps of 
the location of specific microsatellites, the identification of genomic regions 
responsible for quantitative traits became possible.  
Many of the studies utilised the inbred lines and their crosses characterised 
with resistance and susceptibility to certain pathogens in identification of QTL. 
Instead of reviewing all literature on how immune function has been implicated in 
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genomic studies on heritable resistance to infection I will focus on selected 
pathogens as examples. As of August 2015, the animal genome QTL database 
reported 224 publications identifying more than 4,676 QTL for 319 traits, including 
those for specific disease resistance (www.animalgenome.org). The QTLs associated 
with MDV resistance have been studied in resistant and susceptible inbred lines, 
which were developed in ADOL. Several potential QTL have been determined from 
backcrosses between these lines. Vallejo et al. (1998) used inbred lines that differ in 
their susceptibility to Marek’s Disease Virus (MDV) to produce intercross progeny in 
order to map QTL affecting MDV susceptibility. With the use of 78 microsatellites 
markers, six QTL were mapped with significant and suggestive association with 
Marek’s Disease (MD) traits. Following these experiments Yonash et al. (1999) 
genotyped all birds used in the previous study and added 49 new microsatellites 
markers. McElroy et al. (2005) reported identification of the same QTL for MD 
resistance in commercial layers, showing that the experimental inbred lines and 
their crosses are useful tool for commercial populations. In addition, Heifetz et al. 
(2007), using microsatellites markers, confirmed localisation of previously reported 
QTL significantly associated with resistance to MD in commercial lines. 
Mariani et al. (2001) used microsatellite markers in low density QTL mapping 
of a substantial component of resistance to systemic salmonellosis (SAL1) to chicken 
chromosome 5. These experiments were performed on a highly susceptible inbred 
line and highly resistant inbred line to Salmonella infection and their progeny from 
the backcross with the parental line. Separately, Beaumont et al. (2003) 
demonstrated the importance of genomic region carrying gene SLC11A1 in 
Salmonella resistance. Populations derived from inbred lines were used in the 
identification of several QTL for resistance to carrier state using selective 
genotyping approach (Tilquin et al., 2005). The bacteria count of S. Enteritidis and S. 
Typhimurium from cloacal swabs in backcross and F2 progeny determined which 
individuals were characterised by extreme phenotype and selected birds were 
genotyped. Studies on Salmonella carrier state QTL in commercial lines confirmed 
that the locus carrying the SLC11A1 (Nramp1) candidate gene is significantly 
21 
associated with carrier state resistance variations in different chicken lines. In 
addition, a QTL associated with Salmonella gut colonisation has been identified on 
chromosome 2 (Calegne et al., 2009).  
 High-density single nucleotide polymorphism (SNP) panels 1.3.3
Together with the first chicken genome assembly in 2004 a 2,8 million single 
nucleotide polymorphism (SNP) map was produced (International Chicken 
Polymorphism Map Consortium, 2004) which further allowed identification of many 
QTL and determined many disease-related genes, e.g. MHC, SLC11A1 (Nramp1), 
IFN, TLRs, IRAK-4, MyD88, NFκB, TNFSF, using various molecular technologies 
(reviewed in Kaiser et al., 2008).  
The SNP number and density has been increasing since the first published SNP 
map (Wong et al., 2004). Re-sequencing of divergent chicken lines provides 
additional SNP (Rubin et al., 2010). With the use of high-density SNP panel, Fife et 
al. (2009) refined the location of SAL1 locus and two potential candidate genes 
were identified (SIVA1 and AKT1). The SNP panel was used in studies on 
identification of Salmonella colonisation QTL. The four QTL, mapped to 
chromosome 2, 3, 12 and 15, are significant at either the genome-wide or the 
chromosome-wide level (Fife et al., 2010). However, to identify causative genes 
higher density SNP panels are needed. Genomic analysis of advanced intercross 
lines responses to Salmonella has supported the importance of the SAL1 QTL that 
contains AKT1 and SIVA1 genes as candidates that control resistance to systemic 
salmonellosis (Redmond et al., 2011). The fine-mapping of QTLs is limited by poor 
precision in gathering phenotypic data and reliability of these assessments. The 
development of new technologies such as RNA-seq, microarray expression analyses 
and high density SNP genotyping should expedite the search for mechanisms of 
genetic resistance (reviewed in Calenge et al., 2010).  
Other causes of genetic variation, in addition to SNPs, are emerging and can 
be associated with disease resistance. Copy number variations (CNVs) are difficult 
for most mapping approaches and for sequence assembly and were therefore 
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largely ignored in the search for QTL (reviewed in Dodgson et al., 2011). CNVs are a 
type of genomic structural variation involving deletions, insertions and duplications 
and range from kilobase to megabases. Now it is clear that CNVs are involved in 
phenotypic differences such as late feathering (Elferink et al., 2008). The number of 
nucleotides affected by CNVs has been shown to exceed the number of SNPs 
(Conrad et al., 2010). Wang et al. (2010) observed 96 CNVs in 10 sampled birds. 
Among those CNVs, fifteen involved functional genes. Recently the number of CNVs 
and CNV regions (CNVRs) increased to 130 with the use of an Agilent 400k array 
CGH (comparative genomic hybridisation) platform (Wang et al., 2012). 
 Combination of gene expression and genomic markers 1.3.4
By considering gene expression as a quantitative trait or phenotype and 
combining with other genetic markers, the genomic location(s) that control 
variation can be revealed (Cogburn et al., 2007). The combination of gene 
expression studies and marker genotypes has a great promise for studies of 
complex traits. By comparing gene expression data with the location of QTL 
previously associated with MDV traits in inbred lines, the IRG1 gene was identified 
as having a potential role in MD susceptibility (Smith et al., 2011). Heams et al. 
(2011) used gene expression with comparison with mapped QTL region to study 
Eimeria tenella infections. This approach highlighted potential candidate genes that 
are positioned within significant QTL for Eimeria lesions. The QTL associated with 
variation can be either cis or trans to the gene of interest. The cis-eQTL could be 
interpreted as the sequence flanking gene, hence regulating its expression. The 
trans-acting eQTL could modulate the expression by transcription factors. The 
former are more difficult to identify, even with a complete genome sequence 
(Cogburn et al., 2007).  
 Studies on differences in gene expression between chicken lines 1.4
As stated in the previous section, over the years, genetic resistance to 
diseases in chickens has been studied in context of various pathogens. In this 
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section, examples of mRNA gene expression and functional studies will be reviewed 
in context of heritable natural genetic resistance. 
Divergent chicken lines were used to study immune responses to Salmonella 
species, Eimeria species, and Campylobacter jejuni. Studies by Wigley et al. (2002) 
on resistant inbred birds showed lower mortality and morbidity when infected with 
Salmonella Gallinarum. Subsequent in vitro comparison of macrophages from 
resistant and susceptible lines revealed that innate immunity played a role in 
responsiveness to S. Gallinarum with better clearance of bacteria in the former line. 
Increased expression of pro-inflammatory cytokines in the resistant line suggested 
efficient initiation of innate and adaptive immune responses that is pivotal in 
immunity to systemic salmonellosis (Beal et al., 2004). The results were confirmed 
in studies on the same lines monocyte-derived macrophages stimulated with S. 
Gallinarum and S. Typhimurium (Wigley et al., 2006) where higher and more rapid 
mRNA gene expression of cytokines and chemokines was observed in macrophages 
from resistant line.  
In addition to macrophages, heterophils from resistant and susceptible lines 
have been shown to respond differently to infection with S. Enteritidis (Swaggerty 
et al., 2003). Commercial lines and their reciprocal crosses were evaluated based on 
heterophil degranulation, phagocytosis and oxidative burst responses when 
challenged with Salmonella. The results showed that the ability of heterophils to 
efficiently react to infection is genetically transferred to the progeny. A study on 
systemic infection with S. Enteritidis administered into the abdomen of day-old 
chickens from the parental line and reciprocal crosses showed heterophil influx to 
the site of infection to be much higher in the resistant line and the progeny 
compared to susceptible line (Swaggerty et al., 2005). These studies were 
supplemented with experiments on mRNA gene expression after stimulation with S. 
Enteritidis in the same commercial lines and their reciprocal crosses (Ferro et al., 
2004; Swaggerty et al., 2004). The upregulation of pro-inflammatory cytokines was 
observed in heterophils isolated from the resistant chickens and their F1 progeny. 
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Similar responses in more resistant lines were observed when birds were 
challenged with the Gram-positive bacterium Enterococcus (Swaggerty et al., 2005).  
Swaggerty et al. (2008) continued the evaluation of commercial broiler line 
immune responses where mRNA expression of pro-inflammatory cytokines and 
chemokines from sires and generated progeny were assessed. The RNA from 
peripheral blood leukocytes (PBL) was used in quantitative PCR reactions where 
expression of IL-1β, IL-6, CXCLi2 and CCLi2 was tested. Gene expression profiles of 
pro-inflammatory cytokines and chemokines in leukocytes from high expression 
sires led to higher expression of the selected genes in generated progeny. In 
addition, the results showed that progeny from sires characterised with low gene 
expression had also lower immune performance. The highest values of gene 
expression from those birds were much lower compared to the lowest values from 
high expression sires progeny. This approach allowed for identification of sires with 
higher/lower than average expression of proinflammatory cytokines and 
chemokines. The progeny produced from the selected sires carried similar immune 
responsiveness without losing the desired growth qualities.  
The same lines, parental and F1 reciprocal crosses were challenged with 
Campylobacter jejuni and evaluation of cloacal swabs revealed that again, resistant 
lines and their sires progeny had significantly fewer C. jejuni colonies. These results 
indicated that paternal effects influenced the resistance to bacterial colonisation (Li 
et al., 2008c). The continuation of testing commercial lines and their F1 crosses 
confirmed that resistant lines and paternal progeny managed to enhance the 
responses to coccidial infections accompanied by higher gain weight (Swaggerty et 
al., 2011; Swaggerty et al., 2015), proving that the efficient innate responsiveness 
guards against not only bacteria but broader range of pathogens, including 
parasites. Transcriptome analysis of splenic gene expression in parental lines 
challenged with Campylobacter revealed differences in molecular regulations during 
infection. Moreover, different defence mechanisms were involved in the 
Campylobacter resistant line where genes involved in apoptosis and cytochrome c 
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release from mitochondria were activated compared to susceptible line (Li et al., 
2012). 
Schokker et al. (2012) studied immune responses of three commercial broiler 
lines after infection of newly hatched birds with S. Enteritidis. The results showed 
that different lines differed in their response to systemic spread of bacteria possibly 
due to variation in intestinal development. Another study on responses to S. 
Enteritidis in broiler, layer and Fayoumi lines showed differences in mRNA gene 
expression in the spleen which suggest that divergent genetic lines use different 
components of immune responses in the response to Salmonella infection (Coble et 
al., 2011). Redmond et al. (2009), obtained similar results with a Fayoumi native line 
showing higher expression of selected innate immunity-related genes in heterophils 
stimulated with S. Enteritidis. Wang et al., (2014) performed RNA-seq analysis on 
lungs from Leghorn and Fayoumi chickens samples and showed the latter to be 
more resistant to AIV infection with haemoglobin family genes playing a pivotal 
protective role. The studies where immune responses of indigenous Fayoumi 
chickens were compared to those of commercial broilers and layers show that 
native lines, without genetic selection, may provide biodiversity to improve 
breeding programmes for the innate immunity in commercial birds. 
 Transcriptomics tools for immune gene expression analysis 1.5
Gene expression triggered by infection is a trait that can be measured in both 
in vitro and in vivo studies on varied tissues and cells in the organism. This approach 
leads to understanding the regulation of genes and pathways during the disease 
and the discovery of biomarkers. To study gene expression, transcriptomics 
methods need to be applied. The transcriptome comprises the complete set of 
transcripts in a cell. Transcriptome profiles in response to biological stimuli, i.e. 
pathogen invasion, provide data to interpret functional elements of the genome 
and understand disease processes (Wang et al., 2011). The transcription process is 
the first step of gene expression. Not every transcript will be translated into 
functioning protein, therefore gene expression cannot be interpreted as 
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corresponding protein levels. In chicken studies, where availability of tools and 
reagents lags behind the mammalian field, experiments with the use of 
transcriptomics methods offer relatively inexpensive way to identify eQTL and 
biomarkers for selection.  
 Microarrays 1.5.1
Microarrays have been used as a genomic tool since 1990 and rapidly 
became the platform of choice in transcriptomics studies in model organisms, 
including the chicken. The principle is based on comparison of transcript levels 
between two samples. Data are generated based on the cDNA reverse transcribed 
from the purified mRNA transcriptome of a sample (Murphy, 2002). The cDNA 
generated from test and control samples are separately labelled with different 
fluorescent dyes and hybridised to an array containing DNA probes for different 
genes. The intensity of the fluorescent signal resulting from hybridisation to a 
specific probe depends on the amount of hybridised cDNA from a given sample, and 
in turn reflects the abundance of the transcript from which it was reverse 
transcribed. The differences in the signals from both samples are analysed and 
interpreted as differential expression. This technology has been useful in many 
aspects of science, including potential biomarkers discovery or drug targets .  More 
than a dozen microarrays, either cDNA- or oligonucleotide-based have been 
developed for chicken gene expression (reviewed in Cogburn et al., 2003).  
A commercial microarray for analysis of the chicken transcriptome with 44k 
probes (Li et al., 2008a) is available from Agilent (http://www.genomicS. 
agilent.com). This new whole genome microarray was designed based on the 2004 
chicken (Gallus gallus) v1.0 draft assembly and it has been widely used to measure 
mRNA levels. For example, Chiang et al. (2008) used this technique to profile 
differential gene expression in heterophils from two genetically distinct lines 
infected with Salmonella Enteritidis. It has been recently used to evaluate gene 
expression in liver of S. Enteritidis infected broilers (Coble et al., 2013) and in 
leukocytes from APEC infected broilers (Sandford et al., 2012). Other chicken arrays 
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were customised for measurement of gene expression in specific cell types (Bliss et 
al., 2005) or gene sets (Smith et al., 2006). The global view of gene expression 
produced by microarrays can identify candidate genes or pathways that are 
associated with differences in phenotype between the test and control systems (or 
animal lines) studied. As the probe set on the microarray is set for known cDNA 
sequences, this technology does not allow the detection of novel transcripts or 
sequence variants (Mortazavi et al., 2008). 
 RNA sequencing 1.5.2
An alternative to microarrays is the use of next generation sequencing of 
cDNA derived by reverse transcription from mRNA (also termed RNA-seq). In this 
technique, the RNA population is converted to a library of cDNA fragments with 
adaptors attached to one or both ends. After amplification, each molecule is 
subjected to massively-parallel sequencing to obtain short sequences of 30-400 bp. 
The reads of sequenced fragments are then aligned to a reference genome (Wang 
et al., 2009). This identifies the transcripts present, whereas the abundance of the 
sequence reads for a specific gene reflect the relative abundance of the transcript in 
the sample. The microarray approach is still preeminent for large numbers of 
samples in regard of costs, but RNA-seq techniques have the advantage that no 
assumptions are made as to which genes are likely to be transcribed. In addition, 
RNA-seq is more sensitive due to its massively-parallel ‘deep sequencing’ nature 
and it is more accurate because the quantification is based on digital counts of the 
sequence reads corresponding to each transcript. RNA-seq is competing to replace 
microarrays for analysing the transcriptome in an unbiased and comprehensive 
manner (Wang et al., 2011). The ability to measure allele-specific expression (ASE) 
in heterozygotes using RNA-seq is advantageous over microarrays technique in 
which the same probe set targets both alleles (Sun, 2012). RNA-seq also provides 
tools for the discovery of new un-annotated genes of interest (Dodgson et al., 
2011).  
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The advantages of RNA-seq over microarrays have advanced progress of 
transcriptomics field producing great amount of data. Since 2008, when RNA-seq 
technology became available, more than a thousand research articles on gene 
expression were published in the PubMed database, including chicken studies .  This 
includes published work on necrotic enteritis (NE) and differential gene expression 
(DEG) in inbred lines (Truong et al., 2015), AIV infection in Fayoumi and leghorn 
lines (Wang et al., 2014), and caecal tissues responses to Campylobacter jejuni 
(Connell et al., 2012). 
 Quantitative polymerase chain reaction (qPCR) 1.5.3
In addition to high-throughput transcriptome analysis tools, quantitative 
PCR (qPCR) has been used for more than two decades to quantify transcription of 
specific genes. It is a technique where amplification and simultaneous quantification 
of targeted DNA molecules is possible. Transcripts are first reverse transcribed to 
cDNA, for example using oligo dT targeting polyA tails and random hexamers. The 
abundance of cDNAs is assumed to mirror that of template transcripts. Specific 
cDNAs can then be detected in PCR reactions using primers that anneal to the 
target sequence. Two main approaches exist to detect amplification. The first uses a 
labelled nucleotide that is incorporated into the cDNA, thus the amount of labelled 
product reflects the abundance of the target transcript. The second uses a probe 
that hybridises to the target cDNA between the primer annealing sites and which 
has a 5’ fluorophore and 3’ quencher. During PCR with flanking primers, the 
fluorophore is removed by the 5’-3’ exonuclease activity of advancing polymerase. 
The quencher no longer inhibits fluorescence of the released fluorophore and the 
fluorescence intensity proportional to the amount of product made in exponential 
phase of PCR (threshold value). Comparison of number of amplification cycles that 
reached particular quantification threshold fluorescence signal allows the initial 
amounts of cDNA template to be quantified. Therefore, fewer PCR cycles are 
needed for the detection if more copies of cDNA molecules are present at the 
beginning of the reaction. Compared to previously described transcriptome 
platforms, qPCR is useful in studies where gene expression of only a subset of 
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transcripts of interest is evaluated during infection or stimulation. This type of 
targeted expression is beneficial when genes involved are known to be responsible 
for different outcomes and it has been widely used in chicken immune responses 
studies (Kaiser et al., 2006; Abasht et al., 2009; He et al., 2012). QPCR analysis does 
not involve complex bioinformatics analysis of the output and is considered straight 
forward relative to RNA-seq. After the cautious selection of primers and 
optimisation of reaction, qPCR delivers results within hours.   
In recent years, emphasis has been placed on selection of reference genes 
for qPCR to permit comparison between samples that may differ in composition and 
integrity. The lack of consensus in reagents, protocols and analysis methods used 
for qPCR, and the high-profile retractions of manuscripts, for example from Science 
(Bohlenius et al., 2007), have forced qPCR experts to provide guidelines for authors, 
reviewers and editors with specification for the minimum information that must be 
included in the manuscript methods. As discussed in Chapter 5, the selection of 
reference genes needs to be more stringent and properly normalised before their 
use in qPCR reactions (Bustin et al., 2009).  
 The BioMark System 1.5.4
The BioMark system from Fluidigm is a platform to run multiple qPCR 
reactions against multiple RNA samples at once. It relies on microfluidics to perform 
qPCR reactions on a nanolitre scale and was made possible by advances in micro- 
and nanofabrication. There are four high-throughput qPCR platforms that use 
microfluidics currently on the market: the BioMark system, the OpenArray from Life 
Technologies, the LightCyclerTM 1536 from Roche and SmartchipTM from 
Wafergen, that allow for parallel gene expression analysis. Only the BioMark System 
is relevant for this project, therefore other platforms will not be discussed here. The 
Dynamic Array Integrated Fluid Controller is a microfluidic chip for the BioMark 
system that allows for amplification of single molecule in the microfluidics chip that 
consists of matrixes of chambers and valves (Figure 1.3). The dynamic array chip 
exists in two formats: 48.48 and 96.96. The 48 (or 96) samples are simultaneously 
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used in qPCR with 48 (or 96) assays which results in 2,304 (or 9,216) reactions from 
one run. The use of a dynamic array greatly reduces the volume of reagents and 
pipetting and is a reliable and rapid method for high-throughput gene expression 





Figure 1.3. Structure of 96.96 Dynamic Array IFC for gene expression. a) 96 assays and 96 samples 
with qPCR master mix are loaded in different dimensions. The IFC controller mix both samples and 
assays in 9,216 contained chambers, each with volume of 6,7 nl; b) The mixing of assays and samples 
is possible with the use of network of control lines and fluid lines that transfer liquids into the 
reaction chambers where qPCR reaction occurs. 
The statistical power of an experiment increases when in a single run greater 
number of replicated reactions can be performed (Weaver et al., 2010). Therefore, 
from biomarker screening perspective, high-throughput qPCR is beneficial with 
additional sensitivity, reproducibility and possible detection of very low abundant 
targets.   




 Aims and objectives 1.6
For decades, breeding selection has focused on overall livability and 
phenotypic traits, such as weight gain and feed conversion efficiency, rather than 
targeting the immune system directly. The widespread use of vaccines and 
antibiotics has meant that relatively little emphasis has been placed on selection for 
disease resistance. A danger exists that breeding for resistance to particular 
pathogen may increase susceptibility to other pathogens. In this context, selection 
for birds with elevated innate immune function is desirable given the non-specific 
nature of the response. Selection of lines with improved immune robustness could 
solve the problems of greater variation of pathogens and emergence of new 
resistant strains and reduce the need for antibiotic use. 
The overarching hypothesis for this study is that disease resistant birds are 
inherently primed to produce a stronger innate immune response, and hence 
control invading pathogens better by killing and mounting stronger adaptive 
immune response. This hypothesis is supported by previous studies, which showed 
that effector cell function and pro-inflammatory gene expression was stronger and 
more rapid in resistant lines compared to susceptible lines. I therefore aimed to: 
1. Evaluate existing cellular and molecular assays as tools for swift and 
accurate determination of immune robustness in the chicken, with emphasis on 
analysis of heterophil, macrophage and dendritic cell phenotypes.  
2. Generate a list consisting of approximately 100 genes of interest that are 
involved in immune responses to a plethora of infections caused by bacteria and 
bacterial components, viruses and parasites.  The gene list will be created based on 
published challenge studies in chicken and mammalian species as well as an RNA-
seq analysis of chicken effector cells (bone marrow-derived dendritic cells (BMDC), 
bone marrow-derived macrophages (BMDM) and heterophils) stimulated with 
lipopolysaccharide (LPS). For novel genes identified by this approach I aimed to 
clone and sequence the genes to aid the design of assays of gene expression. 
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3. Select a platform for gene expression analysis, optimise and validate it 
with the use of an Aviagen broiler line housed in low biosecurity, resembling 
commercial settings (sibling test farm) and high biosecurity (pedigree farm) 
environments. Primers will be designed for selected genes and used in high-
throughput qPCR reactions with tissues and blood RNA as template.  
The ultimate goal was to evaluate if peripheral leukocytes isolated from 
blood could be used to detect changes in the level of immune robustness between 
chickens raised in different environments and within the same farm.  
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 Materials and Methods Chapter 2
 In silico materials 2.1
 Basic Local Alignment Search Tool (BLAST) 2.1.1
 Sequences of all cloned DNA fragments ,presented in Chapter 4, were 
compared with the chicken genome database (Gallus_gallus-4.0) using BLAST 
software. This heuristic algorithm finds similar sequences by locating short matches 
between the query and target sequence. This method allows observed and 
expected sequences to be compared and can identify single nucleotide changes or 
insertion/deletion events (Altschul et al., 1990).  
 ClustalX 2.1 2.1.2
 ClustalX is a general purpose multiple sequence alignment tool for DNA or 
proteins. Differences, similarities and identities can be visualised after the best 
matches are calculated and lined up for the selected sequences. ClustalX uses 
colour coding where the darkest shading indicates highest conservation (Larkin et 
al., 2007). 
 GeneDoc 2.1.3
GeneDoc provides tools for visualising multiple alignments of nucleic acid 
sequences. GeneDoc displays sequence alignments with different shading modes, 
that depend on the level of conservation between observed and expected 
sequences (Nicholas et al., 1997). Both, ClustalX and GeneDoc were used to present 
alignments of cloned genes (Appendix 2, electronic file). 
 Bowtie 1.0.0 2.1.4
Bowtie software was used in RNA-seq analysis pipeline (Appendix 1, Figure 
1). Bowtie is an ultrafast short-read aligner that employs a Burrows-Wheeler index 
and full-text minute-space (FM) index. Reverse permutation of the characters in 
text, as in the Burrows-Wheeler algorithm, is applied in Bowtie to allow large data 
of text to be searched efficiently while keeping the memory footprint small. FM 
index is the exact-matching algorithm and Bowtie uses two extensions to match the 
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sequencing errors or genetic variations. Bowtie input data can be in FASTQ and 
FASTA formats. Bowtie forms the basis for other tools, including TopHat and 
Cufflinks (Langmead et al., 2009). 
 TopHat 2.0.9 2.1.5
 TopHat is a script that aligns RNA-Seq reads to a genome in order to identify 
exon-exon splice junctions. Bowtie cannot align reads that span introns. TopHat was 
created to address this issue of large gaps in alignments. It uses Bowtie as an 
alignment tool and breaks up reads into smaller pieces called segments. Many of 
these segments align contiguously which results in build-up of an index of splice 
junctions (Trapnell et al., 2009). 
 Cufflinks 2.1.1 2.1.6
 Cufflinks uses output data from TopHat to assemble aligned RNA-seq reads 
into transcripts. Multiple splice variants may be present for a given gene, therefore 
to overcome this issue Cufflinks reports a parsimonious transcriptome assembly of 
the data. Only few full-length transcripts fragments (transfrags) are defined by 
Cufflinks to sufficiently explain all the splicing event outcomes in the input data. To 
derive a likelihood of abundance levels and filter out artificial transfrags Cufflinks 
uses a statistical model of paired-end sequencing experiments. The software then 
computes the overall likelihood by multiplying these probabilities. The outcome of 
properly normalised RNA-seq fragment counts can be used as a measure of relative 
abundance of transcripts. Cufflinks uses Fragments per Kilobase of exon per Million 
fragments mapped (FPKM) to present expression of each transcript. Cufflinks 
contains a program (Cuffcompare) that can support comparison of assembled 
transfrags and reference annotation. Cufflinks also includes a script called 
Cuffmerge that allows merging of several Cufflinks assemblies. Differential 
expression of transcripts can be verified using Cuffdiff 2 that tests the observed log-
fold change in gene expression against the null hypothesis of no change. Cuffdiff 2 
predicts how much variance is in the number of reads originating from a gene or 
transcript. It is completed in the form of a table that is keyed by the average reads 
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across replicates. The table is queried to retrieve the variance from the number of 
reads. By simulating assignment to a locus and to the splice isoforms for that locus, 
Cuffdiff 2 accounts for probable errors in gene mapping. At the end of the 
estimation procedure, Cuffdiff 2 obtains an estimate of the number of reads that 
originated from each gene and transcript, along with variances in those estimates. 
The read counts are reported along with FPKM values and their variances. Change in 
expression is reported as the log fold change in FPKM, and the FPKM variances 
allow the program to estimate the variance in the log-fold-change itself. Genes with 
highly variable expression will have highly variable log-fold change between two 
conditions (Trapnell et al., 2010). 
 BestKeeper software 2.1.7
 BestKeeper is an Excel-based programme that is used to compare expression 
levels of reference genes and target genes in up to one hundred biological samples. 
BestKeeper input data is in form of raw Cq values which are plotted in an Excel 
table. Pairwise correlation analysis and the geometric mean determine the ‘optimal’ 
reference genes (Pfaffl et al., 2004). The BestKeeper software was used in Chapter 5 
to select most stable gene. 
 NormFinder 2.1.8
 NormFinder is an algorithm for identifying the optimal reference gene 
among a set of candidates. It ranks a set of genes according to their expression 
stability in a given sample. The software uses a model-based approach of gene 
expression and statistical framework to estimate variation in overall expression and 
variations between subgroups. NormFinder automatically calculates the stability 
value for all candidate genes (Andersen et al., 2004). The Normfinder software was 
used in Chapter 5 to select most stable genes. 
 geNorm 2.1.9
 GeNorm is an algorithm that determine the most stable reference genes 
from a set of tested candidate genes in a given sample panel. A gene expression 
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normalisation factor can be calculated for each sample based on the geometric 
mean of a user–defined number of reference genes. Pairwise variation of each gene 
is determined as standard deviation of the logarithmically transformed expression 
ratios. An M value is calculated for a particular gene as the arithmetic mean of 
pairwise variation with all other genes in the same panel. Genes that are stably 
expressed are characterised by the lowest M value. Stepwise exclusion of the least 
stable genes results in combination of two constitutively expressed reference genes 
(Vandesompele et al., 2001). The geNorm software was used in Chapter 5 to select 
most stable genes. 
 Molecular cloning 2.2
 E. coli JM109 competent cells 2.2.1
 E. coli JM109 strain {endA1, recA1, gyrA96, thi, hsdR17 (rk–, mk+), relA1, 
supE44, Δ(lac-proAB), [F´, traD36, proAB, lacIqZΔM15]} has a mutation in the recA 
gene to improve plasmid stability and reduce scope for unwanted recombination 
events. The JM109 strain also carries the endA1 mutation that inactivates a 
nuclease that might co-purify with plasmids. This mutation allows purification of 
higher quality plasmids. JM109 bacterial cells are classified as an E. coli K strain 
based on the presence of the restriction and modification system that functions 
around EcoK I. JM109 cells carry the hsdR17 (rκ-, mκ+) mutation that inactivates the 
EcoK I restriction enzyme but leaves the methylase intact. Therefore, this strain 
does not degrade plasmid DNA isolated from K strains but does methylate it.  
 pGEM-T Easy  2.2.2
pGEM-T Easy is a 3015 bp linear vector used for cloning of PCR products 
(Figure 2.1). The plasmid contains a single thymidine extension at the 3’-ends that 
are complementary to the non-template-derived 3’-adenosine residues that are 
added to double-stranded DNA products by Taq DNA polymerase. The 3’-end 
thymidine also prevents the vector from recircularisation during ligation. This high-
copy-number vector contains T7 and SP6 RNA polymerase promoters flanking a 
multiple cloning site located within a truncated lacZ gene that encodes the α-
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peptide coding region of the enzyme β-galactosidase. The host E. coli strain carries a 
partial lacZ deletion (lacZΔM15) which encodes the ω-peptide. Neither, α- or ω-
peptide is functional by itself. Transformation of plasmid containing lacZ α sequence 
into the lacZΔM15 cells causes the formation of functional β-galactosidase enzyme. 
A molecular mimic of allolactose - Isopropyl β-D-1-thiogalactopyranoside (IPTG) is 
added to the agar to induce the lac promoter that drives α-peptide synthesis. The 
presence of a functional β-galactosidase is detected by galactose linked to a 
substitute indole, called X-gal (5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside) 
added to the agar. X-gal is cleaved by β-galactosidase to formo 5-bromo-4-chloro-
indoxyl, that spontaneously forms the insoluble pigment 5,5’-dibromo-4,4’-dichloro-
indigo resulting in blue colour in cells containing functional enzyme. The process of 
rescuing function of β-galactosidase by the α-peptide, called α-complementation, is 
used in the blue/white screening method. White colour of JM109 colonies 
transformed by pGEM-T recombinants indicate that formation of an active β-
galactosidase was disrupted by the insertion of a gene of interest into lacZα.  
 
Figure 2.1. Map of pGEM-T EASY vector 
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 Cell cultures 2.3
 Resurrection and passage of COS-7 cells. 2.3.1
COS-7 cells were used to produce of recombinant chicken proteins, which 
were used to generate bone marrow-derived cells, as presented in Chapter 3. COS-7 
[CV-1 (simian) in Origin, carrying the SV40 genetic material] is a fibroblast-like cell 
line derived from African Green Monkey Cercopithecus aethiops. COS-7 cells were 
removed from liquid nitrogen storage and defrosted in a water-bath at 37°C. 
Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented with 10% (v/v) heat-
inactivated foetal calf serum (FCS), 200 mM L-glutamine, 100X non-essential amino 
acids, 1 U/ml of penicillin and 1 µg/ml of streptomycin was used to resuspend the 
cells. After washing and pelleting cells at 1,200 x g for 5 min the supernatant was 
discarded, cells resuspended in 15 ml of complete DMEM in 75 cm2 culture flask 
(Thermo Scientific) and incubated at 37°C, 5% CO2. After 72 hours, cells were 70-
80% confluent and ready to passage. The cell layer was washed twice with pre-
warmed phosphate-buffered saline (PBS). To lift the cells from the flask 5 ml of PBS 
containing 10% (w/w) trypsin/versene solution was then added. After 5 min in 5% 
CO2, at 37°C the flask was tapped several times to detach any remaining cells from 
the surface and complete DMEM was added to quench the trypsin enzymatic 
activity. The cell suspension was pelleted at 1,200 x g for 5 min in a 30 ml Universal 
container. The supernatant was removed and cell pellet resuspended in 10 ml of 
complete DMEM. Cell number was determined using a haemocytometer and trypan 
blue, for exclusion of dead cells. Cells were seeded at 7.5 x 105 cells/ml in 75 cm2 
culture flasks. All cell culture reagents were sourced from Sigma-Aldrich Ltd (Dorset, 
UK). 
 Transfecting cells with plasmid DNA 2.4
 DEAE-dextran transient transfection method for COS-7 cells 2.4.1
Transfection mediated by diethylaminoethyl (DEAE)-dextran works very 
efficiently with the COS-7 cell line. Negatively charged plasmid DNA complexes with 
positively charged DEAE-dextran to create aggregates, which then bind to 
negatively charged surface structures on cell membranes and uptake via 
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endocytosis occurs. Addition of chloroquine prevents endosome acidification and 
inhibits lysosomal degradation of the DNA.  
 COS-7 cells were passaged and seeded in complete DMEM media at 2 x 106 
cells/ml in 25 cm2 flasks. After twenty-four hours DMEM media were replaced by 
serum-free media containing chloroquine (0.1 μM), plasmid DNA (37.5 μg), DEAE-
dextran (30 µg/ml) and cultures were incubated for 3.5 hours at 37°C, 5% CO2. After 
incubation, cells were treated with dimethyl sulphoxide (DMSO) (10% (v/v) in PBS) 
for 2 min to enhance uptake of adsorbed plasmid DNA by increasing the 
permeability of cell membranes. DMSO solution was replaced with complete DMEM 
media and cells were incubated for further a 24 hours at 37°C, 5% CO2. Complete 
media was replaced with serum-free media and recombinant protein-containing 
supernatant was harvested after 72 hours. To remove any cell debris the 
supernatant was centrifuged at 1,200 x g and then stored at 4°C until needed.  
 Production of recombinant chicken IL-4, GM-CSF and CSF-1 2.4.2
Recombinant chicken IL-4, GM-CSF (CSF-2) and CSF-1 proteins were produced 
in the COS-7 transient expression system described in section 2.4.1 for generation 
of bone marrow-derived dendritic cells and macrophages. Plasmids containing CSF-
1, IL-4 and GM-CSF inserts were available in E. coli strains as glycerol stocks. To 
reach a single colony bacterial glycerol stocks were streaked out on LB agar plates 
containing 100 μg/ml of ampicillin (LBAMP100) and incubated overnight in 37°C. Single 
colonies were placed in 5 ml of LBAMP100 Broth and incubated at 37°C, 200 rpm for 
24 hours. LBAMP100 Broth, in volume of 250 ml, was used to subculture bacteria (2.5 
ml) for an additional 18 hours in 37°C, 200 rpm. Bacterial suspensions were 
centrifuged at 3,000 x g for 30 min and pellets were used in a modified plasmid 
extraction protocol (EndoFree Plasmid Maxi Prep, Qiagen; section 2.8.2). 
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 Primary cell experiments 2.5
 Generation of bone marrow-derived dendritic cells (BMDC) and 2.5.1
bone marrow-derived macrophages (BMDM) 
All the animals used in the work reported in this thesis were handled and 
killed in accordance with the Animals (Scientific Procedures) Act 1986. The chickens 
used in the following experiments were Brown Leghorn-J line birds housed by the 
National Avian Research Facility at The Roslin Institute.  
Immediately after death by cervical dislocation, both femurs and tibias were 
removed aseptically from 4-6 week old birds and placed in phosphate-buffered 
saline (PBS) on ice until further use. Using sterile scissors both ends of each bone 
were cut off. Bone marrow was flushed from the bone using a 0.8 x 40 mm 
diameter needle (21G x 1.5 Terumo) and syringe with 10 ml of PBS. Cells 
suspensions were passaged through 70 μm nylon mesh strainers (Fisher Scientific) 
into 50 ml Falcon tubes. Cells were pelleted at 500 x g for 10 min at room 
temperature and resuspended in 10 ml of PBS. Histopaque 1.077 was used to 
separate mononuclear cells (MNCs) by underlying the bone marrow cell suspension 
and centrifugation at 1,200 x g for 20 min with the brake switched off. The enriched 
MNC fraction between the plasma and Histopaque layers was carefully removed by 
aspiration with a Pasteur pipette and placed in 30 ml Universal tube. Cell 
suspensions were washed in PBS by centrifugation at 500 x g for 10 min at 4°C. Cell 
pellets were resuspended in 10 ml of pre-warmed Roswell Park Memorial Institute 
(RPMI) 1640 medium. Cell viability was assessed by Trypan blue staining and live 
cells were counted and adjusted to 1 x 106 cells/ml concentration in RPMI medium 
supplemented with 10% (v/v) chicken serum (CS) (in BMDC cultures) or 2% (v/v) CS 
+ 3% (v/v) foetal calf serum (FCS) (in BMDM), 200 mM L-glutamine, 1U/ml of 
penicillin and 1 μg/ml of streptomycin. To culture BMDC, cells were placed in 6-well 
plates (Thermo Scientific) in a volume of 3 ml with appropriate dilutions of 
recombinant chIL-4 and (1/20) GM-CSF (1/20) (exCOS-7) and incubated at 41°C, 5% 
CO2. After two and four days of culture 75% of the medium was replaced with fresh 
complete RPMI with addition of chIL-4 and chGM-CSF. To culture BMDM cells 
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concentration was adjusted 1.5 x 107/ml in 15 ml complete media with appropriate 
CSF-1 dilutions, placed in square Petri dish and incubated at 41°C, 5% CO2. For 
BMDM culture in 6-well plates, the same concentrations were used as for BMDC. 
Complete medium with cytokines was replaced at day four of culture.  
 Optimising LPS concentrations for stimulating BMDC and BMDM 2.5.2
Primary bone marrow cell cultures were used to determine the 
concentration of lipopolysaccharide (LPS) (Escherichia coli 055:B5, Sigma Aldrich) to 
induce maturation of antigen-presenting cells (APCs). BMDC and BMDM were 
cultured in 6-well plates, as described in section 2.5.1. Stimulation of cells was 
performed on day 6 of culture with various amounts of LPS: 20, 200 and 250 ng/ml 
LPS (20 min, 1 h and 4 h) for BMDM or 20 ng/ml and 200 ng/ml LPS (4 h and 24 h) 
for BMDC. Cells were removed from wells by pipetting and pelleted for 5 min at 500 
x g. RLT buffer from RNeasy Mini Kit (QIAGEN) was used to lyse the cells. The lysate 
was stored at - 20°C until use. Total RNA was purified from each sample following 
the manufacturer’s protocol as described in section 2.6.1. The amount of LPS used 
in stimulation of heterophils was previously optimised (Farnell et al., 2003) and 
10 μg/ml for 1 h was used. LPS stimulated bone marrow-derived cells were used in 
Chapter 3 (evaluation of cellular methods) and in Chapter 4 (RNA-seq). 
 Isolation of heterophils from chicken blood 2.5.3
 Peripheral blood was collected by cervical dislocation and decapitation of 
day-old chickens from Hy-Line W36, Aviagen broilers or RI-J line into Spray-coated 
K2  ethylenediaminetetraacetic acid (EDTA) tubes (BD Diagnostics, USA). The blood 
from Novogen breed was collected from embryos at day 20 into Universal tubes 
containing 5 mM EDTA. Blood from approximately 100 chickens was pooled and 
mixed 1:1 with 1% (w/v) methylcellulose (Sigma Aldrich, Poole, UK), prepared in 
RPMI medium. The mix was centrifuged at 25 x g for 15 min at 4°C. The supernatant 
was carefully removed to a fresh 50 ml Falcon tube. Ca2+- and Mg2+-free Hanks 
balanced salt solution (HBSS, Sigma Aldrich) was added to the supernatant to a final 
volume of 50 ml. A discontinuous Histopaque gradient (Sigma Aldrich, specific 
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gravity 1.077/1.119) was prepared by adding 10 ml of Histopaque 1.077 to a Falcon 
tube and carefully under layering 15 ml of Histopaque 1.119. The supernatant (25 
ml) was then layered over the gradient solution and centrifuged at 250 x g for 1 h at 
room temperature. The mononuclear cells appeared between the plasma and 
gradient phases, whereas heterophils were suspended in the 1.119 gradient phase. 
Heterophils were collected into a new tube and mixed with RPMI to dilute the cell 
solution and centrifuged at 425 x g for 15 min at 4°C. The cell pellet was then 
resuspended in RPMI. Cells were counted, diluted to the desired concentration and 
stored on ice before use. The RNA isolated from heterophils (Novogen, Aviagen, RI-J 
lines) was used in RT-qPCR reactions, as described in Chapter 3. In addition, RI-J 
heterophils RNA was used in RNA-seq analysis, as described in Chapter 4. 
 Isolation of peripheral leukocytes from chicken blood 2.5.4
 Blood was collected from three-week-old male Aviagen broilers into tubes 
containing 5 mM EDTA. Peripheral blood leukocytes were separated from 1 ml of 
whole blood sample and red blood cells removed, as described above in section 
1.5.3. PBS was combined with blood to a total volume of 4 ml. A Histopaque 
1.077/1.119 (Sigma Aldrich, Dorset, UK) discontinuous gradient was prepared by 
underlying 4 ml of Histopaque 1.077 with 4 ml of Histopaque 1.119 in 15 ml Falcon 
tube and overlying 4 ml of blood/PBS mixture. The gradient mixture was centrifuged 
at 700 x g with brakes off for 30 min at room temperature. Cells were removed 
from plasma/1.077 Histopaque interface (mononuclear cells) and from the 
1.077/1.119 Histopaque interface (heterophils). Cells were combined and washed 
twice with an equal volume of PBS by centrifugation at 600 x g for 10 min at room 
temperature. Cells were counted and 107 cells/ml was pelleted and lysed with 
buffer RLT with β-mercaptoethanol for further total RNA extraction. The RNA from 
PBL was used in optimisation of 96.96 Dynamic Array, as decribed in Chapter 6. 
 Phagocytosis assay 2.5.5
Live Salmonella Enteritidis (SE, #97-11771 strain; 107 cells/ml) was 
suspended in normal chicken serum (CS) and opsonised for 30 min at 39°C on a 
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rotary shaker. Bacterial suspension was washed twice with Ca2+, Mg2+ - free HBSS 
and stored in 4°C until used. Heterophils from W36 Hy-Line were diluted to 5 x 106 
cells/ml. A combination of 2 ml of heterophils and 2 ml of SE was centrifuged in 
sterile conical tubes for 15 min at 1,500 x g at 4˚C. Heterophils with the SE 
suspension were then incubated at 39˚C, 5% CO2 for 1 h. The sample was 
submerged in an ice bath for 15 min to stop phagocytosis. Cells were washed with 
ice-cold RPMI and centrifuged for 15 min at 1,500 x g, 4˚C. The pellet was 
resuspended in 2 ml ice-cold gentamicin (100 μg/ml) and diluted in RPMI without 
phenol red. Cells were incubated for 1 h at 37˚C to kill extracellular bacteria and 
then centrifuged at 1,500 x g for 15 min, at 4˚C. The pellet was washed three times 
in ice-cold RPMI, for 15 min at 1,500 x g. Phagocytosis of SE by heterophils was 
evaluated microscopically. For each treatment group, five cytospin slides were 
prepared using 200 μl of cell suspension. Results were recorded as the phagocytosis 
index: PI = (number of heterophils that contain bacteria x the average number of 
bacteria per ingesting heterophil) x 100. Results are presented in Chapter 3. 
 Oxidative burst 2.5.6
Production of reactive oxygen species (ROS) by chicken heterophils during 
oxidative burst was measured by oxidation of 2’7’ dichlorofluorescein-diacetate 
(DCFH-DA) to fluorescent DCF. Chicken heterophils isolated from W36 Hy-Line (900 
μl; 1 x 107 cells/ml) were incubated with Salmonella Enteritidis (#97-11771 strain) 
(90 μl; 1 x 108 cfu/ml) and DCFH-DA (10 μg/ml) for 1 h at 37˚C. Phorbol A-myristate 
13-acetate (PMA) (2 μg/ml), a well-known agonist that activates protein kinase C 
(PKC) was used as a positive control. Aliquots of cell cultures (150 μl) were placed in 
a black 96-well CoStar flat-bottomed plate and the relative fluorescent units (RFUs) 
were measured at excitation wavelength 485 nm and emission wavelength 530 nm 
using a GENios Plus Fluorescence Microplate Reader (TECAN US Inc, Research 
Triangle Park, NC). Results are presented in Chapter 3. 
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 Degranulation assay 2.5.7
Degranulation was monitored by quantifying the levels of β-D-glucuronidase 
in culture medium following stimulation of heterophils with opsonised Salmonella 
Enteritidis (1 x 108 cfu/ml). The heterophils from W36 Hy-Line were adjusted to 1 x 
107 cells/ml and incubated with stimulants for 1 h, at 39˚C in a 5% CO2 incubator. 
The reaction was stopped by transferring the tubes containing the cells to an ice 
bath for 5-10 min. Cell suspensions were then centrifuged for 10 min at 250 x g, at 
4˚C. The supernatants were removed from each sample and used for the assay. 
Each sample (25 μl) was added to non-treated, black CoStar flat-bottomed ELISA 
plate and incubated with 50 μl of freshly prepared substrate buffer (10 mM 4-
methylumbelliferyl-β-D-glucoronide, 0.1% Triton X-100 in 0.1 M sodium acetate 
buffer) for 4 h at 41˚C. The reaction was stopped by adding 200 μl of stop solution 
(0.05 M glycine and 5 mM EDTA; pH 10.4). Liberated 4-methylumbelliferone was 
measured fluorimetrically (excitation wavelength of 355 nm, emission wavelength 
of 460 nm) with a GENios Plus Fluorescence Microplate Reader (TECAN US Inc, 
Research Triangle Park, NC). Results are presented in Chapter 3. 
 Purification of nucleic acids  2.6
 Purifying total RNA from chicken cells 2.6.1
Total RNA from cells (BMDC, BMDM, PBL, heterophils) was extracted using 
the Qiagen RNeasy Mini Kit following the manufacturer’s instructions. The cell 
lysate was mixed by pipetting with one volume of 70% (v/v) ethanol. The mix was 
placed in an RNeasy spin column housed in 2 ml collection tube and centrifuged for 
15 s at 8,000 x g. The flow-through was discarded and 700 μl of RW1 buffer was 
used once to wash RNA bound to the silica membrane for 15 s at 8,000 x g and RPE 
buffer, diluted in absolute ethanol, was used twice (15 s and 2 min) at 8,000 x g. 
After washing steps, the RNeasy column was placed in a new collection tube and 
centrifuged at 16,000 x g for 1 min to remove any RPE buffer residues. Columns 
were moved to 1.5 ml collection tubes, 30 μl of RNase-free water was placed onto 
the membranes and centrifuged for 1 min at 8,000 x g. The eluate was re-applied to 
the silica membrane and centrifugation repeated in order to increase the RNA yield. 
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 Purifying total RNA from chicken tissues  2.6.2
 Total RNA from chicken tissues (spleen, bursa, caecal tonsils, and ileum), for 
experiments in Chapter 5 and Chapter 6, was extracted using an RNeasy Mini Kit 
(Qiagen) according to manufacturer’s instructions. Tissues were stored in RNA later 
(Ambion) solution at 4°C. Stabilised tissues were removed from the reagent using 
sterile forceps. No more than 30 mg of tissues was used for RNA extraction. 
FastPrepTM Lysing Matrix tubes containing ~30 mg of tissues were filled with 600 μl 
of RLT buffer. To disrupt and homogenize tissues the FastPrep® FP120 Cell Disrupter 
was used. Each sample was homogenized for 45 sec at speed of 6.5 m/sec. The 
lysate was centrifuged for 3 min at 16,000 x g to remove any remaining insoluble 
material. Cleared lysate was mixed by pipetting with 1 volume of 70% (v/v) ethanol. 
The mix was placed in an RNeasy spin column placed in a 2 ml collection tube and 
centrifuged for 15 sec at 8,000 x g. The flow-through was discarded and 350 μl of 
RW1 buffer was used once to wash RNA bound to the silica membrane for 15 sec at 
8,000 x g. DNase I stock solution was prepared by dissolving the lyophilised DNase I 
(1500 Kunitz units) in 550 μl of RNase-free water. The DNase I stock solution (10 μl) 
was mixed with buffer RDD (70 μl) and 80 μl of the mix was placed directly onto the 
column for 15 min at room temperature. After the incubation, an additional 350 μl 
of buffer RW1 was added and the column was centrifuged for 15 sec at 8,000 x g. 
RPE buffer, diluted in absolute ethanol, was used twice (15 sec and 2 min) at 8,000 x 
g. After washing steps, the RNeasy column was placed in a new collection tube and 
centrifuged at 16,000 x g for 1 min to remove any RPE buffer residues. Columns 
were moved to 1.5 collection tubes, 30 μl of RNase-free water was placed onto the 
membranes and centrifuged for 1 min at 8,000 x g. The eluate was re-applied to the 
silica membrane and centrifugation repeated in order to increase the RNA yield. 
 DNA and RNA amplification  2.7
 Oligonucleotide primer design 2.7.1
 Oligonucleotides for cDNA amplification were designed based on predicted 
sequences available from Ensembl (ensembl.org) or NCBI 
(http://www.ncbi.nlm.nih.gov/gene) databases. The design of primers for cloning of 
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full length sequences of target gene (Chapter 4) was performed manually by 
comparing candidate oligonucleotides melting temperatures and GC content in 
OligoAnalyzer 3.1 online tool 
(http://eu.idtdna.com/analyzer/applications/oligoanalyzer/default.aspx). 
 First-strand reverse transcription using SuperScript III 2.7.2
 Complementary DNA (cDNA) was used as a template in gene cloning 
experiments (Chapter 4). Various mRNA samples were used to generate cDNA 
panels using SuperScript III (Invitrogen) following the manufacturer’s instructions. 
First strand cDNA synthesis required mixing 10 pg - 5 μg total RNA, 1 μl of 
oligo(dT)20 (50 μM) and 1 μl of 10 mM dNTP Mix with 10 μl of sterile, distilled water. 
The mixture was incubated at 65°C for 5 min and then placed on ice for 1 min. Next, 
4 μl of 4X First-Strand Buffer, 1 μl of dithiothreitol (DTT) reducing agent, 1 μl of 
RNaseOUT (Promega) and 1 μl of SuperScript III reverse transcriptase were added. 
The final mixture was incubated at 50°C for 60 min. The reverse transcription 
reaction was inactivated by heating to 70°C for 15 min. Complementary DNA was 
ready to use and could be stored at -20°C.  
 To synthesise template cDNA for qPCR with EvaGreen fluorescent dye for 
experiments presented in Chapter 5 and Chapter 6, random primers (250 ng) were 
used instead of oligo(dT)20 which modified the second part of reaction. Additional 5 
min incubation at 25°C was performed before temperature increased to 55°C for 60 
min for the reverse transcription phase. Inactivation of enzymatic reaction was the 
same.  
 First strand reverse transcription using High Capacity Reverse 2.7.3
Transcription Kit 
The High Capacity Reverse Transcription Kit was used to generate cDNA for 
experiments described in Chapter 6. The reverse transcription kit (Applied 
Biosystems) contains reagents that when combined form a 2X reverse transcription 
(RT) master mix (Table 2.1).  
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Table 2.1 High Capacity Reverse Transcription Master Mix components 
Component Volume [μl] 
10X RT Buffer 1 
25X dNTP Mix (100 mM) 0.4 
10X RT Random Primers 1 
MultiScribe™ Reverse Transcriptase 0.5 
RNase Inhibitor 0.5 
Nuclease-free water 1.6 
Total 5 
 
The RNA sample was diluted to a concentration of 100 ng/μl and 5 μl of RNA was 
mixed with 5 μl of master mix. The sample was centrifuged briefly and placed in a 
thermocycler with set temperatures as follows: 25°C for 10 min, 37°C for 120 min 
and 85°C for 5 min. Complementary DNA (cDNA) was stored at -20°C until further 
use. 
 DNA amplification by PCR 2.7.4
Candidate gene cDNA sequences predicted to reflect transcripts were 
collected from both Ensembl and NCBI databases. Primers were designed using full -
length and/or common regions if there were differences in the predicted sequences 
between databases or transcripts. Gene list with transcripts accession numbers 
used to design primers is presented in Appendix 1, Table 4. If needed, more than 
one primer pair was designed and tested. For longer cDNAs, partial sequences were 
used to design primers. To clone full or partial sequences, a panel of c DNA was 
generated by reverse transcription PCR (RT-PCR) of separate RNA samples isolated 
from caecal tonsils and spleen from a Campylobacter trial, bursa from an infectious 
bursal disease virus (IBDV) trial, spleen from IBDV and Marek’s disease virus (MDV) 
trial, HD11 cells stimulated with LPS, heterophils stimulated with Salmonella 
enterica serovar Enteritidis, or BMDM, BMDC and heterophils stimulated with LPS. 
Polymerase chain reactions were performed in 20 μl and 50 μl volumes. For each 
reaction, the following components were added: 1X PCR buffer (-Mg), 0.2 mM of 
each dNTP, 1.5 mM of MgCl2, 0.5 μM of primers, 1U of Taq DNA Polymerase and 
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100 ng of template cDNA. All PCRs were performed using an MJ Thermal Cycler (MJ 
Research).  
Thermal cycling conditions (35 cycles): 
95°C for 5 min 
95°C for 30 sec 
X°C/ for 30 sec * 
72°C for 1 to 3.5 min ** 
72°C for 10 min 
*Annealing temperatures were dependent on the Tm of the each set of primers and ranged from 50-
69°C; **The length of the elongation steps was dependent on the size of the product. For every kb, 1 
min was added.  
 
For difficult to amplify regions touchdown PCR was designed with the following 
cycling conditions: 
95°C for 5 min 
95°C for 30 sec 
X°C/ for 30 sec * 
72°C for 1 to 3.5 min ** 
 
95°C for 30 sec 
X°C/ for 30 sec * 
72°C for 1 to 3.5 min ** 
 
95°C for 30 sec 
X°C/ for 30 sec * 
72°C for 1 to 3.5 min ** 
 
72°C for 10 min Final extension 
*Annealing temperatures were dependent on the Tm of the each set of primers and ranged from 50-
69°C. 
**The length of the elongation steps was dependent on the size of the product. For every kb, 1 min 
was added.  
 
 Quantitative PCR – hydrolysis probe-based gene expression 2.7.5
analysis 
Quantitative PCR (qPCR) is a dominant tool for the quantification of gene 
expression. Both hydrolysis probe(TaqMan)-based RT-qPCR and dye-based qPCR 
detection methods were used in this project to detect and measure very small 
amounts of nucleic acids in a range of chicken tissues and cells. In hydrolysis probe-
based RT-qPCR, normalisation using r28S ribosomal RNA as a reference was 





used in Chapter 3. For each gene, a primer pair and hydrolysis probe were designed 
based on the template target gene sequence using Primer Express software 
(Applied Biosystems). Primers were synthesised by Sigma Aldrich (Poole, UK) and 
probes by Eurogentec (Southampton, UK). The 5’ end of each probe was labelled 
with 5-carboxyfluorescein (FAM) fluorophore and the 3’ end with 
tetramethylrhodamine (TAMRA) quencher dye.  
Primer design was performed with consideration of general guidelines. The 
melting temperature of all primers was set between 58°C and 60°C, with probes 
being 10°C higher. Both probes and primers default length was no longer than 30 
nucleotides and GC content in the range of 30-80% where amplicon length did not 
exceed 150 bp. The last five nucleotides at the 3’ end of each primer consisted of ≤ 
3 guanines or cytosines and preferably no triplicates of the same base. At least one 
of the primers or the probe overlapped a predicted intron-exon boundary to 
increase specificity of reaction.  
The 5’-3’ exonuclease activity of Taq DNA polymerase is the driving force 
behind the RT-qPCR method. During the RT-qPCR the probe anneals to the target 
template. Fluorescence from the FAM moiety is quenched by the nearby TAMRA 
moiety at this stage. If Taq polymerase extends the 3’ end of primer annealed to the 
template it encounters the FAM fluorophore at the 5’ end of the probe uses its 5’-3’ 
exonuclease activity to displace the 5’ end and degrade the probe. Separation of the 
fluorophore and quencher at this stage results in emission of fluorescence. The 
temperature of probe hybridisation is usually set at 8-10°C above the melting point 
of the primers to ensure attachment to the template and extension is performed at 
a lower temperature than normal for PCR to guarantee maximum 5’-3’ exonuclease 
activity of the enzyme. These reaction conditions reduce Taq polymerase 
processivity, hence to ensure maximum efficiency short amplicons are designed. 
The number of cycles at which the fluorescence levels of the probe passes the 
background of detection is called quantification cycle (Cq) and this value is used to 
present the raw data. The set of primers used in RT-qPCR were previously 
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optimised: r28S rRNA, IL-1β, IL-6 (Kaiser et al., 2000); IL-18 (Kaiser et al., 2003); 
CXCLi1 and CXCLi2 (Kogut et al., 2005). All RT-qPCR reactions were performed using 
TaqMan FAST Universal PCR Master Mix and One-step RT-PCR MultiScribe (Applied 
Biosystems). For each sample 10 μl reaction mix consisting of 5 μl 2X Fast Master 
Mix, 0.5 μl of primer mix, 0.25 μl (125 nM) of probe, 0.25 μl 40X MultiScribe 
enzyme, 1.5 μl of DEPC treated-H2O and 2.5 μl of diluted RNA. RNA samples were 
diluted 1:500 for r28S rRNA analysis and 1:5 for target gene detection. All assays 
were performed in triplicate wells. For standard curve and slope analysis in r28S 
rRNA assay RNA from HD11 cells stimulated with LPS (200 ng/ml for 6 h) was used. 
In IL-1β, IL-6, IL-18, CXCLi2, RNA derived from transfected COS-7 cells was used. The 
Applied Biosystems 7500 Fast Real-Time PCR System was used to amplify and detect 
products. The thermal cycles were set for reverse transcription steps: 48°C for 30 
min, 95°C for 20 sec followed by PCR steps: 95°C for 3 sec, 60°C for 30 sec repeated 
for 40 cycles. Primer and probe sequences and concentrations for all target genes 
tested are given in Appendix 1, Table 2. To calculate levels of expression for all 
target genes standard curves were created using Cq values of the serially diluted 
standard RNA for specific gene. The slope of the standard curve (y = mx + c) was 
used to determine efficiency of the reaction using formula E = (10(-1/slope)). To correct 
for differences between RNA levels in samples within the experiment, the 
difference factor was calculated by dividing the mean Cq value for r28S rRNA 
specific product from the same sample. Normalised Cq values were calculated using 
the formula Cq + (N’t – C’q) * S/S’, where N’t is the mean Cq for r28S rRNA among 
all samples, C’q is the mean Cq for r28S rRNA in the sample and S and S’ are the 
slopes of the regressions of the standard plots for the cytokine/chemokine mRNA 
and the r28S rRNA, respectively. Results are expressed as fold-difference from levels 
in control samples.  
 Fluorescent dye-based qPCR 2.7.6
EvaGreen dye is a green fluorescent nucleic acid dye used in several 
applications including qPCR. Excitation and emission spectra of EvaGreen are very 
close to those of fluorescein (FAM) or SYBRGreen I, therefore EvaGreen is already 
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compatible with instruments equipped with visible light excitation with wavelengths 
in that region. The dye is nonfluorescent by itself, but becomes highly fluorescent 
upon binding to DNA. Compared to SYBRGreen, EvaGreen dye is non-mutagenic and 
non-toxic as it is impermeable to cell membranes. It is also less inhibitory towards 
qPCR and less likely to cause nonspecific amplification. Similarly to SYBRGreen, 
EvaGreen binds to double stranded DNA (dsDNA). With every PCR cycle the amount 
of dsDNA increases which results in fluorescence intensity. The Applied Biosystems 
7500 Fast Real-Time PCR System was used to amplify and detect products. The 
reaction mix was prepared using the following components for each of the samples: 
10 μl ABI TaqMan Gene Expression Master Mix (Applied Biosystems), 1 μl 20X 
EvaGreen (Biotum, VWR-Bie & Berntsen), 2.3 μl 20 μM specific primer pair (forward 
and reverse) and 4.7 μl nuclease-free water. Each reaction contained 2 μl of cDNA 
diluted 1:5 in nuclease-free water. The following cycle parameters were used: 2 min 
at 50°C, 10 min at 95°C, followed by 40 or 30 cycles with denaturing for 15 sec at 
95°C and by annealing/elongation for 1 min at 60°C. Melting curves were generated 
after each run to confirm a single PCR product (from 60°C to 95°C, increasing 1°C/3 
sec). The EvaGreen-based qPCR was used in reference gene normalisation 
experiments (Chapter 5) and in 96.96 Dynamic Array optimisation in Chapter 6, 
following the sample and assay mix preparation protocols as described in section 
2.10.6. 
 Agarose gel electrophoresis  2.7.7
To determine presence and size of DNA in PCR and qPCR, agarose gel 
electrophoresis was performed. Agarose gels were prepared by mixing agarose 
powder at a (w/v)%, which was dependent on the size of expected PCR product, 
with 1X Tris Acetate-EDTA (TAE) buffer. TAE is a mixture of 
tris(hydroxymethyl)aminomethane (tris base), glacial acetic acid and EDTA, that 
works to sequester divalent cations. Compared to TBE buffer, TAE is less stable but 
double-stranded DNA runs faster through agarose dissolved in TAE buffer. The mix 
was heated until the agarose powder dissolved completely. An intercalating dye, 
SYBR Safe® (Invitrogen), was added to the gel solution in order to visualise any DNA 
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molecules amplified by PCR. The molten agarose was poured into a plastic tray with 
appropriate comb sizes inserted. 
 Gel extraction 2.7.8
Agarose gel electrophoresis was used to detect and visualise products of 
PCRs. To extract products a QIAquick Gel Extraction Kit (QIAGEN) was used 
according to the manufacturer’s instructions, as follows. Agarose gel containing 
amplified DNA of interest was excised with a clean, sharp scalpel on a UV 
transilluminator. The gel slice was weighted in a 1.5 ml Eppendorf tube. QG buffer 
was added at 3 times the volume of the excised gel fragment (300 μl; QG buffer/100 
mg of gel) and incubated at 50°C for 10 min with frequent vortexing to liquefy it. 
The QG buffer contains a pH indicator allowing easy determination of the optimal 
pH for DNA binding. QG buffer of yellow colour indicated pH is <7.5 which is ideal 
for DNA adsorption. Sodium acetate (3 M, pH 5.0) was added to the sample when 
needed to adjust for the optimal pH. To increase the yield of DNA fragments <500 
bp, 1 volume of isopropanol was added to the mix. To bind DNA, the sample was 
placed in the QIAquick column with 2 ml collection tube and centrifuged at 10,000 x 
g for 1 min. The flow-through was discarded and an additional 500 μl of QG buffer 
was added to remove all traces of agarose and centrifuged for 1 min. The flow-
through was discarded and the silica membrane was washed by adding 750 μl of PE 
buffer to the column and centrifugation for 1 min. The flow-through was discarded 
and dry spin was applied to remove residual ethanol from PE buffer. The column 
was then placed in a clean 1.5 ml microcentrifuge tube. DNA was eluted by adding 
30 μl of EB buffer (10 mM Tris Cl, pH 8.5) to the centre of the column and incubated 
at room temperature for 1 min followed by centrifugation at 13,000 x g for 1 min. 
Samples were used immediately in ligation reactions. Remaining samples were 
stored at -20°C. 
 Ligation 2.7.9
Ligation is a process to create recombinant DNA molecules by joining DNA 
fragments together. The DNA ends are joined together by the formation of 
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phosphodiester bonds between the 3’-hydroxyl of one DNA terminus with the 5’-
phosphoryl of another. The ligation reaction buffer contains adenosine triphosphate 
(ATP), which is required as the energy source for T4 DNA ligase. This enzyme is 
derived from Enterobacteria phage T4 and its ability to repair nicks in double 
stranded DNA with 3’ OH and 5’ phosphate ends is used in connecting DNA 
fragments with plasmids. Cohesive end ligation was carried out at 16°C to maintain 
good balance between annealing of ends and activity of the enzyme. All ligation 
reactions were carried out using 2X ligation buffer (80 mM Tris HCl, 20 mM MgCl2, 
20 mM DTT, 2 mM ATP), pGEM-T Easy Vector, T4 DNA ligase (Promega) and 
nuclease-free water. 
 Transformation  2.7.10
Transformation was performed using high-efficiency chemically competent 
E. coli cells (≥ 1 x 108 cfu/μg DNA). Escherichia coli JM109 cells (Promega) were 
removed from -80°C storage and defrosted on ice for 5 min. A 50 μl aliquot of the 
cell suspension was added to 1.5 ml Eppendorf tube containing 2 μl of ligation 
reaction, mixed by gently flicking the tube and incubated on ice for 20 min. Sample 
was then heat-shocked for 50 s at 42°C and immediately placed on ice for additional 
2 min. The heat-shock approach creates small holes in the cell wall of the bacteria 
allowing the uptake of DNA. Super Optimal Broth media (SOB) was added in 950 μl 
volume and incubated for 1.5 h at 37°C with shaking (~180 rpm) to allow 
transformants to recover and express plasmid-encoded antibiotic resistance. Cells 
were pelleted by centrifugation for 10 min at 1,000 x g and resuspended in 200 μl of 
SOB media. LB agar containing 100 μg/ml ampicillin (LBAMP100), 100 μl isopropyl β-D-
1-thiogalactopyranoside (IPTG) and 20 μl X-gal (BCIG, 5-bromo-4-chloro-3-indolyl-β-
D-galactopyranoside) was used to plate out transformation reactions in duplicate 
(100 μl each). 
 Screening bacterial colonies by colony PCR 2.7.11
In colony PCR, gene-specific primers or plasmid-specific primers flanking the 
multiple cloning region (Appendix 1, Table 1) were used to examine for presence of 
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inserted DNA of expected size. Single white colonies were picked using a pipette tip 
and streaked in numbered areas of an LBAMP100 agar plate. The same pipette tip was 
used to inoculate 50 μl of dH2O for 1 min. The bacterial suspensions were then 
heat-shocked for 5 min at 95°C and centrifuged for 10 min at 9,000 x g. Supernatant 
was used as a template DNA in PCR. Amplicons were analysed by agarose gel 
electrophoresis. The streaked LBAMP100 agar plates were incubated for 24 h in 37°C. 
The positive colonies identified by colony PCR were used to inoculate 5 ml of 
LBAMP100 broth for 24 h in 37°C with shaking at 200 rpm for plasmid purification. 
 Plasmid DNA purification 2.8
 Small scale plasmid purification  2.8.1
To confirm cloning of genes (Chapter 4), recombinant pGEM-T Easy plasmids 
were sequenced. To prepare samples for sequencing, DNA from Escherichia coli 
pGEM-T Easy–containing cells was purified using QIAprep Spin Miniprep Kit 
(QIAGEN) as follows. After inoculation of LBAMP100 broth with a single colony of a 
putative recombinant the bacterial suspension was pelleted for 15 min at 3,000 x g. 
Supernatant was discarded and cells were resuspended in 250 μl of P1 buffer with 
added RNase A for sufficient digestion and LyseBlue as a colour indicator for visual 
identification of optimum buffer mixing. The sample was moved to a 1.5 ml 
Eppendorf tube and 250 μl of lysis buffer P2 was added. The solutions were mixed 
by inverting the tube 4-6 times without vortexing to avoid genomic DNA shearing. 
To neutralize the lysate and adjust to high-salt binding conditions, 350 μl of N3 
buffer was added and mixed by inverting the tube 4-6 times or until the solution 
became cloudy and without visible localised precipitation. The sample was then 
centrifuged for 10 min at 17,900 x g to pellet denatured proteins, chromosomal 
DNA and cellular debris. Supernatant containing smaller plasmid DNA was applied 
to the QIAprep spin column by pipetting and centrifuged for 1 min at 17,900 x g to 
capture DNA in the silica matrix. A brief wash step with 500 μl of PB buffer was 
performed to efficiently remove endonucleases and prevent plasmid DNA 
degradation. A second wash step using 750 μl of PE buffer was applied to remove 
salts. The flow-through was discarded and the column was centrifuged for an 
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additional 1 min to remove residual wash buffer, which could inhibit subsequent 
enzymatic reactions. The QIAprep column was placed in a clean 1.5 ml Eppendorf 
tube and 50 μl of elution buffer EB was added to the centre of the spin column for 
centrifugation for 1 min followed by 1 min, at 17,900 x g. The plasmid DNA yield 
was examined using NanoDrop™ 1000 Spectrophotometer. 
 Large scale endotoxin-free plasmid purification  2.8.2
To obtain a high yield of plasmid DNA for transfection and recombinant 
protein production an EndoFree Plasmid DNA Purification Maxi Kit was used 
according to the manufacturer’s instructions with minor modifications as follows. 
Previously sequenced plasmids containing genes of interest were stored as glycerol 
stock of bacterial cells (i.e. JM109, DH5α). Single colonies were used to inoculate 
5 ml of LBAMP100 broth and samples were incubated at 37°C with shaking at 200 rpm 
for 12 h. Larger volumes (250 ml) of LBAMP100 broth were inoculated with 2.5 ml of 
the bacterial starter culture and incubated for 24 h at 37°C with shaking at 200 rpm. 
Bacterial cells were pelleted in 50 ml Falcon tubes for 30 min at 2,465 x g. 
Supernatant was discarded and the pellet resuspended completely by vortexing in  
10 ml of P1 buffer containing RNase A and LyseBlue. To lyse the cells 10 ml of buffer 
P2 was added and mixed by inverting the tube 4-6 times. The lysate was incubated 
at room temperature for 5 min. During the incubation, a QIAfilter Cartridge was 
prepared by screwing the cap onto the outlet nozzle of the QIAfilter Maxi Cartridge 
and placing in a convenient tube. Precipitation was enhanced by adding 10 ml of 
chilled buffer P3 to the lysate and inverting the tube 4-6 times. Precipitated 
material (genomic DNA, proteins, cell debris) forms fluffy white material. The lysate 
was moved immediately into QIAfilter Cartridge and incubated at room 
temperature for 10 min. After this period, the precipitate floated and formed a 
layer on top of the solution. The outlet nozzle was opened on the QIAfilter Cartridge 
and a plunger inserted to filter the lysate into the 50 ml tube. The endotoxin 
removal (ER) buffer that prevents LPS molecules from binding to the resin in the 
QIAGEN tips was added in 2.5 ml volume to the filtered lysate and allows 
purification of DNA. The solution was incubated on ice for 30 min, when the 
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QIAGEN-tip 500 was being equilibrated by applying 10 ml of buffer QBT and 
allowing the column to be emptied by gravitational flow. After the incubation on ice 
the filtered lysate was applied to the QIAGEN-tip and allowed to enter the resin by 
gravity flow. The tip was washed twice with 30 ml of QC buffer. DNA was eluted 
using 15 ml of buffer QN and precipitated by addition of 10.5 ml of isopropanol. The 
solution was mixed and centrifuged immediately at 3,220 x g for 1 hour. 
Supernatant was carefully removed and the pellet was washed with 5 mL of 70% 
(v/v) ethanol and collected by centrifugation at 3,220 x g for 1 h, 4°C. Supernatant 
was carefully removed without disturbing the pellet. The DNA was left to air-dry for 
5-10 min and redissolved in appropriate volume of TE buffer for 5 min at room 
temperature. The DNA solution was vortexed for several seconds and its 
concentration was measured using NanoDrop™ 1000 Spectrophotometer. 
 Sequencing plasmid DNA 2.8.3
To confirm gene cloning, recombinant plasmids were sequenced using 
plasmid-specific primers and analysed using Sanger ABI 3730xl (GATC Biotech, 
Germany). Expected and observed sequences were aligned using ClustalX (section 
2.1.2). 
 RNA-seq 2.9
 Sample preparation and sequencing 2.9.1
The BMDC, BMDM and heterophils were cultured as described in Chapter 2, 
section 2.5. For RNA sequencing, BMDM were stimulated with 250 ng/ml of LPS 
(Escherichia coli O55:B5, Sigma Aldrich) for 4 h, BMDC with 200 ng/ml for 24 h (Wu 
et al., 2010) and heterophils with 10 μg/ml for 1 h (Farnell et al., 2003). Total RNA 
was extracted as described in Chapter 2, section 2.6.1 with additional steps. The 
cells were lysed with 600 μl of buffer RLT with added β-mercaptoethanol (β-ME) 
and on-column DNase digestion was performed. Total RNA extracted from BMDC, 
BMDM and heterophils (control and LPS stimulated) was diluted to 100 ng/μl in 20 
μl of RNase-free water. The sample preparation was performed by Edinburgh 
Genomics facility (Roslin Institute, Midlothian, UK) using a Tru-Seq total RNA Sample 
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Preparation v2 kit as per the manufacturer's protocol. Resulting libraries were 
quality-checked on an Agilent DNA 1000 Bioanalyzer (Agilent Technologies, South 
Queensferry, UK) and then clustered onto a paired end flowcell using the Illumina 
TruSeq® Rapid PE Cluster Kit at a 8 pM concentration. The paired-end sequencing, 
consisting of 100 cycles, was carried out on the Illumina HiSeq 2500 using an 
Illumina TruSeq® Rapid SBS Kit (Illumina, Little Chesterford, UK).  
 Transcriptome alignment and differential expression analysis 2.9.2
The RNA-seq pipeline is presented in Appendix 1, Figure 1. The raw reads 
were subject to quality control measures, including the removal of remaining 
sequence adapters. The cleaned, paired-end 100 bp reads were aligned to the 
chicken reference genome (Galgal4) assembly from the Ensembl database 
(http://ensembl.org) with TopHat (v2.0.9) splice junction mapper, which aligned 
reads using Bowtie aligner (v1.0.0). Cufflinks software (v2.1.1) assembled reads into 
transcripts that were used as input data together with aligned reads in Cuffdiff to 
determine expression levels by calculating the Fragments per Kilobase per Million 
mapped reads (FPKM) and the differential expression between conditions using 
default options. 
 Quantitative PCR (qPCR) using 96.96 Dynamic Array Integrated 2.10
Fluidic Circuits. 
The BioMark System 96.96 Dynamic Array is a high-throughput platform that 
allows combining 96 samples with 96 primer pairs into 9,216 qPCRs in one 
integrated fluidic circuit (IFC). The system includes optical, thermal cycling and 
software components to perform quantitative PCR. The Dynamic Array IFC is a 
nanofluidic network that allows to run 24-fold more reactions compared to 384-well 
plate. The liquid handling steps, number of pipetting and volumes of reactions are 
greatly reduced. The high-resolution CCD camera that covers whole chip area 
images all reactions simultaneously. The quantification cycle (Cq) values from each 
reaction chamber in the chip are visualised as an easy to analyse heat map. The 
values behind the heat map can be exported and further analyse using gene 
expression analysis software.  
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 Primer design and optimisation 2.10.1
Primers for qPCR using 96.96 Dynamic Array were designed in the same 
manner as primers for RT-qPCR outlined in section 2.7.5. At least one primer was 
designed to overlap intron-exon boundaries of a gene, where possible. Optimisation 
of primers was performed to assess their specificity in binding to a single template 
at a working concentration of 1.15 μM. Primer amplification efficiencies and 
dynamic range were acquired from standard curves constructed from dilution series 
of highly responding samples. Melting curves were inspected for all primer assays. 
Agarose gel electrophoresis and sequencing of selected amplicons were performed 
to ensure primer specificity. To prepare qPCR products for sequencing DNA bands 
were excised from an agarose gel using sterile scalpel and products were cleaned-
up using Nucleo-Spin Gel and PCR Clean-up kit (Macherey-Nagel, UK) following 
manufacturer’s instructions. For every 100 mg of gel fragment, 200 μl of buffer NTI 
was added and incubated at 50°C for 10 min. Completely dissolved samples was 
then placed in Nucleo-Spin Gel and PCR Clean-up Column with collection tube and 
centrifuged for 30 s at 11,000 x g. The flow-through was discarded and column was 
washed with 700 μl of buffer NT3 with added 96-100% ethanol, by centrifugation 
for 30 s at 11,000 x g. The silica membrane was dried by centrifugation for 1 min at 
11,000 x g to remove buffer NT3 completely. The column was placed into a new 1.5 
ml microcentrifuge tube and 30 μl of buffer NE was added. The column was 
incubated at room temperature for 1 min and centrifuged for 1 min at 11,000 x g. 
Cleaned-up qPCR product was sent for direct sequencing. 
 Reference gene normalisation 2.10.2
 The stability of reference genes was examined using BestKeeper, 
NormFinder and geNorm outlined in sections 2.1.7, 2.1.8 and 2.1.9. More detail is 
provided in Chapter 5. 
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 RNA extraction and cDNA generation for 96.96 Dynamic Array 2.10.3
IFC 
RNA for high throughput qPCR was extracted as described in paragraph 
2.6.2. The cDNA was reversely transcribed using SuperScript III Kit and High Capacity 
Reverse Transcription Kit as described in section 2.7.2 and 2.7.3, respectively. 
 Preamplification 2.10.4
Preamplification was performed using TaqMan PreAmp Master Mix (Applied 
Biosystems, PN 4391128). A stock of 200 nM primer mix was prepared combining 
equal concentration of all primers used in the following qPCR. TaqMan PreAmp 
Master Mix (10 μl) was mixed with 5 μl of 200 nM stock primer mix and 5 μl of 
cDNA in concentration of 185 ng/μl. Reaction tubes were vortexed and centrifuged 
briefly before PCR. Samples were incubated at 95°C for 10 min followed by 14 cycles 
of 95°C for 15 sec and 60°C for 4 min. Preamplified cDNA was stored in -20°C until 
further use. Steps taken to optimise preamplification are discussed in Chapter 6, 
section 6.3.3. 
 Exonuclease I treatment 2.10.5
A clean-up step using Exonuclease I (E. coli) (New England Biolabs; M0293S) 
was performed to remove unincorporated primers from preamplified cDNA. 
Exonuclease I was diluted to 4 U/μl by mixing 1.4 μl of water, 0.2 μl of Exonuclease I 
Reaction Buffer and Exonuclease I (at 20 U/μl). For each 5 μl of preamplified cDNA a 
total volume of 2 μl Exo I reaction solution was added and incubated at 37°C for 30 
min. The reaction was stopped by heating at to 80°C for 15 min. Reactions were 
held at 4°C until storage at -20°C. 
 Quantitative PCR assay and sample master mix preparation 2.10.6
Assay mix was prepared by mixing 2.5 μl 2X Assay Loading Reagent 
(Fluidigm, PN 85000736), 2.3 μl of primer pair mix and 0.2 μl low EDTA TE buffer 
which combined gave 5 μl of assay mix. Sample mix was prepared by mixing 2.5 μl 
TaqMan Gene Expression Master Mix (Applied Biosystems; PN 4369016), 0.25 μl 
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20X DNA Binding Dye Sample Loading Reagent (Fluidigm; PN 100-388), 20X 
EvaGreen DNA binding dye (Biotum; PN 31000) and 2 μl of preamplified cDNA 
which combined gave 5 μl of sample mix.  
 Chip priming 2.10.7
96.96 Dynamic Array IFC was primed by injecting 150 μl of control line fluid 
into each accumulator on the chip followed by placing the chip into the Integrated 
Fluidic Circuit (IFC) controller and running the Chip Prime (138x) script. 
 Chip loading 2.10.8
Assay mix and sample mix solutions (5 μl) were pipetted into the inlets on 
the chip after priming. Using IFC controller software, Load Mix (138x) script was 
applied. After loading finished, the chip was removed from IFC controller and any 
dust particles or debris were cleaned from the chip surface using scotch tape. 
 qPCR and data analysis 2.10.9
Quantitative PCR was performed in the BioMark HD instrument using the 
Data Collection Software. The loaded chip was placed into the reader. After barcode 
verification, application was set as Gene Expression (GE), passive reference as ROX, 
probe as single probe and probe type as EvaGreen. Thermal cycling protocol was 
chosen for 96.96 chip: GE 96x96 PCR+Melt v1.pcl. Auto Exposure was confirmed 
and the program was verified.  
Thermal conditions for GE 96x96 qPCR: 
Thermal mix 50°C for 2 min 
70°C for 30 min 
25°C for 10 min 
Hot start 50°C for 2 min 
95°C for 10 min 
PCR cycle (x30) 95°C for 15 sec 
60°C for 60 sec 
Melting 60°C for 3 sec to 95°C 
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Real-Time PCR Analysis software was used to visualise results. Analysis 
settings were as follows: quality threshold was set to 0.65, baseline correction to 
linear (derivative) and Cq threshold method to auto (global). Data from the qPCR 
were analysed under these settings and a heat map was generated to visualise the 
results. Sample names and assays symbols were assigned to each row/column using 
template documents in .xls format. Melting curves and amplification graphs were 
examined for each gene. Data from the heat map view were exported as .csv file 
that was used as an input data in GenEx5 software. 
 GenEx5 pre-processing 2.10.10
Data from 96.96 Dynamic Array runs was examined in Real Time PCR 
Analysis software and handled in GenEx5 software before statistical analysis. Data 
exported from heat map views were arranged with the measured genes in columns 
headed with gene symbols and samples in rows. Additional classification columns 
were included with labels: #tissue, #bird, #farm. A classification column for #repeats 
was added automatically by the GenEx5 software. Validation of data in pre-
processing included removal of columns/rows with less than 50% values. Gene 
quality graphs were produced to examine the number of empty values. The missing 
data were either filled with the mean of replicates or by imputation based on a 
tissue. Data were corrected for reaction efficiency for each primer assay individually 
before normalisation with the reference genes: ACTB, GAPDH and TBP as selected in 
Chapter 5. Normalised dataset repeats were averaged and further normalisation to 
maximum Cq value for a given gene was performed. Relative quantities were 
transformed to logarithmic scale (log2) before statistical analysis. 
 GenEx statistical analysis 2.10.11
Groups for comparison were created using GenEx5 Data Manager. Data were 
grouped depending on the farm (pedigree, sibling test), bird (1-8), tissue (bursa, 
spleen, caecal tonsils, ileum, PBL) and tissue/farm (e.g. bursa/sib, bursa/ped). 
Groups were compared in bar graphs using descriptive statistics. Each comparison 
generated a table with data values sorted by gene and group. Statistical analysis 
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was performed using a t-test. For principal component analysis (PCA), a trial version 
of GenEx Enterprise was used. Gene expression was considered highly significant (p 
value ≤ 0.0005) and significant (p value ≤ 0.05) for fold change values lower than -1 
and higher than 1. 
 Statistical analysis 2.11
Chapter 3 oxidative burst and degranulation data were analysed by the 
Student’s t-test using SigmaStat software (Jandel Scientific, USA) and expressed as 
the mean ± SD. RT-qPCR data in Chapter 3 were checked for normality and 
statistical analyses were carried out using Mann Whitney-U in Minitab 16.1.0 (State 
College, USA). Statistical significance was determined as p≤0.05 (significant) or 
p≤0.001 (highly significant). Mann-Whitney-U test (GenEx5) was used in validation 
of the arrays expeiment.  
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 Evaluation of cellular and molecular methods Chapter 3
as diagnostic tools for immune robustness  
 Introduction 3.1
The main aim of this study was to evaluate the practicality of widely used 
cellular and molecular methods for measuring immune robustness in chickens. This 
work was completed to answer the question if in vitro cultured bone marrow-
derived macrophages (BMDM) and dendritic cells (BMDC) and heterophils isolated 
from blood provide an inexpensive, swift and informative tool for predicting 
immune robustness that could be used in wider selection programmes. Evaluation 
was based on BMDM and BMDC from Roslin Institute J line (RI-J) birds and on 
heterophils isolated from blood samples of RI-J line, Novogen layers and Aviagen 
broilers. A panel of proinflammatory cytokines and chemokines, known to be 
differentially expressed during the regulation of immune responses, was examined 
in effector cells stimulated with a lipopolysaccharide. The phagocytosis, 
degranulation abilities and production of reactive oxygen species (ROS) was 
examined in heterophils isolated from W36 Hy-Line and stimulated with opsonised 
Salmonella Enteritidis. 
In the animal breeding sector, genetic selection can increase resistance to 
specific pathogens (Janss and Bolder, 2000) but genetic or phenotypic markers for 
resistance to the wide spectrum of viral, bacterial and protozoan pathogens are 
lacking. Disease resistance is often a polygenic trait therefore genetic selection for 
the immune robustness is complex. It is therefore of interest to explore phenotypes 
that may be predictive of the response to infection. There have been studies on 
chicken immune responses to infections which showed that the number and types 
of effector cells and the timing and magnitude of effector cells of their responses 
influences resistance and susceptibility to diseases (Chapter 1). 
The bone marrow, as the source of the myeloid lineage of white blood cells, 
can be used to develop functional macrophages and dendritic cells, which can be 
screened for phenotypes associated with the response to infection. The use of 
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primordial cells to derive effector cells results in broad representation of the 
immune repertoire that has not influenced by cytokines and other features of 
immune system (Sun et al., 2015). Studies on the effector cells and their 
performance during stimulation with TLR ligands and/or live pathogens suggest that 
the increased resistance to Salmonella correlates with the increased levels of 
transcripts encoding proinflammatory cytokines and chemokines (Swaggerty et al., 
2003; Ferro et al., 2004, Wigley et al., 2006). Such molecules orchestrate the nature, 
strength and kinetics of later stages of immunity. Hence, stronger and more rapid 
innate defences can not only influence the first line of defence against pathogens 
but also trigger more effective adaptive immune responses.  
In chickens, the degranulation process of heterophils is closely associated 
with phagocytosis (Kogut et al., 2001). Not only live bacteria but also various 
microbial components have been shown to stimulate degranulation (Kogut et al., 
2005). The ability of heterophils to degranulate and produce an oxidative burst was 
examined in vivo after CpG ODN treatment or Salmonella stimulation (He et al., 
2007; Kogut et al., 2005) and in vitro in two F1 reciprocal crosses (Swaggerty et al., 
2006). Chicken macrophages cell line (HD11), monocyte-derived macrophages and 
heterophils isolated from blood have been used in many studies where immune 
gene expression was evaluated upon stimulation with antigens in different breeds 
(Iqbal et al., 2005; Smith et al., 2005, Lavric et al., 2008; Nerren et al., 2009). The 
macrophages isolated from a Salmonella-resistant inbred line expressed 
proinflammatory cytokines and chemokines more rapidly, and at greater levels, 
compared to a susceptible line (Wigley et al., 2006) and could be used as 
biomarkers. Since the first report on generation of the chicken bone-marrow 
derived dendritic cells was published (Wu et al., 2010) recent studies have focused 
on the nature of interactions between BMDC and various antigens/pathogens (Liang 
et al., 2013; Vervelde et al., 2013; Rajput et al., 2014). The finding of differential 
responses to the pathogens between resistant and susceptible inbred chicken lines 
and the studies on the nature of gene expression in effector cells isolated or 
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differentiated from such lines suggest that it may be feasible to find biomarkers of 
the innate response that are predictive of resistance to disease.   
66 
 Materials and methods 3.2
 Generation and stimulation of bone marrow-derived dendritic 3.2.1
cells and macrophages 
Chicken macrophages and dendritic cells can be derived from the bone 
marrow cells by differentiation driven by recombinant CSF-1 or IL-4 and GM-CSF 
(CSF-2), respectively. The recombinant chicken proteins were produced by 
transfecting the COS-7 cells with plasmids containing chicken CSF-1, IL-4, GM-CSF 
gene inserts, as described in Chapter 2, section 2.4.2. The bone marrow cells from 
4-6 week old RI-J line chickens were differentiated into dendritic cells (BMDC) and 
macrophages (BMDM) after six days of cultures, as described in Chapter 2, section 
2.5.1.  
 Phagocytosis, oxidative burst and degranulation assays 3.2.2
The peripheral blood was used to isolate a heterophil population as 
described in Chapter 2, section 2.5.3. Live Salmonella Enteritidis, opsonised with 
normal chicken serum was used to stimulate phagocytosis, oxidative burst and 
degranulation of heterophils after 1 h incubation. All three experiments were 
performed during a visit to the USDA facility in College Station, Texas using 100 one 
day old Hy-Line W36 chickens. The protocols are described in Chapter 2, section 
2.5.5, 2.5.6 and 2.5.7.  
 Assessment of cytokine and chemokine expression using 3.2.3
reverse transcription quantitative polymerase chain reaction (RT-
qPCR) 
The total RNA from unstimulated and stimulated BMDM, BMDC and 
heterophils was used in RT-qPCRs to determine the levels of expression of cytokines 
and chemokines. Primers and probes used in this experiment are listed in Appendix 
1, Table 2. The amplification and detection was carried out using fluorescent 
hydrolysis probes in the Applied Biosystems 7500 Fast Real-Time PCR System as 
described in Chapter 2, section 2.7.5.  
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 Results  3.3
The populations of macrophages and dendritic cells in chicken body tissues 
are generally vast but difficult to isolate, therefore to evaluate their immune gene 
expression levels, cells were differentiated from bone marrow for analysis of 
responses to different stimuli ex vivo. If such assays prove reliable they could be 
used to understand the basis of differential resistance and/or as predictive tools for 
selection of immune robustness. 
 Bone marrow-derived macrophage and dendritic cell cultures 3.3.1
 In this study, addition of CSF-1 and GM-CSF and IL-4 to bone marrow cells 
generated clumping formation of adherent colonies. On day six, cells were 
stimulated with LPS to induce immune gene expression. LPS is a strong stimulator of 
innate immunity. For the purpose of this experiment 250 ng/ml was added to 
BMDM. Dendritic cells were stimulated with 200 ng/ml of LPS, a concentration 
previously described as optimal to trigger immune response in BMDC (Wu et al., 
2010). The stimulation with LPS triggered changes in the appearance of both BMDM 
and BMDC + LPS cultures (Figure 3.1b and Figure 3.1c) compared to the 
unstimulated control cells (Figure 3.1a). In BMDC culture, larger colonies of cells 
decreased in numbers and single cells became more visible. BMDC that underwent 
maturation during LPS stimulation displayed long veils or dendritic appearance 
(Figure 3.1d). The BMDM population after stimulation with LPS was characterised 







Figure 3.1. Morphology of chicken bone marrow cells from RI-J line. a) control cells; magnification 
60x; b) cells cultured for 7 days in presence of CSF-1and stimulated with 250 ng/ml LPS for 24 h; 
magnification 60x; c) cell aggregates at day 7 of culture with presence of GM-CSF and IL-4 and 
stimulated with 200 ng/ml of LPS; magnification 60x; d) single cell from BMDC culture after 
stimulation with 200 ng/ml of LPS for 24 h, showing apparent long veils; 100x. 
 Isolation of heterophils from blood 3.3.2
A technique described by Kogut et al. (2001) was followed to isolate 
heterophils, initially using blood from four to eight birds of 3-6 weeks age. The 
number of circulating heterophils drastically drops from ~70% of total blood cells at 
the first week to ~25% at the third week of life (reviewed by Maxwell and 
Robertson, 1998). The age of the chickens and the small amount of blood (~8 ml) 
used affected the final yield of heterophils. The purity and number of the isolated 
cells was low (Figure 3.2a and Figure 3.2b). The population consisted of different 






heterophils are round, although it has been reported that their shape may be 
distorted because of a polar distribution of the specific cytoplasmic granules or 
lobulation. They have two nuclear lobes, faintly pink cytoplasmic matrix, brick-red 
rod-shaped granules with the May-Grunwald and Giemsa combination of stains, as 
reported by Lucas and Jamroz (1961) (reviewed by Maxwell and Robertson, 1998). 
To undertake any heterophil functional assays the number of cells has to be at least 
1 x 106 per ml. The use of ~100 day-old chickens increased the yield and purity of 






                                   c) 
 
Figure 3.2. Leukocytes isolated from blood using a discontinuous gradient. Cells were 
cytocentrifuged and stained with May-Grunwald Giemsa stain (a and b) and with Hematology 3-step 
stain (c); a) and b) heterophils isolated from blood of three-six week old RI-J line chickens; (b) 
heterophils isolated from blood of W36 Hy-Line day-old chickens, magnification with immersion oil 
100x. 
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 Induction of heterophil phagocytosis, degranulation and 3.3.3
oxidative burst by Salmonella Enteritidis 
The ability of live opsonised Salmonella Enteritidis to induce phagocytosis, 
degranulation and oxidative burst was measured in heterophils isolated from blood 
of day-old W36 Hy-Line chickens after 1 h incubation. Phagocytosis in heterophils 
was evaluated microscopically (Figure 3.3). Not all heterophils contained bacterial 
cells but those that did phagocytose Salmonella, on average, contained more than 
two bacterial cells. For every 100 heterophils on a cytospin slide, 63 contained 
Salmonella Enteritidis. Rarely, heterophils were observed with a large number of 
internalised bacteria. The results are presented as phagocytic index (Chapter 2, 




Figure 3.3. Phagocytosis of S. Enteritidis by heterophils isolated from day-old chickens. Cytospin 
smears were stained with Hematology 3-step stain and examined by light microscopy with the oil 




Table 3.1. Phagocytic index.  Phagocytosis of opsonised S. Enteritidis (107 cfu/ml) by heterophils (106 
cells/ml) isolated from day-old chickens. The numbers are from two independent studies, each 
consisting of five technical replicates. 
% heterophils containing 
S. Enteritidis 
Average number of 
bacteria per heterophil 
Phagocytic Index (PI) 
63 ± 2.94 2.62 ± 0.38 165.17 ± 23.10 
 
Live, opsonised S. Enteritidis and phorbol A-myristate 13-acetate (PMA) were used 
to evaluate production of reactive oxygen species (ROS) by heterophils using an 
oxidative burst assay. The levels of ROS production were indicated by the amount of 
fluorescence caused by oxidation of DCFH-DA to DCF. PMA gave the strongest 
stimulation to the oxidative burst. Although bacteria were a less effective stimulant 
than PMA, the level of ROS produced by heterophils in the presence of S. Enteritidis 
doubled after 1 h incubation compared to control cells (Figure 3.4).  
 
Figure 3.4. Ability of heterophils to generate an oxidative burst response following stimulation with 
opsonised S. Enteritidis and the inflammatory agonist phrorbol A-myristate 13-acetate. Reactions 
contained 1 x 107 cells/ml, 10 μg DCFH-DA/ml and 108 cfu/ml of opsonised S. Enteritidis. Samples 
were incubated at 37˚C for 1 h. The control relative fluorescence units (RFU) value was obtained 
from unstimulated cells at the same time point. Data represent the mean ± standard deviation (SD) 
of three independent assays. C - control cells, SE - cells stimulated with S. Enteritidis, PMA - cells 
stimulated with . phorbol A-myristate 13-acetate; *p ≤ 0.05. 
 
The levels of enzymatic processes of degranulation was measured in 
heterophils incubated with S. Enteritidis. The presence of bacteria triggered the 
release of granule contents, which was detected by quantifying the levels of β-D-
* 
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glucuronidase, an enzyme that cleave the glyosidic bond of glucoronide. This is 
detected owing to the fluorescence of 4-methylumbelliferone liberated from the 4-
methylumbelliferyl-b-D-glucuronide complex, which is highly fluorescent in alkaline 
solution and proportional to the enzyme activity present in a sample. The 
degranulation ability of heterophils following stimulation with bacteria was 
compared with that of unstimulated cells. The level of bactericidal intracellular 
granules released after stimulation of heterophils with live, opsonised S. Enteritidis 
doubled at 1 h timepoint (Figure 3.5).  
 
Figure 3.5. Effect of opsonised S. Enteritidis on degranulation by heterophils.  Degranulation of 
heterophils (107 cell/ml) induced by stimulation with opsonised S. Enteritidis (108 cfu/ml). Data 
represent the mean±standard deviation (SD) of two biological replicates, each with four technical 
replicates; H + SE – heterophils stimulated with S. Enteritidis; ** p ≤ 0.001. 
 
The phagocytosis triggers the release of bactericidal components in a form 
of degranulation and reactive oxygen species and all three processes often occur 
simultaneously. Based on the above experiments, heterophils are a good indicator 
of early immune responses when stimulated with live bacteria or mitogen. The 
presented assays can be performed within minutes after isolation of heterophils 
from blood. However, the isolation process itself and the high cell yield required for 
73 
the experiments make these methods not useful for screening older and larger 
populations of birds.  
 Pro-inflammatory cytokine and chemokine expression upon 3.3.4
stimulation with lipopolysaccharide (LPS) 
The value of bone marrow-derived cell cultures in evaluating immune 
robustness was examined by testing BMDC and BMDM responses to LPS as an 
example. The mRNA levels of the pro-inflammatory cytokines IL-1β and IL-6, and of 
the Th1-associated cytokine IL-18, were studied in BMDM and BMDC + LPS after six 
days of culture. Additionally, transcript levels for the pro-inflammatory chemokines 
CXCLi1 and CXCLi2 were quantified. The BMDC cultures were stimulated with 200 
ng/ml of LPS for 24 hours and the BMDM with 250 ng/ml of LPS for 4 hours. The 
timepoints were selected based on the published data. 
The level of transcription varied greatly between cell types. For some 
transcripts, there was also a large variation observed between replicates. The 
highest induction of expression was observed for IL-6 transcripts, in both BMDC and 
BMDM. The IL-1β transcript was upregulated in both cell types with higher levels in 
BMDM after 4 h stimulation. The Th1-associated cytokine IL-18 was also 
upregulated in both cell types but the level of expression was much lower in BMDM 
when compared to IL-1β and IL-6. The mRNA expression of CXCLi1 in BMDC was 
detected at 24 hours but the levels were much lower compared to BMDM. The 
mRNA expression of CXCLi2 chemokine in BMDC was upregulated reaching 20 fold 
change, where in BMDM expression of CXCLi2 was not detected at 4 h timepoint 





















Figure 3.6. Evaluation of expression of proinflammatory cytokine genes in BMDM and BMDC 
stimulated with LPS a) IL-1β; b) IL-6; c) IL-18 and chemokines d) CXCLi1; e) CXCLi2; in bone marrow-
derived dendritic cells (BMDC), stimulated for 24 h with 200 ng/ml of LPS and in bone marrow-
derived macrophages (BMDM), stimulated for 4 h with 250 ng/ml of LPS. Data are presented as fold 
change compared to unstimulated control cells, each bar represent average of three biological 
replicates ± SD; *p ≤ 0.05.  
The transcript levels for proinflammatory cytokines (IL-1β, IL-6 and IL-18), 
proinflammatory chemokine (CXCLi2) and anti-inflammatory cytokine (TGF-β4) 
were also examined in heterophils upon LPS stimulation (Figure 3.7). Three different 










































level of expression of IL-1β was observed in the Novogen line heterophils. In the 
same line IL-6 mRNA expression was the lowest compared with other lines tested, 
where the RI-J line showed the highest level of mRNA expression. The IL-18 cytokine 
was differentially expressed compared to the control cells in all lines tested but the 
levels were low. In the case of CXCLi2, Aviagen line and RI-J line exhibited similar 
level of expression with Novogen line demonstrating higher upregulation. The anti -
inflammatory cytokine TGF-β4 showed little or no consistent change in expression 
across the lines studied. 
 
Figure 3.7. Evaluation of proinflammatory gene expression in heterophils as measured by RT-qPCR.  
Level of mRNA expression of cytokines: IL-1β; IL-6; IL-18; chemokine CXCLi2 and anti-inflammatory 
cytokine TGF-β4 in heterophils isolated from three breeds; heterophils were stimulated with 
10 μg/ml of LPS for 1 h. Data are presented as fold change compared to unstimulated control cells, 


























 Discussion  3.4
Commercial broiler lines have distinct immune function parameters, due to 
differences in their genetic make-up, which results in a disease resistance and/or 
susceptibility (Lakshmanan et al., 1997). Disease resistance is a complex trait, which 
is influenced by genetics, environment, diet and other factors. Enhancing innate 
resistance to pathogens in chickens is of increasing interest as an alternative to 
antimicrobial use. There are widely used laboratory-based assays that could be 
implemented to test chicken’s responsiveness to different stimuli. Their usage in 
screening chickens, as a diagnostic tool, has been evaluated here in pilot studies. 
Studies on regulation of innate immune cells are important as effector cells direct 
the adaptive immune response. Although studies of cytokine expression in primary 
cells provide comprehensive data, culturing dendritic cells and macrophages from 
bone marrow is time-consuming and the quality of cell culture will vary depending 
on breed type and the age of the birds. More rapid, cheaper and reproducible 
techniques will have to be applied for assessment of differences in immune 
robustness in chicken lines. 
Heterophils act early in response to invading microorganisms and have 
evolved many mechanisms to clear pathogens. They are therefore useful functional 
biomarkers for evaluating innate immune competence in poultry (Swaggerty et al., 
2003). Recognition of PAMPs of foreign microorganisms stimulates phagocytosis, 
degranulation and generation of oxidative burst (Kogut et al., 2003; He et al., 2005) 
that was also shown in current study in which heterophils were stimulated with S. 
Enteritidis. Similar results were obtained by He et al. (2003) where S. Enteritidis-
stimulated heterophils increased production of oxidative burst. The above data and 
other studies show that functional comparisons of heterophils, using phagocytosis, 
degranulation and oxidative burst assays, provide comprehensive data on the 
performance of the early immune response. Heterophils were also used in mRNA 
expression experiments and similarly to published studies (Swaggerty et al., 2003) 
there were great differences observed in cytokine expression between different 
breeds of chickens. The RT-qPCR experiment showed that, although most of the 
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genes tested were expressed in heterophils stimulated with LPS, there were great 
differences in level of expression between broiler (Aviagen) and layer (Novogen and 
RI-J) lines. There have been few reports on differences in immune responses 
between layers and broilers in studies on LPAI H7N2 strains (Ladman et al., 2008), 
after IBV infection (Smith et al., 1985) and on cellular and humoral responses to 
antigens (Koenen et al., 2002; Parmentier et al., 2010). 
An alternative method could involve assessment of the number and activity of 
heterophils and the measurement of differences in levels of proinflammatory 
responses. It has been shown that the number of heterophils that migrate to the 
site of infection is associated with increased resistance against systemic S. 
Enteritidis (Swaggerty et al., 2005). Together with the correlation between 
resistance to S. Enteritidis and differences in expression of innate immune genes, 
these methods could be used to select for increased resistance to other pathogens 
but their role as diagnostic tool would be limited considering high number of 
heterophils needed to perform the experiments. Insufficient numbers can be 
obtained in blood to permit analysis of heterophil function as a screening tool. 
Without the need for culture, they are able to phagocytose, degranulate and 
produce ROS, but those functions can be deficient in newly hatched birds (Wells et 
al., 1998). Although using heterophils to study differences in responses to 
pathogens is faster than using bone marrow-derived effector cells, the isolation of 
sufficient number of cells requires bleeding of at least 100 day-old chicks.  
Quantitative PCR was performed to determine whether pro-inflammatory 
cytokines (IL-1β, IL-6), the Th1-associated cytokine IL-18 and pro-inflammatory 
chemokines (CXCLi1, CXCLi2) were induced upon stimulation of BMDM and BMDC 
with LPS. Upregulation of IL-1β, IL-6 and CXC chemokines by Salmonella has been 
shown in various tissues, including ileum and liver (Withanage et al., 2004), spleen 
(Cheeseman et al., 2007), heterophils and macrophages (Kaiser et al., 2006; Kogut 
et al., 2006; Swaggerty et al., 2008). Bone marrow-derived macrophages and 
dendritic cells have been proven a good source for studying mRNA gene expression 
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triggered by pathogens and mitogens (Wigley et al., 2006; Wu et al., 2010; Vervelde 
et al., 2013). In the current study, LPS stimulation of BMDM and BMDC from 
outbred, vaccinated chickens has shown the mRNA levels of cytokines markedly 
different in magnitude compared to unstimulated cells and between biological 
replicates.  
In the current study, the mRNA gene expression varied greatly between cell 
types, timepoints and LPS concentrations. Depending on the time of stimulation 
and LPS concentration, some genes may not be detected leading to a conclusion 
that they are not expressed, but the real reason may be that this particular cell 
culture has responded and is in homeostasis. As the bone marrow-derived cells 
have to be in culture for six days, their responses may differ due to differences in 
developmental stages and maturity at the time of stimulation. Therefore, the 
selection of stimulant concentration and the timepoints would have to be well 
thought through as the improper choices may lead to false conclusions. 
The cited studies confirm that different types of microbes and different 
strains trigger varied levels of response of the genes tested in presented 
experiments not only in in vitro studies but also in tissues from infection studies. It 
is difficult to agree what genes and at what level of expression are perfect 
signatures of immune responsiveness. The bone-marrow derived macrophages and 
dendritic cells are not a good choice for determination of immune resistance or 
susceptibility. As the current study and previous reports show, the differences in 
the speed and the magnitude of gene expression depend on a time of stimulation, 
type of antigen/pathogen used and antigen/pathogen load. The use of progenitor 
cells, their culture outside the body in simulated settings and stimulation with one 
pathogen or antigen does not mimic the real environment of broilers. The culture of 
BMDM and BMDC are a standard technique in chicken mRNA gene expression 
studies where immune responses are evaluated. They may be informative and 
useful to further characterise cell populations but the selection of birds that 
supposed to have a robust immune response, based on expression of few genes 
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produce less information compared to high-throughput techniques. Although a 
small number of immune-related genes could be practical in distinguishing which 
line of chickens have better early immune response to particular pathogen, a bigger 
panel of genes would return a broader view.  
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 Generation of gene list - selection and cloning Chapter 4
of genes involved in early immune responses. 
 Introduction 4.1
The cellular and molecular assays described in the previous chapter were 
dismissed as being effective and rapid tools for testing immune robustness in 
chicken lines. To screen the immune performance of greater number of birds, a new 
high-throughput qPCR platform, the 96.96 Dynamic Array with BioMark System 
from Fluidigm, will be tested as alternative (introduced in Chapter 6). This type of 
qPCR platform allows the expression of up to 96 genes across 96 samples to be 
tested simultaneously. Therefore, it is necessary to select a panel of ~100 immune-
related genes of interest to test their expression in commercial lines of chickens.  
There have been many studies performed on various chicken lines, 
susceptible and resistant to particular pathogens and on cells isolated from chickens 
and stimulated with antigens and/or pathogens. These types of studies are 
important to examine the immune response to the particular pathogen of interest 
but they do not reflect immune responses in the commercial environment where 
birds are exposed to multiple pathogens and stressors. Many of those 
microorganisms act simultaneously on the chicken’s immune system. As the 
screening tool should be suitable for testing birds reared under both clean and 
commercial circumstances, selected genes have to reflect immune responses to 
different antigens and/or pathogens. A list of genes was compiled from studies 
using resistant and susceptible chicken lines as well as cell lines and primary cells  
challenged with a range of pathogens or constituents thereof. Studies with similar 
agents but using mammalian species were also included to determine if there are 
conserved immune responses across species to different stimuli. Additionally, RNA-
seq analysis was performed on effector cells stimulated with LPS and the results 
were compared to the panels of genes differentially expressed (DE) in previous 
studies to increase the number of genes of interest.  
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The selected genes have their sequences available in the latest chicken 
genome assembly (Galgal4). With the use of Ensembl and NCBI databases each gene 
sequence can be compared and used as a template in primer design for future qPCR 
applications. As the chicken genome sequence is still under development and the 
published studies based their studies on preceding genome release, there is a need 
to confirm the sequences using molecular cloning followed by sequencing. This 




 Materials and methods 4.2
 Selection criteria for creation of gene list 4.2.1
The articles were collected by searching the NCBI database with the queries 
‘innate immune response’, ‘gene expression infection’ in both chicken and 
mammalian species, and by doing searches of cited references in selected articles. 
The publications used to select the genes had to contain an analysed differential 
expression (DE) dataset in the body of text and/or in the supplementary data 
available online. Infection studies on various pathogens and their interactions with 
the host as well as in vitro studies on stimulated primary cells and/or cell lines were 
included in this collection. Each article’s differential expression (DE) dataset was 
compared with other studies and the genes that were upregulated in two or more 
studies were considered a good candidate for the gene list.  
 RNA sequencing of BMDC, BMDM and heterophils 4.2.2
Sample preparation and RNA sequencing methods are described in Chapter 
2, section 2.9.1. The analysis of sequencing results was performed as described in 
Chapter 2, section 2.9.2. The RNA-seq pipeline is shown Appendix 1, Figure 1.  
 Comparison of RNA-seq data between analyses and published 4.2.3
studies for further gene selection 
The three lists of significantly DE genes obtained from RNA-seq analysis of 
BMDC, BMDM and heterophils stimulated with LPS were compared between each 
other. The genes that were common for two or more lists were selected. The genes 
with significant differential expression in one cell type in the RNA-seq results were 
screened against the lists of genes from the articles used in the first selection 
(Chapter 4, 4.3.1). Genes that were present in two or more lists (RNA-seq results 
and published studies lists) were placed on the final gene list. 
 Amplification, cloning and sequencing of candidate gene cDNA 4.2.4
Amplicon lengths, primer sequences and genes IDs are described in Appendix 
1, Table 3 and Table 5. PCR was performed as described in Chapter 2, section 2.7.4. 
PCR products were separated and visualised by agarose gel electrophoresis 
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(Chapter 2, section 2.7.7) and amplicons of the expected size were excised DNA 
extracted and ligated into the pGEM-T Easy vector (Chapter 2, section 2.7.8 and 
2.7.9). Transformation of highly competent JM109 cells with ligated PCR products 
was performed as described in Chapter 2 section 2.7.10. Blue/white screening of 
transformed bacterial cells helped to distinguish putative recombinants, which were 
then confirmed by dideoxy chain termination (Sanger) sequencing. The results were 
assembled and visualised using the DNASTAR® SeqMan Pro application. Cloned and 
reference sequences were aligned by ClustalX (Chapter 2, section 2.1.2). Alignments 
were visualised by using GeneDoc software (Chapter 2, section 2.1.3). Alignments of 





 Creation of innate immune gene list 4.3.1
The data from 16 infection studies on different chicken lines and cells and 
the data from 13 studies on mammalian species were collected. By selecting the 
upregulated genes from each study, a file consisting of 29 separate lists was 
created. The results of PubMed search queries: ‘innate immune response’, ‘gene 
expression infection’ in chickens, humans and other mammalian species are shown 
in Table 4.1. 
Table 4.1. Results of search queries for creation of the gene list. 
Authors Studies Type of platform used 
Bliss et al., 2005 Chicken PBL-derived macrophages 
stimulated with LPS 




Human macrophages and dendritic cells 
stimulated with parasites 
Affymetrix HU95A microarray; no 
accession number 
Chiang et al., 
2008 
Chicken heterophils from two distinct 
parental meat-type broiler lines stimulated 
with S. Enteritidis 
44 K Agilent microarray; GEO 
accession: GSE9416 
Ciraci et al., 
2010 
Chicken HD11 macrophage-like cell line 
stimulated with S. Typhimurium endotoxin 
Affymetrix GeneChip; GEO 
accession GSE23881 
Connell et al., 
2012 
Caecal response of Barred Rock chickens to 
C. jejuni infection 
RNA-seq; raw data as 
supplementary file 
de Kleijn et al., 
2012 
Human neutrophils stimulated with LPS Affymetrix Human ST 1.0 exon 
array; GEO accession GSE35590 
Gou et al., 2012 Chicken PBMCs response to S. Enteritidis 
infection 
qPCR 
Guo et al., 2012 Chicken bursal response to IBDV infection Agilent microarray; no accession 
number 
Huang et al., 
2001 
Human monocyte-derived dendritic cells 
stimulated with E. coli, Candida albicans, 
influenza virus 
Human oligonucleotide 
microarray, no accession number 
Jensen et al., 
2006 
Bovine PBMC stimulated with LPS 5 K bovine macrophage 




Pig macrophages stimulated with LPS Affymetrix GeneChip Porcine 
Genome Array; GEO accession 
GSE30956 
Killick et al., 
2011 
PBL from Mycobacterium bovis infected 
and non-infected Holstein-Friesian cattle 
Affymetrix GeneChip Bovine 
Genome Array; GEO accession 
GSE33359 
Kim et al., 2011 Chicken duodenal response to primary and 
secondary infections with Eimeria 
acervulina 
9.6K avian intestinal intraepithelial 
lymphocyte cDNA 
microarray (AVIELA); GEO 
accession GSE16230 
Lavric et al., 
2008 
In vitro studies on monocyte-derived 
macrophages responses to M. synoviae and 
Avian macrophage microarray 
(AMM) and the avian innate 
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Authors Studies Type of platform used 
E. coli stimulation immunity microarray (AIIM); GEO 
accession GSE1794 
Lee et al., 2010 Chicken embryo lung cells infected with 
ILTV 
44 K Agilent custom microarray; 
GEO accession GPL6413 
Li et al., 2010 Caecal response to C. jejuni infection in two 
commercial broiler lines 
44K Agilent microarray; GEO 
accession GSE10257 
Martins et al., 
2013 
Mesenteric lymph nodes (MLN) from 
piglets infected with S. Typhimurium 
qPCR 
Mellits et al., 
2009 
Human colonocyte line (HCA-7) incubated 
with C. jejuni 
Affymetrix Human Genome U133A 
array; no accession number 
Munir et al., 
2004 
Chicken embryo cells infected with avian 
metapneumovirus 
cDNA microarray; no accession 
number 
Nau et al., 2002 Human macrophages stimulated with 
multiple bacteria and bacterial components 
Affymetrix Hu6800 GeneChip; no 
accession number 
Reemers et al., 
2010 
Chickens infected with avian influenza 
H9N2 
Gallus gallus Roslin/ARK CoRe 
Array Ready Oligo Set V1.0; 
accession numbers: E-TABM-771 
and E-TABM-772 
Roach et al., 
2007 
Human peripheral blood-derived 
mononuclear cells stimulated with LPS 
HG-U133 Plus2 GeneChip; GEO 
accession GSE5504 
Ruby et al., 
2006 
Chickens infected with IBDV Microarray; accession number E-
MEXP-756 
Rue et al., 2011 In vitro studies on chicken splenocytes 
responses to NDV stimulation 




Neutrophils from Iberian pigs stimulated 
with LPS 
Affymetrix Porcine GeneChip; no 
accession number 
Schokker et al., 
2012 
Chicken jejunal response to S. Enteritidis 
infection 
ARK-genomics Gallus gallus 20 K; 
GEO accession GSE27069 
Schreiber et al., 
2006 
Human U937 cells stimulated with LPS custom DNA microarray; accession 
number E-WMIT-6 
Wang et al., 
2012 
Porcine alveolar macrophage responses to 
Haemophilus parasuis 
Affymetrix GeneChip Porcine 
Genome Array; GEO accession 
GSE30172 
Zaffuto et al., 
2008 
Chicken embryo cell lines infected with 
avian influenza virus 
Agilent complete chicken genome 
(42K) microarray;  
 
A list of 12 immune-related genes was generated from the studies on infected 
chicken cells and tissues by selecting the significantly upregulated genes that were 
present in two or more separate studies. The same selection method was used 
when comparing the 16 panels of DE genes from chicken studies with the 
mammalian gene expression studies. This approach resulted in the additional 
twenty genes of interest (GOI). The final list consisted of 32 genes upregulated 
during in vitro and in vivo infections in mammalian species and in the chicken (Table 
4.2). 
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Table 4.2. A list of genes of interest upregulated upon stimulation with pathogens or agonists based 
on published studies.  
Chicken and mammalian species Chicken only 
CCL20; CCL4;CCL5; CD83; CXCL13; IL12B; IL18; IL1B; 
IL8; IRAK2; IRF1; MYD88; NFKBIA; NFKBIZ; NLRC5; 
SOCS1; SOCS3; TIMD4; TLR4; TNFAIP3 
CD80; CXCLi1; IFIT5; iNOS; IRF7; IRF10; 
JUN; LYZ; PPARG; TIRAP; TOLLIP; 
TRAF3IP2 
 
The accession numbers of genes with different symbols were compared to confirm 
that the same transcript was differentially expressed in the selected studies. The 
gene ID’s from the chicken studies with known differences in sequences were 
compared to clarify which transcript was upregulated in a particular study. The 
chemokine CCL4 (C-C motif ligand 4) was present in five chicken panels (Chiang et 
al., 2008; Ciraci et al., 2010; Lee et al., 2010; Rue et al., 2011; Guo et al., 2012). The 
accession numbers for genes that were used to either design the probe for a 
microarray or that were a result of a RNA-seq alignment analysis differed. The 
transcript with accession number NM_204720 was chosen, as it was differentially 
expressed in two studies. This transcript sequence is identical with the sequence of 
chicken CCLi3. The chemokine CCL5 (C-C motif ligand 5), also known as CCLi4 or 
ah294, was upregulated in two chicken studies and both of the transcripts had 
different accession numbers assigned (Lavric et al., 2007; Guo et al., 2012). Guo et 
al. (2012) study used ENSGALT00000001405 Ensembl identification number, which 
is no longer present in gene set, therefore the sequence under the NM_001045832 
number, was used in further studies. The chicken K60 gene, also known as IL-8-like 
1 or CXCLi1, was upregulated in two studies where commercial and customised 
microarrays were used and probes were designed based on the same sequence – 
NM_205018 (Chiang et al., 2008; Connell et al., 2012). A third study did not include 
accession numbers for studied genes. Interleukin 8 (IL-8 or CXCLi2) was present in 
six panels and the same sequence (NM_205498) was used in probe design. One of 
the studies used RNA-seq platform for DE and the assembled transcripts aligned to 
region of a genome where IL-8 is annotated (Connell et al., 2012). 
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 RNA-seq analysis 4.3.2
The genes selected, based on previous studies, resulted in a small list 
consisting of 32 genes involved in immune response to pathogens or agonists. To 
increase the number of the genes of interest, an RNA-seq analysis was performed 
on RNA from chicken primary cells (BMDC, BMDM and heterophils) stimulated with 
LPS. The Illumina HiSeq 2500 platform generated 14.1-18.6 million RNA-seq tag 
pairs per sample (95.8 million in total) each 100 nucleotides in length resulting in 
19.7 Gb of data. The Cufflinks program containing Cuffdiff algorithm was used to 
find significant changes in transcript levels between LPS-treated and control cells. 
The DE genes were determined by using the fold change >1 (Figure 4.1a). Among 
the differentially expressed genes, there was only one gene, TGM4, upregulated in 
all of the three cell types. Between BMDC and BMDM, 30 DE genes were common 
and each cell type shared only nine DE genes with the heterophils (Figure 4.1b). The 
DE analysis revealed that many of the significantly expressed genes have not been 
annotated in chicken genome. For further analysis, only the annotated genes were 
taken under consideration. The reads for four differentially expressed genes 
assembled into transcripts that spanned the location of two closely annotated 
genes. It has resulted in pair of genes assigned to the same genomic location with 
shared fold change value. Therefore, 24 genes significantly differentially expressed 






Figure 4.1. RNA-seq results a) Number of significantly differentially expressed genes in chicken 
primary cells stimulated with LPS. Abbreviations: BMDC, bone marrow-derived dendritic cells; 
BMDM, bone marrow-derived macrophages; DE- differentially expressed compared to 
unstimulated cells; b) Venn diagram showing the number of transcripts significantly DE; A) in 
heterophils; B) in BMDM; C) BMDC; D) common DE gene for three cell types; E) shared 
between BMDC and BMDM; F) shared between BMDM and heterophils; G) shared between 
BMDC and heterophils; numbers of unannotated genes are presented in brackets. 
 Comparison of RNA-seq results with previous studies 4.3.3
The criteria for genes to be ranked as genes of interest were as follows: 
candidate gene had to be differentially expressed in any of the cell type tested from 
the RNA-seq analysis and at least once in the previous studies used to generate the 
initial list of 32 genes. Against this criterion, 17 genes qualified. A further 15 genes 
were added to the list, based on their overexpression in more than one of the 
previous studies analysed. From the RNA-seq data, 44 genes were added to the list 
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as they were differentially expressed in at least two cell types stimulated with LPS. A 
flow chart visualising the pathway of gene selection is presented in Figure 4.2a. 
Based on these, the final list consisted of 104 genes of interest (Figure 4.2b). The 
type of cell and treatment that caused the differential expression of the selected 






Figure 4.2. Comparison of published studies and RNA-seq gene lists ; a) flow chart representing the 
criteria for selection of GOI based on RNA-seq data and published studies; b) the Venn diagram 








Table 4.3. Genes of interest and the type of studies with differential expression in mammalian 
species and the chicken. 
Gene symbol Type of study with differential expression 
ABCG2 BMDM and BMDC + LPS RNA-seq 
ADM BMDM and BMDC + LPS RNA-seq; hNEUT + LPS; bMph + LPS; 
hMph + bacteria and bacterial components 
ATF3 HET +LPS RNA-seq; hMph + LPS 
BATF3 BMDM and BMDC + LPS RNA-seq; ELC + ILTV; hNEUT + LPS 
BCL2A1 HET and BMDM + LPS RNA-seq; hMph and hDCs + parasites; 
hDCs + E. coli, C. albicans, influenza virus 
C3ORF52 BMDM and BMDC + LPS RNA-seq 
CCL19 BMDM + LPS RNA-seq; chicken intestines + C. jejuni 
CCL20  ELC + ILTV; chicken intestines + C. jejuni; chMph + LPS; HCA-7 C. 
jejuni; hNEUT + LPS; bMph + LPS 
CCL4 HET + S. Enteritidis; chPBMC + S. Enteritidis; HD11 + S. 
Typhimurium; ELC + ILTV; Chicken spleen + NDV; hNEUT+ LPS; 
hMph + LPS; pMph + LPS 
CCL5 bursa + IBDV; chMph + APEC; hMph + LPS; bMph + LPS; pMph+ 
LPS; hMph and DCs + parasites 
CD40 BMDM and HET +LPS RNA-seq; bMph + LPS; chPBMC + S. 
Enteritidis 
CD72 BMDM and BMDC + LPS RNA-seq; chicken intestines + C. jejuni 
CD80 Chicken jejunum + S. Enteritidis; chPBMC + S. Enteritidis; bMph 
+ LPS 
CD83 HET + LPS RNA-seq; mMph + LPS; Chickens + IBDV; bMph + LPS; 
hNEUT + LPS; HD11 + S. Typhimurium; chMph + APEC; chicken 
intestines + C. jejuni; hMph + bacteria and bacterial 
components; hMph and DCs + parasites 
CSF1 BMDC RNA-seq ; pMph + LPS 
CXCL13 BMDM and BMDC + LPS RNA-seq; Chicken spleen + NDV; pMph 
+ LPS 
CXCL13L2 BMDM and BMDC + LPS RNA-seq; chicken intestines + C. jejuni 
CXCLI1 HET + S. Enteritidis; chicken intestines + C. jejuni; CE cells 
infected with avian metapneumovirus 
CXORF21 HET and BMDM + LPS RNA-seq 
DLG3 BMDM and BMDC + LPS RNA-seq 
DTX2 HET and BMDM + LPS RNA-seq; chicken intestines + C. jejuni 
EAF2 BMDM and BMDC + LPS RNA-seq 
EDN1 BMDM + LPS RNA-seq; pMph +LPS; bMph + LPS; hMph and DCs 
+  parasites 
EGR1 HET + LPS RNA-seq; mMph + LPS; chicken intestines + C. jejuni 
ENSGALG00000002955 BMDM and BMDC + LPS RNA-seq 
ENSGALG00000005747 BMDM and BMDC + LPS RNA-seq 




BMDM and BMDC + LPS RNA-seq 
ENSGALG00000022324 BMDM and BMDC + LPS RNA-seq 
ENSGALG00000025905 BMDM and BMDC + LPS RNA-seq 
ENSGALG00000026592 HET and BMDC + LPS RNA-seq 
ETS2 BMDM + LPS RNA-seq; bMph + LPS; hMph + LPS; hNEUT + LPS; 
hMph + bacteria and bacterial components 
F3 BMDC + LPS RNA-seq; bMph + LPS 
G0S2 HET and BMDC  + LPS RNA-seq; hNEUT + LPS; hMph and DCs + 
parasites 
GABRA5 BMDM + LPS RNA-seq ; chicken intestines + C. jejuni; 
GCH1 BMDM + LPS RNA-seq; HD11 + S. Typhimurium; hNEUT + LPS; 
hMph + bacteria and bacterial components 
GLUL BMDM and BMDC + LPS RNA-seq 
HPS5 BMDM and BMDC + LPS RNA-seq 
IFIT5 Chicken spleen + NDV; chMph+ APEC; chicken intestines + C. 
jejuni; Chickens +  IBDV 
IL10RA HET ; hNEUT + LPS 
IL12B HET + LPS RNA-seq; PMph + LPS; HET + S. Enteritidis; chPBMC+ 
S. Enteritidis; hMph + bacteria and bacterial components 
IL13RA2 BMDC + LPS RNA-seq; chMph+ APEC 
IL17REL HET and BMDM + LPS RNA-seq; chicken intestines + C. jejuni 
IL18 Chicken spleen + NDV; Chickens + IBDV; pMph + LPS; hNEUT + 
LPS; bMph + LPS; Chickens + AIV 
IL19 BMDM and BMDC + LPS RNA-seq 
IL1B BMDC + LPS RNA-seq; hNEUT + LPS; bMph + LPS; hMph + LPS; 
pMph + LPS; chMph+ APEC; HD11 + S. Typhimurium; ELC+ ILTV; 
chPBMC+ S. Enteritidis; chMph+ LPS; HET + S. Enteritidis; hMph 
and DCs +  parasites; hDCs +  E. coli, C. albicans, influenza virus 
IL1R2 HET + LPS RNA-seq; hNEUT + LPS 
IL20RA BMDM + LPS RNA-seq ; chicken intestines + C. jejuni 
IL4I1 HET and BMDC + LPS RNA-seq 
IL6 HET and BMDM + LPS RNA-seq; bMph + LPS; HET + S. 
Enteritidis; ELC+ ILTV; chPBMC+ S. Enteritidis; hMph + bacteria 
and bacterial components; hMph and DCs +  parasites; hDCs + 
E. coli, C. albicans, influenza virus 
IL8 HD11 + S. Typhimurium; ELC+ ILTV; chPBMC+ S. Enteritidis; 
chicken intestines + C. jejuni; HET + S. Enteritidis; ELC+ ILTV; 
Chickens +  IBDV; hMph + LPS; HCA-7 C. jejuni; pMph + LPS; 
bMph + LPS; hMph + bacteria and bacterial components; hMph 
and DCs + parasites; hDCs +  E. coli, C. albicans, influenza virus 
iNOS  chMph+ LPS; Chicken spleen + NDV; ELC+ ILTV; chMph+ APEC; 
Chickens +  IBDV 
IRAK2 HD11 + S. Typhimurium; hNEUT + LPS; bMph + LPS 
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IRF1 chPBMC+ S. Enteritidis; chicken intestines + C. jejuni; Chicken 
spleen + NDV; Chickens +  IBDV; hMph + LPS; pMph + LPS; 
hMph + bacteria and bacterial components; hMph and DCs + 
parasites; Chickens +  AIV 
IRF10 Chicken spleen + NDV; chPBMC+ S. Enteritidis; Chickens +  AIV 
IRF7 Chicken spleen + NDV; chicken intestines + C. jejuni; chPBMC+ 
S. Enteritidis; hMph + LPS; pMph + LPS; hMph and DCs + 
parasites 
IRG1 HET RNA-seq ; chicken intestines + C. jejuni; ELC+ ILTV 
JUN  HD11 + S. Typhimurium; chPBMC+ S. Enteritidis; hMph + 
bacteria and bacterial components 
LYG2 BMDM + LPS RNA-seq; chicken intestines + C. jejuni; ELC+ ILTV 
LYZ Chicken spleen + NDV; ELC+ ILTV; chicken intestines + C. jejuni 
MADPRT BMDM and BMDC + LPS RNA-seq; chicken intestines + C. jejuni 
MAFA BMDM and BMDC + LPS RNA-seq 
MAFF BMDC + LPS RNA-seq; hMph + LPS 
MARCKSL1 BMDM and BMDC + LPS RNA-seq; chicken intestines + C. jejuni 
MYD88 ChPBMC+ S. Enteritidis; pMph + LPS; hMph and DCs + parasites; 
Chickens +  AIV 
NDNF BMDM and BMDC + LPS RNA-seq 
NFKB2 BMDC + LPS RNA-seq; chPBMC+ S. Enteritidis; chicken intestines 
+ C. jejuni; hMph + LPS; hNEUT + LPS; hMph and DCs + parasites 
NFKBIA HD11 + S. Typhimurium; hNEUT + LPS; bMph + LPS; pMph + LPS; 
hMph + bacteria and bacterial components; hMph and DCs + 
parasites 
NFKBIZ chPBMC+ S. Enteritidis; ELC+ ILTV; hNEUT + LPS; PMph + LPS 
NLRC5 BMDC + LPS RNA-seq ; HD11 + S. Typhimurium; hNEUT + LPS 
NR4A3 HET + LPS RNA-seq; chicken intestines + C. jejuni; bMph + LPS 
PFKFB3 BMDM and BMDC + LPS RNA-seq; bMph + LPS 
PKD2L1 BMDM and BMDC + LPS RNA-seq 
PLA2G5 BMDM + LPS RNA-seq ; chicken intestines + C. jejuni 
PLK3 BMDM and BMDC + LPS RNA-seq; hNEUT + LPS 
PPARG ELC+ ILTV; HET + S. Enteritidis: chicken intestines + C. jejuni 
PTGS2 BMDM and BMDC + LPS RNA-seq; bMph + LPS; HET + S. 
Enteritidis; hMph and DCs + parasites 
RASD1 HET + LPS RNA-seq; chicken intestines + C. jejuni; ELC+ ILTV 
RNF19B BMDC + LPS RNA-seq ; chicken intestines + C. jejuni 
SAAL1 BMDM and BMDC + LPS RNA-seq 
SDC4 BMDM + LPS RNA-seq; HCA-7 + C. jejuni; hMph + bacteria and 
bacterial components; Chickens + AIV 
SELE BMDC + LPS RNA-seq; pMph + LPS; chicken intestines + C. jejuni 
SERPINE2 BMDM and BMDC + LPS RNA-seq 
SLC39A8 BMDM + LPS RNA-seq; bMph + LPS 
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SLCO6A1 BMDM and BMDC + LPS RNA-seq 
SNX10 HET + LPS RNA-seq; ELC+ ILTV 
SOCS1 BMDC and BMDM + LPS RNA-seq; Chicken spleen + NDV; 
chPBMC+ S. Enteritidis; ELC+ ILTV; pMph + LPS; Chickens + AIV 
SOCS3 BMDC + LPS RNA-seq ; Chicken intestines + C. jejuni; ELC+ ILTV; 
chPBMC+ S. Enteritidis; bMph + LPS; pMph + LPS; hNEUT + LPS; 
hMph and DCs + parasites 
SPTSSB BMDM + LPS RNA-seq; chicken intestines + C. jejuni 
STEAP1 BMDM and BMDC + LPS RNA-seq 
STEAP4 HET and BMDC + LPS RNA-seq; pMph + LPS 
TGM4 HET, BMDM and BMDC + LPS RNA-seq; chicken intestines + C. 
jejuni; CE cell lines + AIV 
TIMD4 HET + S. Enteritidis; pMph + LPS 
TIRAP chPBMC+ S. Enteritidis; HET + S. Enteritidis; bMph + LPS 
TLR15 HET + LPS RNA-seq; chPBMC+ S. Enteritidis 
TLR4 HET + LPS RNA-seq ; ChPBMC+ S. Enteritidis; PMph + LPS; 
BMph + LPS 
TNFAIP3 Chicken intestines + C. jejuni; HD11 + S. Typhimurium; bMph + 
LPS; HCA-7 C. jejuni; hNEUT + LPS; pMph + LPS; hMph + bacteria 
and bacterial components; hMph and DCs + parasites 
TNIP2 BMDM and BMDC + LPS RNA-seq 
TOLLIP ChPBMC+ S. Enteritidis; ChPBMC+ S. Enteritidis 
TP53I11 BMDM + LPS RNA-seq ; hNEUT + LPS 
TRAF3IP2 ELC+ ILTV; ChPBMC+ S. Enteritidis 
UPP1 BMDC RNA-seq ; hNEUT + LPS 
WDR24 HET + LPS RNA-seq; chicken intestines + C. jejuni 
Legend: hNEUT – human neutrophils; bMph – bovine macorphages; chMph – chicken macrophages; 
hMph – human macrophages; pMph – pig macrophages; chPBMC – chicken peripheral blood 
mononuclear cells; HET- heterophils; ELC – embryonic lung cells; hDC- human dendritic cells; CE – 
chicken embryo; + LPS – stimulated with LPS; Genes symbols highlighted in red – genes not cloned in 
this study; blue – downregulated genes in selected studies 
 
 Molecular cloning and sequencing of candidate genes 4.3.4
Among the 32 candidate genes selected based on analysis of published 
literature (Table 4.1), 12 were cloned and confirmed by other group members. From 
the 20 remaining genes, 19 were cloned and sequenced in this study. In order to 
design the primer pairs for molecular cloning, the sequences for the candidate 
genes were searched in both the Ensembl (www.ensembl.org) and the NCBI 
(www.ncbi.nlm.nih.gov/) databases. The primer pairs were designed to clone either 
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full or partial sequence of the gene in cases were more than one transcript was 
available and either 5’ or 3’ end sequence differed.  
The same approach was used to clone the mRNA coding sequences of genes 
selected based on the RNA-seq results. Out of 104 genes of interest, six were cloned 
previously by other members of the group. From the remaining number of genes, 
72 were cloned in this study and their sequences were confirmed. The cloned 
sequences for all the genes are shown in Appendix 2 (electronic file). Examples of 
agarose gel images for selected amplicons are shown in Figure 4.3.  
 
Figure 4.3. Examples of agarose gel images of amplicons of cDNAs for selected genes of interest. 
Primers for each gene were used in PCR reactions with cDNA from BMDC + LPS, HD11 cell line + LPS 
and CD40L, heterophils + LPS, BMDM + LPS (left to right for each amplicon A-L). Panel A - 
ENSGALG00000005747 (1056 bp), B - C3ORF52 (700 bp), C - MADPRT (891 bp), D - STEAP1 (759  bp), 
E - ETS2 (1440 bp), F - LYG2 (541 bp), G - EDN1 (618 bp), H - BATF3 (292 bp), I - SDC4 (545 bp), J -
 MARCKL (no band), K - MAFA (861 bp), L - PFKFB3 (1189 bp); Ladder - GeneRulerTM DNA Ladder Mix 
10kb. 
  
A               B                   C               D                   E               F 
G                H                  I                J                     K               L 
95 
An example of agarose gel electrophoresis to confirm cloning of amplicons by 
colony PCR is shown in Figure 4.4. Though in most cases amplicons of the expected 
size were obtained, rarely amplicons of an aberrant number or size were detected 
(e.g. amplicons from clones E2, G2, I3 and K1) .
 
Figure 4.4. Examples of agarose gel electrophoresis to validate pGEM-T clones of selected amplicons 
by PCR. Panel A - ENSGALG00000005747 (1056 bp), B - C3ORF52 (700 bp), C - MADPRT (891 bp), D - 
STEAP1 (759 bp), E - ETS2 (1440 bp), F - LYG2 (541 bp), G - EDN1 (618 bp), H - BATF3 (292 bp), I - 
SDC4 (545 bp), J - MAFA (861 bp), K - PFKFB3 (1189 bp); Ladder - GeneRulerTM DNA Ladder Mix 10kb. 
  
G                 H                     I                   J                       K 
A                  B                      C                  D                      E                F 
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 Discussion 4.4
The aim of this study was to select ~100 genes involved in innate immune 
responses in chickens that represent immune robustness/performance. Their 
expression will be examined using a high-throughput qPCR platform 96.96 Dynamic 
Array from Fluidigm. Many genes are repeatedly used in qPCR experiments on 
immune responses, such as proinflammatory cytokines and chemokines. These 
genes are proven to be important markers in immune-related studies but there are 
many additional genes which may assist in estimation of the immune robustness. To 
create a broader view of immune performance, a list of genes of interest was 
generated by scrutiny of available literature and RNA-seq analysis of primary cells 
stimulated with bacterial LPS.  
The use of whole transcriptome platforms, such as microarrays, or the use of 
RNA-seq would be more informative as a screening tool but these techniques could 
not be used for screening a larger number of birds in a rapid and cost-effective 
manner. In addition, analysis of the sequencing data would be complex and time-
consuming. To be included in the list of genes of interest, the corresponding 
transcript had to be upregulated at least twice in two different studies. This 
instruction allowed selection of more genes, as many of the DE genes were only 
characteristic to one of the experimental settings. The published studies were 
performed with a number of pathogens infecting different organs or cell types. The 
genes selected from those studies were upregulated in early timepoints suggesting 
their involvement in the innate immune responses. Addition of the data from RNA-
seq studies performed on primary chicken cells stimulated with LPS expanded the 
list of genes.  
Molecular cloning was performed in order to confirm the sequences of 
selected genes of interest as many of them have few mRNA transcript sequences 
available in the databases. Therefore, the primer design had to include only the 
common part of the transcript to avoid difficulties with molecular cloning. As a 
result, many genes were detected in numerous cDNA samples used as a template, 
which means that they were involved in immune responses to different 
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pathogens/antigens used in a particular study. There were also amplicons that were 
only obtained in one of the cDNA templates used in the cloning panel and few were 
not obtained at all. The reason behind this may lie in the primers not being optimal 
for the qPCR reactions but also the design could have been based on an incorrectly 
assembled or annotated sequence. The first release of the chicken genome draft in 
2004 has proven to be an important tool in avian genomic research but since then 
many changes have been introduced to improve the annotation. The main tools for 
building predicted annotations were based on the homology with sequences from 
human and mouse full-length cDNA making this approach successful for protein-
coding genes. This method was not effective when translated across to birds which 
are evolutionary distant from mammals. This has proven to be even less useful for 
the annotation of rapidly evolving innate immune genes or non-coding genes. The 
Ensembl gene annotation protocol now incorporates the RNA sequencing data to 
expand the prediction of chicken genes (Flicek et al., 2014). The gene list was 
created before the update of Ensembl chicken genome with the RNA-seq results, 
which could lead to changes in the mRNA sequences of the selected innate immune 
genes. When genes were selected from previous studies, the gene symbols along 
with the annotation IDs were examined to ensure that all studies reported 
upregulation of the same mRNA fragment. Many genes have multiple names but 
also mammalian nomenclature is often assigned to genes, which cause confusion 
when used interchangeably with chicken names. By carefully selecting the gene 
accession numbers and sequences behind them, the final list of cloned genes of 
interest consists of transcripts that were confirmed to be overexpressed in various 
studies.  
Before high-throughput qPCR assays can be used to evaluate transcription of 
the immune-related genes selected here, careful consideration of the reference 
genes for normalisation of data is required. This is the subject of the next Chapter.  
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 Reference gene normalisation Chapter 5
 Introduction  5.1
The aim of this study was to select a set of genes that could serve as internal 
controls in chicken immune-related tissue mRNA expression studies. The expression 
levels of 7 reference genes: β-actin (ACTB), β-2-microglobulin (B2M), 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH), β-glucuronidase (GUSB), 
TATA box binding protein (TBP), α-tubulin (TUBAT), r28S ribosomal RNA (r28S) were 
measured in tissues (spleen, bursa, caecal tonsils, ileum and blood) isolated from 
Aviagen male broilers reared on pedigree and sibling test farms. In order to identify 
the most stable reference genes across the tested samples, the expression 
stabilities of the reference genes were examined using three algorithms: 
NormFinder, Best Keeper and geNorm. NormFinder and geNorm software recognise 
the most suitable control genes by determining their stability value whereas 
BestKeeper uses descriptive statistics and the Pearson correlation coefficient to 
evaluate the most stable reference gene. The use of three algorithms to calculate 
reference gene stability will guide the selection of the most reliable reference 
gene(s) to avoid misinterpretation of expression studies. 
Over the decades, different techniques have been applied to study 
transcriptional regulation in infection studies from northern blotting, cDNA 
microarrays, in situ hybridisation to quantitative PCR (qPCR) (Matulova et al., 2013; 
Sandford et al., 2012; Bojesen et al., 2004). High sensitivity and potential for high 
throughput and enhanced specificity makes qPCR the most exploited molecular 
technique in host-pathogen interaction studies. These characteristics are very 
important in immunological research where genes of interest frequently have many 
splice variants and very low expression levels (Huggett et al., 2005). It is therefore 
an especially useful technique in chicken immunology where not many species-
specific antibodies are commercially available (de Boever et al., 2008). Although it is 
the most relevant method for many experiments, there are still many problems 
associated with its use, mainly inherent variability of RNA samples and differences 
in efficiencies of reverse transcription (RT) and PCRs (Bustin, 2002). An efficient 
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normalisation strategy is needed to collect reproducible and relevant qPCR results 
corrected for non-biological sample-to-sample variations (Andersen et al., 2004). 
Several strategies are available to correct experimentally introduced variation, each 
with their own advantages and considerations (Huggett et al., 2005). Not all the 
sources of variation can be completely reduced, therefore control along the entire 
workflow of qPCR analysis is very important. Lack of standardisation of each step 
and application of normalisation at the final step cannot eliminate errors (Ståhlberg 
et al., 2003). Similar sample sizes for RNA extraction with DNase treatment and 
reverse transcription are recommended together with use of standard curves using 
samples spiked with known quantities of RNA molecules (Gilsbach et al., 2006). 
These are the methods to indicate the efficiency of reverse transcription and qPCR 
inhibition. All these aspects were discussed at the 3rd London qPCR Symposium in 
April 2005 and the agreement was that the reference gene concept is the favoured 
technique for normalisation of qPCR data. The Minimum Information for Publication 
of Quantitative Real- Time PCR Experiments (MIQE) guidelines (Bustin et al., 2009) 
describes the necessary information that should be included in evaluation of qPCR 
experiments and publication of the work. The guidelines emphasise the need to use 
more than one reference gene and the need to report the method of determination 
of reference gene stability.  
Several commercial companies provide optimised reference gene panels for 
many species. The idea of using a housekeeping gene as an internal control is 
attractive as those genes are affected by the same experimental variations as the 
tested genes but are predicted to show stable constitutive expression. Quantitative 
PCR results for a gene of interest are then normalised by using the housekeeping 
reference gene that is measured using the same methods (Vandesompele et al., 
2009). To minimise inaccuracies there are several rules that can be followed, for 
example: uniform sample size, RNA extraction method, reduction of gDNA 
contamination and internal controls. These guidelines are not mutually exclusive 
and can be all included in the protocol (Huggett et al., 2005). In theory, mRNA 
expression levels of any reference gene are stable due to the permanent function 
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that they play in cellular processes (Zhu et al., 2008). Ideal reference genes show 
consistent expression in varying experimental and environmental conditions. 
Expression of genes of interest can then be normalised with internal control genes 
in samples that vary in qualities and quantities of starting RNA. Differences in 
enzymatic efficiencies are compensated when reference genes are used as 
normalisers because they undergo the same preparation steps and are exposed to 
the same treatments as the gene of interest.  
So far an ideal reference gene has not yet been identified (Bär et al., 2009). 
Many authors suggest that definite or universal internal control gene for every 
condition in different tissues and cells does not exist (Vandesompele et al., 2002; 
Coulson et al., 2008; Maltseva et al., 2013). There is an increasing number of studies 
on widely employed reference genes that prove many of them are not resistant to 
changes in the experimental environment (Bas et al., 2004; Yin et al., 2011; Sugden 
at al., 2010; Yang et al., 2013; Schmittgen and Zakrajsek 2000; Lupberger et al., 
2002; Dheda et al., 2004; He at al., 2008; Yue et al., 2010). Based on these and 
many other studies that prove there is no universal internal control for gene 
expression analyses it has been suggested that determination of appropriate 
reference genes should be performed for every qPCR experiment (Riemer et al., 
2012). Most frequently used reference genes are: ACTB, GAPDH, r18S or r28S. 
GAPDH is a catalytic enzyme in glycolysis and it participates in DNA repair (Meyer-
Siegler et al., 1991). In the early years of qPCR technique, the use of GAPDH as a 
reference gene was shown to be constant (Edwards and Denhardt 1985; Winer et 
al., 1999). There have been many reports of GAPDH instability in gene expression 
induced during the experiment (Lin et al., 2009; Sudgen et al., 2010). An 
investigation of IL-4 and Toll-like receptors expression in TB patients has shown that 
normalisation to inappropriate reference gene (GAPDH and ACTB) changed the 
significance of results (Dheda et al., 2005). Earlier, Suzuki et al. (2000), Stűrzenbaum 
and Kille (2001) established that GAPDH mRNA expression levels could be 
influenced by experimental conditions, both in vivo and in vitro. Mozdziak et al. 
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(2003) also established that in chickens, nutritional manipulations can alter 
transcription of GAPDH and its levels are upregulated with age.  
Yin et al. (2011) evaluated the stability of expression for 11 genes in mouse 
and 8 genes in chicken under different experimental conditions. Results have shown 
that practice of use of popular reference genes without prior stability normalisation 
could lead to inaccurate and divergent qPCR data. The conventional use of a single 
reference gene was also demonstrated to introduce large errors (Vandesompele et 
al. 2002). Often the decision which gene should be included as reference in 
particular study is based on past experiments. The published studies on evaluation 
of mRNA expression levels in different tissues or cells, under different treatments 
and from various species use similar reference genes to normalise the data 
(Banskota et al., 2015; Ji et al., 2014, Xiao et al., 2015). A literature search has also 
shown that no single gene has been consistently used as reference gene in studies 
related to chicken immune system (Abasht et al., 2009; Adams et al., 2009, Brisbin 
et al., 2010).  
RNA extraction techniques do not guarantee the total exclusion of genomic 
DNA (gDNA), which in consequence could give false-positive readings unless reverse 
transcription is designed to span exon-intron boundaries. Genomic pseudogenes 
retain introns, thus their size is bigger (Smith et al., 2001). There are also intronless 
pseudogenes that have arisen by retrotransposition. They resemble target 
sequences and have 3’ polyA tail, therefore, designing primers that span intron -
exon boundaries is not applicable as these DNA structures cannot be distinguished 
from cDNA (Mighell et al., 2000).  
Researchers have used many methods to identify reference genes. The most 
popular strategies are the use of algorithms such as GeNorm (Vandesompele et al., 
2002), BestKeeper (Pfaffl et al., 2004) and NormFinder (Andersen et al., 2004). As 
the statistical methods behind these programs differ in their assumptions, many 
researchers use more than one program to assess stability of candidate reference 
genes (Chang et al., 2012; Ledderose et al., 2011; Perez et al., 2008).  
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Vandesompele et al. (2002) suggests using an expression stability index (M 
value) that would be calculated based on mean pair-wise variations between the 
gene and the other candidate genes across all samples. The underlying principle for 
software is that the expression ratio of two reference genes is constant across all 
samples. geNorm calculates pairwise variation for each gene with all other genes as 
the standard deviation of the logarithmic transformed expression ratios. Next, the 
stability value (M) is calculated as the pairwise variation of particular reference 
gene with all other tested candidate genes. The software performs additional 
variation analysis of normalisation factors calculated for an increasing number of 
reference genes to determine the minimal number of reference genes for accurate 
normalisation (Vandesompele et al., 2009). The NormFinder algorithm, developed 
by Andersen et al. (2004), identifies the most stable gene (pair of genes) with the 
use of mathematical model supported by a statistical framework. It ranks the 
candidate genes in a given sample and given experimental design based on their 
expression stability value. Mathematical, ANOVA-based model uses statistical 
framework to determine the overall expression variation of the genes but also the 
variation between subgroups. NormFinder relies on Q values to estimate the 
stability of each gene. Quantities are first log-transformed and then used in an 
ANOVA model-based approach to calculate expression variation where intra- and 
inter-group variations are estimated. The two sources of variation represent 
systematic error that will occur when the given gene will be used (Andersen et al., 
2004). The gene with the lowest M value is the most stable in expression and the 
gene with the highest M value has the least stable expression. BestKeeper 
calculates the gene expression variation for the chosen reference genes based on 
the collected Cq values. The examination consists of two steps: first is the 
descriptive statistics analysis: geometric mean (GM), arithmetic mean (AM), 
minimal (Min) and maximal (Max) value, standard deviation (SD) and coefficient of 
variance (CV). Using CV and SD values, in a second step, pairwise correlation 
analysis is performed using BestKeeper Index (BKI). The most stable genes have the 
lowest CV and where the SD value is below 1. Internal controls with SD higher than 
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1 are regarded as unreliable. All the candidate genes showing stable expression are 
combined into BKI values for the individual sample using geometric mean of Cq 
values for each of the reference genes using the Equation 1. BestKeeper also 
analyses inter-HKG relations by Pearson correlation coefficient (r) and the 
probability (p) value.  
𝐵𝐾𝐼 = √𝐶𝑞1 𝑥 𝐶𝑞2 𝑥 𝐶𝑞3 𝑥 … 𝐶𝑞𝑧
𝑧
 
Equation 1.  BestKeeper Index calculation 
The Pearson correlation coefficient (r) and the p-value are then used to describe the 
correlation between each candidate gene and the index. Comparison of each gene 
using pair-wise correlation analysis and the BKI gives the optimal reference genes in 
terms of their stability (Pfaffl et al., 2004).  
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 Materials and methods 5.2
 Tissue collection 5.2.1
Samples were collected from broiler chickens reared at an Aviagen high 
biosecurity pedigree farm and a farm where environment aimed to resemble 
broader commercial conditions - sibling test farm. The 3-week-old birds (n=10) 
came from the same hatch. Bursa of Fabricius, spleen, caecal tonsils and part of the 
gut (ileum) were collected and stored at 4°C in RNAlater until further use. Blood, in 
a volume of ~1 ml, was collected into EDTA containing tubes and isolation of white 
blood cells was performed the same day, as described in Chapter 2, section 2.5.4.  
 RNA extraction and cDNA synthesis 5.2.2
To perform EvaGreen-based qPCRs for reference gene normalisation, total 
RNA was isolated from collected tissue and blood samples and reversely transcribed 
to generate cDNA, which was then used as a qPCR template. Total RNA was isolated 
using an RNeasy Mini Kit (Qiagen, Crawley, UK), as described in Chapter 2, section 
2.6.1 and 2.6.2 with an additional DNase step. The quality and quantity of extracted 
total RNA was evaluated by spectrophotometry using a NanoDrop™ 1000 
instrument. First-strand cDNA synthesis was performed using a SuperScript III 
reverse transcription kit (Paisley, UK) containing random primers (Sigma-Aldrich, 
Poole, UK), as described in Chapter 2, section 2.7.2. The same amount of total RNA 
(1 μg) was used to generate cDNA from the tissues and blood collected. The cDNA 
was stored in -20°C until further use.  
 Gene selection and quantitative PCR 5.2.3
Seven genes commonly used as reference genes in quantitative PCR (qPCR) 
gene expression experiments were selected and are briefly described in Table 5.1. 
All qPCR primers were designed using Primer Express Software 3.0 (Life 
Technologies) and synthesised by Sigma Aldrich (Poole, UK). Primer sequences and 
amplicons length are shown in Appendix 1, Table 6. Quantitative PCR, using 7500 
Fast Real-Time PCR System was performed as described in Chapter 2, section 2.7.6. 
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For each primer pair internal standard curves (serial dilutions of pooled cDNA 
samples for all tissues) were used to assign relative concentrations to the samples. 
Table 5.1. Reference genes selected for evaluation and the function of the encoded products. 
Gene 
symbol 
Gene name Function 
ACTB β-actin 
Essential component of the cytoskeleton, critical roles in a wide 
range of cellular processes, including cell migration and cell 
division 





Catalytic role in the oxidative phosphorylation of glyceraldehyde 
3-phosphate to 1,3-bisphospoglycerate during glycolysis and in 
gluconeogenesis 
GUSB β-glucuronidase Catalytic role in breakdown of complex carbohydrates 
TBP 
TATA box binding 
protein 
Subunit of the transcription factor TFIID, first protein to bind to 
DNA during the formation of the pre-initiation transcription 
complex of RNA polymerase II (RNA Pol II) 
TUBAT α-tubulin Part of the microtubule forming system, binds to GTP 
r28S r28S ribosomal RNA 
Structural RNA for the large component of eukaryotic 
cytoplasmic ribosomes 
 
 NormFinder, geNorm and BestKeeper analyses 5.2.4
To select suitable internal controls, the stability of each gene was statistically 
analysed with three software tools: GeNorm (Vandesompele et al., 2002; section 
2.1.?); NormFinder (Andersen et al., 2004; section 2.1.8) and BestKeeper (Pfaffl et 
al., 2004; section 2.1.7). All three packages were used according to the 
manufacturer’s instructions.  
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 Results 5.3
 Validation of reference gene primers 5.3.1
Primer pairs for seven reference genes were designed against the template 
using Primer Express software 3.0 and following six strict conditions described in 
Chapter 2, section 2.7.5. Primers pairs span exon-intron boundaries for the ACTB, 
B2M, GAPDH, GUSB and TBP gene. The r28S ribosomal RNA does not carry coding 
sequence and the TUBAT gene primer pair does not cross exon-intron boundaries, 
as attempts to optimise previously designed oligonucleotides were unsuccessful. 
Primer pair specificity was tested in qPCR by examining the melting curve 
performed at the end of the reaction (Figure 5.1a). The single peak with no 
shouldering suggested the specificity of primer annealing. Primer pairs that 
produced more than one peak and/or shoulder were tested again and, when 
needed, redesigned. Amplicons from qPCR reactions were confirmed by agarose gel 
electrophoresis, where a single band suggested a single amplicon. Results of melting 
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Figure 5.1. Specificity of qPCR reaction with reference gene primers ; a) melting curve analysis to 


































 Expression profiles of reference genes 5.3.2
Expression profiles of each reference gene were examined by calculating 
quantification cycle (Cq) value, which represents the cycle number at which the 
fluorescence generated in the reaction crosses the fluorescence threshold above 
the background signal. It usually is the middle of exponential phase of reaction. The 
expression levels of the seven reference genes tested varied widely between the 
genes studied with Cq values ranging from 9 to 38 cycles (Figure 5.2) and most of 
the Cq values were between 18 and 31 cycles. The r28S gene was most abundantly 
transcribed with Cq values of less than 17 cycles and ACTB, B2M and GAPDH were 
moderately expressed with average Cq values between 18 and 23 cycles. GUSB, TBP 
and TUBAT showed average Cq values between 27 and 31 cycles. The lowest 
expression level was observed in TUBAT with Cq value as high as 38 cycles. The 
inspection of raw Cq values alone is not sufficient for determining gene expression 
stability. The data obtained from qPCR were further analysed using NormFinder, 
geNorm and BestKeeper. Only the last algorithm allows for input of raw Cq data 
from qPCR. For the others, data was transformed into relative quantities. The 
transformation process is described in paragraph 5.3.3. 
 
Figure 5.2. Quantification cycles (Cq) values reflecting expression levels of seven reference genes in 
all tissues tested. Data points represent single sample (n=50, 10 birds, 5 tissues) Cq value for 

































 Transformation of Cq values to quantities (Q) 5.3.3
Quantification cycle values were generated in qPCRs for each gene tested 
and in each tissue sample derived from birds reared on the pedigree and sib ling test 
farms. In order to optimise qPCRs for each reference gene, 10-fold serial dilutions of 
pooled cDNA samples (n=50) were tested on the same plate to avoid run-to-run 
differences and results were used to generate standard curves. To calculate the 
efficiency of reaction, the slope value was calculated from serial dilutions for each 
gene, which was then used to determine the efficiency of reaction (Equation 2). 
Complete calculations for all reference genes are presented in Appendix 1, Table 7 
for the sibling-test farm and Table 8 for the pedigree farm. In order to obtain 
accurate and reproducible results, reactions should have efficiency close to 2 
(100%), which means that the template doubles with each cycle during exponential 
amplification. A slope of - 3.32 indicates optimal PCR efficiency. 
𝑬 = 𝟏𝟎(− 𝟏/𝒔𝒍𝒐𝒑𝒆) 
alternative                        [%] 𝑬 = (𝟏𝟎(−𝟏/𝒔𝒍𝒐𝒑𝒆) − 𝟏) x 100 
Equation 2. Calculation of efficiency (E) of reaction 
Mean quantification cycle (Cq) values were transformed into quantities (Q) by the 
deltaCq (ΔCq) method where the Cq value of a particular sample was related to the 
control/calibrator. In this experiment, the control/calibrator was the sample with 
the highest expression (lowest Cq value). Relative quantities were generated by the 
ΔCq formula for transforming Cq values to relative quantities with the highest 
expression level set to one (Equation 3).  
𝑸 = 𝑬−𝜟𝑪𝒒 
Equation 3. Relative quantities formula 
The ΔCq method generated raw, non-normalised expression values, which required 
normalisation if used for gene expression studies, by dividing with the normalisation 
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factor. The Q values were used as input data in NormFinder and geNorm 
programmes.  
 NormFinder analysis 5.3.4
The analysis with NormFinder software identified ACTB and TBP as the best 
combination of genes for all tissues with a stability value across all tissues of 0.076, 
where TBP (0.110) was ranked the most stable gene. The TUBAT gene (0.596) was 
ranked the most unstable gene in tissue panel tested. The stability of the genes 
varied depending on the tissue tested. Analysis was also performed for each tissue 
type separately. TBP was ranked the most stable gene in bursa (0.188), spleen 
(0.052) and caecal tonsils (0.157). In the Peyer’s patches region of the ileum, GUSB 
(0.220) was ranked the most stable. In blood samples, GAPDH (0.137) was selected 
as the best gene. In spleen and blood TBP was paired with GUSB (0.037 and 0.147), 
in bursa samples with GUSB (0.171), in caecal tonsils with r28S (0.125) and in ileum 
with ACTB (0.194) as the best pair of genes. Results showing the most stable genes 
and their stability values as predicted by NormFinder are shown in Table 5.2.  
Table 5.2. NormFinder (NF) analysis of the most stable reference genes and their stability values for 
all sample tested. 
Tissue Best gene NF stability value Combination of two genes NF stability value 
Bursa TBP 0.188 GUSB, TBP 0.171 
Spleen TBP 0.052 GAPDH, TBP 0.037 
Caecal tonsils TBP 0.157 r28S, TBP 0.125 
Ileum GUSB 0.22 ACTB, TBP 0.194 
Blood GAPDH 0.137 B2M, GAPDH 0.147 
All tissues TBP 0.11 ACTB, TBP 0.076 
Legend: ACTB - β-actin; b2m - β-2-microglobulin; GAPDH - glyceraldehyde-3-phosphate dehydrogenase; GUSB - 
β-glucuronidase; TBP - TATA box binding protein; TUBAT - α-tubulin; r28S - r28S ribosomal RNA. 
Overall, the TBP gene was selected as the most stable gene in most of the 
tissues either as the best gene or paired with a second gene as the best reference 
gene combination in given tissue panel. When samples from two different farms 
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were examined separately, TBP was selected as the best gene for tissues from birds 
raised on the pedigree farm and the best combination of two genes was TBP and 
GAPDH (0.154). For the sibling test farm GAPDH was paired with GUSB (0.096) and 
GUSB was ranked the most stable.  
 geNorm analysis 5.3.5
Reference gene normalisation was also performed using geNorm, a visual 
basic application (VBA) for Excel. The analysis of all samples from both farms using 
geNorm identified TBP and B2M (M = 0.73) as the most stable pair of genes (Table 
5.3). Similar to analysis with NormFinder, ranking of genes was performed on 
separate tissues. For both bursa and spleen tissues GAPDH and TBP were selected 
the best pair of genes with stability M values of 0.4 and 0.34, respectively. Ileum 
and blood tissues shared B2M as one of the most stable genes that was paired with 
TBP (M = 0.79) and GAPDH (M = 0.4), respectively. Caecal tonsils analysis resulted in 
ACTB and r28S (M = 0.42) being the best pair of reference genes. Results are shown 
in Table 5.3. 
Table 5.3. geNorm analysis showing the pairs of most stable reference genes for each tissue sample 
tested and their stability expression M value. 
Tissue Combination of two genes geNorm M value 
Bursa GAPDH, TBP 0.4 
Spleen GAPDH, TBP 0.34 
Caecal tonsils ACTB, r28S 0.42 
Ileum B2M, TBP 0.79 
Blood B2M, GAPDH 0.4 
All tissues B2M, TBP 0.73 
Legend: ACTB - β-actin; b2m - β-2-microglobulin; GAPDH - glyceraldehyde-3-phosphate dehydrogenase; GUSB - 
β-glucuronidase; TBP - TATA box binding protein; TUBAT - α-tubulin; r28S - r28S ribosomal RNA. 
The geNorm algorithm proposes the optimal number of reference genes in 
studied samples. The levels of variation in average reference gene stability are 
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calculated based on the stepwise inclusion of a subsequent gene or genes. The 
geNorm software calculates normalisation factor (NF) from at least two genes. The 
pairwise variation (V) between two sequential NFs is determined. The additional NF 
for reference gene should decrease the variation, preferably below the cut-off point 
of 0.15 in order to include it in the panel of final reference genes for given samples. 
In this study, addition of a fourth gene caused the decrease in variation in stability 
in all types of tissues. For bursa and spleen tissues, ACTB and B2M were included, 
which decreased variation in stability to 0.13 and 0.14 respectively. For caecal 
tonsils, TBP and GAPDH addition had similar effect (V = 0.14). In case of ileum ACTB 
and r28S, decreased variation in stability from 0.25 to 0.22 and in blood ACTB and 
TBP reduced the variation to 0.17. When all tissues were analysed together, 
addition of ACTB and GAPDH to the calculation caused the decrease in variation to 
an almost ideal point of 0.16 (Figure 5.3). 
 
Figure 5.3. The pairwise variation (Vn/Vn + 1) between the normalisation factors NFn and NFn+1 to 
determine the optimal number of reference genes for normalisation. 
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 BestKeeper analysis 5.3.6
In this study, Cq values of all tissues for each reference gene tested were 
combined. The first step of analysis showed that none of the genes passed the 
ranking based on standard deviation (SD) and coefficient of variance (CV) levels. 
According to BestKeeper developers, the standard deviation for any given gene 
should be below value of 1. Genes with this parameter higher than 1 can be 
considered inconsistent. Standard deviations for all of the analysed genes were 
higher than 1, with TUBAT SD of 3.03. The lowest SD were calculated for ACTB 
(1.27) and r28S (1.22). Based on the results from descriptive statistics for all tissues 
combined, ranking of reference genes using BestKeeper was impossible.  
The Cq values for tissues were tested separately. Results are presented in 
Table 5.4. Standard deviation of Cq values from bursa (Table 5.4a) were below value 
of 1 for ACTB, GAPDH, TBP and r28S. The lowest CV was calculated for TBP. Based 
on those rankings B2M, GUSB and TUBAT were excluded from the analysis. 
BestKeeper Index calculated based on the remaining four reference genes was then 
correlated with each gene separately. The highest correlation was for ACTB, 
followed by GAPDH, TBP and r28S.  
The same approach was used to analyse Cq data from caecal tonsils (Table 
5.4b). Standard deviation for B2M and TUBAT were above 1 and genes were 
excluded from the analysis. This resulted in high correlations, with p values lower 
than 0.001, for all remaining genes: r28S, TBP, GUSB, GAPDH and ACTB. 
In BestKeeper analysis of ileum tissues (Table 5.4c) three reference genes 
(B2M, TUBAT and r28S), were excluded from further calculations based on their 
high SD. Further analysis with four remaining genes showed the highest correlation 
for TBP, GUSB and ACTB, with GAPDH having the lowest correlation among tested 
genes. 
Based on descriptive statistics calculations performed on Cq values from 
spleen, TBP and TUBAT did not pass the ranking (Table 5.4d). After exclusion of TBP 
and TUBAT from the analysis, calculations of correlation showed that ACTB was the 
most stable gene, followed by GAPDH, B2M, r28S and GUSB. 
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Table 5.4. BestKeeper analysis results. SD, CV values and pair-wise correlation with BestKeeper Index 
describing stability for tested reference genes. Genes with SD > 1 (red) were excluded from the pair-
wise correlation analysis. The most stable genes for each tissue are highlighted in green. 
a) Bursa ACTB B2M GAPDH GUSB TBP TUBAT 28S 
Standard 
deviation [± Cp] 
0.79 1.05 0.74 2.05 0.79 3.65 0.43 
Coefficient of 
variance[% Cp] 
4.25 5.16 3.22 7.95 2.82 12.90 3.88 
Pair-wise correlation with BestKeeper Index (n = 4) 
 
BestKeeper  vs. ACTB B2M GAPDH GUSB TBP TUBAT 28S 
Coefficient of  
correlation [r] 
0.959 - 0.929 - 0.856 - 0.802 
p-value 0.001 - 0.001 - 0.002 - 0.005 
b) Caecal tonsils ACTB B2M GAPDH GUSB TBP TUBAT 28S 
Standard 
deviation [± Cp] 
0.51 1.22 0.58 0.79 0.71 1.59 0.49 
Coefficient of 
variance[% Cp] 
2.78 6.07 2.53 2.85 2.51 4.88 4.45 
Pair-wise correlation with BestKeeper Index (n = 5) 
 
BestKeeper  vs. ACTB B2M GAPDH GUSB TBP TUBAT 28S 
Coefficient of  
correlation [r] 
0.906 - 0.916 0.939 0.972 - 0.984 
p-value 0.001 - 0.001 0.001 0.001 - 0.001 
c) Ileum ACTB B2M GAPDH GUSB TBP TUBAT 28S 
Standard 
deviation [± Cp] 
0.69 1.23 0.85 0.76 0.93 2.29 1.27 
Coefficient of 
variance[% Cp] 
3.54 5.82 3.63 2.69 3.18 6.96 10.99 
Pair-wise correlation with BestKeeper Index (n = 4) 
 
BestKeeper  vs. ACTB B2M GAPDH GUSB TBP TUBAT 28S 
Coefficient of  
correlation [r] 
0.825 - 0.719 0.836 0.940 - - 
p-value 0.003 - 0.019 0.003 0.001 - - 
d) Spleen ACTB B2M GAPDH GUSB TBP TUBAT 28S 
Standard 
deviation [± Cp] 
0.97 0.88 0.93 0.82 1.02 2.15 0.67 
Coefficient of 
variance[% Cp] 
5.50 4.35 4.14 2.97 3.72 6.95 6.32 
Pair-wise correlation with BestKeeper Index (n = 5) 
 
BestKeeper  vs. ACTB B2M GAPDH GUSB TBP TUBAT 28S 
Coefficient of  
correlation [r] 
0.920 0.846 0.917 0.680 - - 0.756 
p-value 0.001 0.002 0.001 0.031 - - 0.011 
Legend: ACTB - β-actin; B2M - β-2-microglobulin; GAPDH - glyceraldehyde-3-phosphate dehydrogenase; GUSB - 
β-glucuronidase; TBP - TATA box binding protein; TUBAT - α-tubulin; r28S - r28S ribosomal RNA. 
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Blood samples Cq values were also tested in BestKeeper. Results were similar 
to the test performed on all tissues. All reference gene standard deviation values 
were higher than one, which excluded them from analysis.  
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 Discussion 5.4
The present study simultaneously investigated a panel of seven commonly 
used reference genes in order to establish their expression stability in varied tissue 
samples and birds. NormFinder and geNorm results differed slightly. BestKeeper 
ranking only agreed with NormFinder when caecal tonsil samples were analysed. 
The results for all tissues combined in one analysis were available only from 
NormFinder and geNorm. Three out of four most stable genes were common for 
both analyses: TBP, GAPDH and ACTB. In separate tissues, TBP was the most 
common gene selected by NormFinder and geNorm. There are no published studies 
that use TBP as a reference gene in chicken mRNA expression experiments. Recent 
investigation of five candidate genes in tissues related to growth and fat deposition 
showed that TBP was the most stably expressed in chicken thigh muscle and second 
most stable in liver but its expression varied in breast muscle and fat tissue (Bages 
et al., 2015). TBP was stably expressed together with B2M in bovine granulosa cells 
subjected to different plating densities, oxygen concentrations and follicle 
stimulating hormone (FSH) stimulation (Baddela et al., 2014). The geNorm software 
selected B2M and ACTB as the most optimal reference genes in qPCR studies on 
human mesenchymal stem cells where other programs did not agree and ranked 
ACTB, GAPDH and TBP as the most unstable for that type of cells (Li et al., 2015). 
The variation of expression of a particular candidate gene may be due to its role in 
the tested tissue which has been shown in case of GAPDH where 72 human cells 
and tissues where used. The results exposed up to 14-fold difference of expression 
between some of the samples used (Barber et al., 2005). In this study, GAPDH and 
ACTB surprisingly were ranked as the second or third stable reference genes in 
some chicken lymphoid tissues. A different study on human bone marrow-derived 
mesenchymal stromal cells showed that TBP is the most stably expressed together 
with TFRC and HPRT1 (Rauh et al., 2015).  
There are few published studies on results of reference gene normalisation in 
chicken tissues or cells but all of the existing results differ in ranking of the genes. 
Most of the studies focused on chicken embryo fibroblasts (CEFs) as a virus 
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infection model. Yin et al. (2011) indicated ACTB as the most stably expressed gene 
in CEFs infected with Newcastle disease virus (NDV) and GAPDH with 18S as the 
least stable genes based on their transcriptional profiles only. Yue et al. (2010) used 
CEFs infected with avian influenza virus (AIV) and showed in cell response studies 
that YWHAZ is the most stable gene, where in virus replication studies ACTB and 
RPL4 were most reliable controls according to geNorm calculations. The same 
software was used to determine the best reference gene in CEFs infected with 
subgroup J avian leukosis virus (ALV-J). The geNorm ranked RPL30 and SDHA as the 
best candidates and ACTB and GAPDH as the least stable genes (Yang et al., 2013). 
Studies by the de Boever et al. (2008) on LPS inflammation in chickens resulted in 
GAPDH and UBC being the best pair of internal controls. In duck and chicken 
primary lung cells, infected with low pathogenic AIV and high pathogenic AIV, 
GAPDH was ranked as the second best reference gene after 18S (Kuchipudi et al., 
2012). The use of ribosomal RNA as normaliser has been controversial based on its 
technical limitations and led to exclusion from the analysis (Lu et al., 2013). 
Nevertheless, ribosomal RNA, including r28S and r18S has been shown to be a 
stably expressed reference (Wang et al., 2011; Roge et al., 2007). Li et al. (2007) 
reported that r28S was among few genes with stable expression in chicken embryo 
cells (CEs) infected with infectious bursal disease virus (IBDV) but in the same 
experiment, B2M and TBP were the least stable according to gene fold changes. In 
in vitro stimulation of human blood cells, TBP was shown to be good reference gene 
in studies on T lymphocytes, neutrophils and total blood leukocytes (Ledderose et 
al., 2011). In the current study r28S ranked as the most stable gene in caecal tissues 
together with TBP according to NormFinder and geNorm. After including additional 
genes to the best combination in geNorm analysis, r28S was the fourth most stable 
reference gene in ileum tissue. Although all tissues were normalised with genes 
selected by analysing values from all samples together it would be advantageous to 
select different panel for each tissue in separate calculations.  
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This study is the first report of reference gene normalisation in chicken 
lymphoid tissues. These results demonstrate the need to carefully select reference 
genes for immune gene expression studies as the frequently used genes and 
ribosomal RNA are not always appropriate internal controls. Although this 
experiment showed that TBP, GAPDH and ACTB are the suitable gene expression 
normalisers it is strongly recommended to test internal controls as a first 
experiment in gene expression studies. The selected reference genes will be used in 
the high-throughput qPCR experiment described in Chapter 6. 
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 Optimisation and validation of 96.96 Dynamic Chapter 6
Array as a diagnostic tool 
 Introduction 6.1
The main objectives for this chapter were to develop and validate a custom 
Fluidigm qPCR array for analysis of the transcription of immune-related genes as a 
tool for rapid screening of immune robustness in chickens. Working with our 
partners in Aviagen, the aim was to compare gene expression in related birds in 
high biosecurity clean housing (‘pedigree farm’) and an environment with lower 
biosecurity akin to commercial broiler farms (‘sibling test farm’), as well as to define 
the extent of variance between animals in a given environment. A further goal for 
this study was to compare responses in peripheral blood compared to internal 
organs as a predictor of the robustness of immune responses in the chicken, as non-
lethal methods would allow selective breeding from the live birds screened.  
Immune responses to encountered microorganisms are coordinated on 
cellular and molecular levels. The most exhaustive analysis of tissues and cells can 
be achieved by studying RNA expression. For many years researchers focused their 
efforts on nucleic-acid based tools to detect transcripts, with microarrays being the 
most widely used tool (Germain et al., 2011). Although the levels of mRNA inside 
the cells do not always correspond with the amount of proteins that will be 
produced, exploring immune responses at transcript levels is more accessible. 
Large-scale gene expression analyses are widely used in biological and medical 
studies (Zhong et al., 2008; Nie et al., 2010; Zheng-Bradley et al., 2010). Depending 
on the aim of the study, different tools can be implemented, such as RNA 
sequencing, microarrays or qPCR-based platforms, to analyse changes in the 
transcriptome (Svec et al., 2013). Screening hundreds of targets and samples in 
parallel qPCR for gene expression is possible with high throughput qPCR tools, for 
example the 96.96 Dynamic Array from Fluidigm (Spurgeon et al., 2008). This type 
of gene expression platform supports the effort of broad, unbiased explorations of 
biological systems in comparison to studying a single component in much detail 
with previously set hypotheses (Benoist et al., 2006).  
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The Fluidigm chip has been used to study mRNA and miRNA gene expression 
in different species, for example in pig lung tissues infected with influenza virus 
H1N2 (Skovgaard et al., 2013) or bovine mammary epithelial cells from mastitis 
infections (Sorg et al., 2013). There are also Fluidigm platforms available for single-
cell gene expression analysis (Pieprzyk and High, 2009). The Fluidigm 96.96 chip 
produces data for 96 transcripts in each of 96 total RNA samples (9,216 reactions in 
total). Optimisation of primers, reverse transcription and preamplification, prior the 
use of chip is essential in order to obtain reliable data. The integration of results 
from such a high-throughput qPCR platform with confirmed biological networks is a 
useful approach for gene expression studies.  
In this study, transcription of immune-related genes defined in Chapter 4 was 
compared in a genotypically similar commercial line of chickens housed separately 
at two different levels of biosecurity. The organs that were sampled included: gut-
associated lymphoid tissues (caecal tonsils, ileum part with Peyer’s Patches), bursa, 
spleen and peripheral blood leukocytes. All of these tissues are well known to play a 
role in immune responses. Gene expression responses to viral infections have been 
studied in the bursa (Smith et al., 2015; Rasoli et al., 2015; Smith et al., 2014). Gene 
expression in caecal tonsils has been studied in response to bacterial infections, 
mainly with Salmonella and Campylobacter (Akbari et al., 2008; Shaughnessy et al., 
2009) but also to viral (Heidari et al., 2015) and parasitic infections (Wils-Plotz et al., 
2013). The spleen is very important in mounting both innate and adaptive immune 
responses and is crucial for immune regulation, therefore its responses to different 
stimuli, including parasites and viruses, have been widely studied (Pleidrup et al., 
2014; Lian et al., 2012; Hong et al., 2012). The most frequently studied chicken 
blood cells are lymphocytes but heterophils and peripheral blood leukocytes as a 
whole population were also examined during infections (Chiang et al., 2008; 
Sandford et al., 2012).  
The high-biosecurity ‘pedigree’ farm sampled herein resembles a specific-
pathogen free setting and the ‘sibling-test’ farm mimics the commercial farm 
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environment. The populations received different vaccines (in detail 6.2.1 section). It 
cannot be said with precision what types of pathogens and microflora were acting 
on the immune system of birds in the different environments but there were 
certainly pathogens present on sibling-test farm, including E. coli and Eimeria 
species. From a breeder point of view, identifying transcriptional signatures 
associated with immune robustness in a basal state, or improved responses to 
exposure to pathogen challenge, would only be valid if birds with desirable 
characteristics could be further used in breeding programme, hence a blood test 
would be the ideal tool. 
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 Materials and methods 6.2
 Tissue collection and sample preparation 6.2.1
 Tissues and blood samples were obtained from eight Aviagen broilers from 
the same hatch. Four birds were raised in a high-biosecurity environment (the 
pedigree farm), and four birds were raised in an experimental, pathogen-
challenged, sibling-test farm. The pedigree farm birds were vaccinated at hatchery 
against MDV and IBV then against coccidiosis at day 5, against avian rhinotracheitis 
(TRT) at day 11 and against IBDV at day 15. Birds housed at the sibling-test farm 
were vaccinated against TRT, NDV and IBV at hatch and only received IBDV vaccine 
at day 19. The samples were collected at three weeks of age. Fragments 
(0.5 x 0.5 cm) of four tissues (bursa, spleen, caecal tonsils and ileum with Peyer’s 
patches) were collected aseptically from the same locations in each bird and stored 
in RNAlater until further use. Peripheral blood (1 ml) was collected into tubes 
containing EDTA. Peripheral blood leukocytes (PBLs) were isolated on the same day, 
as described in Chapter 2, section 2.5.4. RNA extractions for PBLs and tissues were 
performed as described in Chapter 2 section 2.6.1 and 2.6.2 with an additional 
DNase digestion step in the cell extraction protocol. 
 cDNA synthesis  6.2.2
 Reverse transcription was performed using SuperScript III (Invitrogen) as 
described in Chapter 2, section 2.7.2. In the first strand reaction, one μg of total 
RNA was used. Synthesised cDNA was diluted 1:5 in nuclease-free water prior to 
preamplification. Reverse transcription using a High Capacity Reverse Transcription 
Kit (Applied Biosystems, UK) was performed as described in Chapter 2, section 2.7.3.  
 Primer design and optimisation 6.2.3
The qPCR primer design is described in Chapter 2, section 2.7.5. Final primer 
sequences are presented in Appendix 1, Table 5. The primer pairs were tested in 
qPCR reactions with serial dilutions of pooled cDNA obtained from RNA isolated 
from tissues and cells from various infection studies. A melting curve step was 
performed to evaluate the specificity of primer pairs. The selected products were 
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purified using Nucleo-Spin Gel and a PCR Clean-up kit (Macherey-Nagel, UK) before 
sequencing. The primer pairs were screened for potential cross-reactivity using the 
AutoDimer algorithm. 
 The BioMark System qPCR 6.2.4
The BioMark System with 96.96 Dynamic Array platform allows to 
simultaneously perform 9,216 reactions, as described in Chapter 1, section 1.5.4 
and Chapter 2, section 2.10. A stock of primer mix was prepared by mixing one μl of 
each primer pair, excluding r28S and ENSGALG00000015395 primers, to the final 
concentration of 200 nM. Preamplification was performed as described in Chapter 
2; section 2.10.4. Unincorporated primers were digested with exonuclease I 
enzyme, as described in Chapter 2, section 2.10.5. To optimise the preamplification, 
different volumes of PreAmp Master Mix and different dilutions of template cDNA 
were used to test optimal concentrations. The qPCR was performed using the 
Applied Biosystems 7500 Fast Real-Time PCR System. Thermal cycling conditions are 
described in Chapter 2, section 2.7.6. Sample and assay mixes were prepared as 
described in Chapter 2, section 2.10.6 and stored in 4°C until further use. The 
priming and loading of 96.96 chip was performed as described in Chapter 2, section 
2.10.7 and 2.10.8. The BioMark HD system Data Collection Software was used to 
perform the qPCR as described in Chapter 2, section 2.10.9.  
 Data analysis settings and visualisation 6.2.5
To analyse the data from 96.96 Dynamic Array Real-Time PCR Analysis 
Software was used as described in Chapter 2, section 2.10.9. The raw Cq values in a 
.csv file were used as an input data in GenEx5 software. Pre-processing, statistical 





 Primer optimisation 6.3.1
The designed primer pairs were tested in qPCR using serial dilutions of pooled 
cDNA samples isolated from tissues from various infection studies as a template. 
The same cDNA pool was used throughout. The melting curve of each primer pair 
was examined to evaluate their specificity. Examples of melting curves and their 
interpretation are shown in Figure 6.1. Each primer pair in this study was set to 
work efficiently at the concentration of 1.15 μM in the final reaction mix to avoid 














CD40 STEAP1 TLR4 
Figure 6.1. Examples of optimisation of primer pairs based on melting curve analysis.  The melting 
curves for each primer pair were investigated; a) two peaks reflects two amplicons; b) one distinctive 
peak corresponds to a single amplicon and additional peaks to genomic DNA products; c) one peak 
with a shoulder corresponds to genomic DNA amplification; d) no peak corresponds to no 
amplification; panels e) and f) show further examples of the desired melting curve. 
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The use of DNA binding dye – EvaGreen, as an amplification detector, instead of 
internal oligonucleotide probes, allowed to design and test several primer pairs 
around the transcript of interest. The design of primer pairs was considered 
successful once the melting curve analysis showed a single sharp peak with no 
additional peaks or shoulders and when single band was visualised by agarose gel 
electrophoresis. The qPCR products with many peaks in the melting curves 
presented in Figure 6.1 produced multiple species on agarose gels, as shown in 
Figure 6.2. 
                 
Figure 6.2. Examples of primer specificity confirmation by agarose gel electrophoresis. Selected qPCR 
products were tested; 1 – CCL19; 2 – IL19; 3 – CD40; 4 – NOS2. 
Amplicons from a subset of 10 qPCR reactions that produced only a single species 
were excised from the agarose gel, cleaned-up and sequenced. Results for selected 















ACTB : CCAGACATCAGGGTGTGATGGTTGGTATGGGCCAGAAAGACAGCTACGTTGGTGATGAAGCCCAGAGCAA :  70 
FWD  : CCAGACATCAGGGTGTGATGGTTGGTATGGGCCAGAAAGACAGCTACGTTGGTGATGAAGCCCAGAGCAA :  70                                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                
ACTB : AAGAGGTATCCTGACCCTGAAGTACCCCATTGAACACGGTATTGTCACCAACTGGGATGATATGGAG    : 137 




r28S    : GGCGAAGCCAGAGGAAACTCTGGTGGAGGTCCGTAGCGGTCCTGACGTGCAAATCGGTCGTC : 62 
FWD     : .....................CGTAGAGATC.GTAGCGGTC.TGACGTGCAA.TCGGTCGTC : 38 
                                                                            
 
IL4I1________________________________________________________________ 
IL4I1  : GCCCTGCAGTCGGCTGTCAAGGAGTTCCAGACCATGAACTGCAAGGAGTATCTGGCTAAACACGACTCCT :  70 
FWD    : ...................................................CTGGCTAA.CACGACTCCC :  18 
                                                                                                                                                                                                                                                             
IL4I1  : TTC.CACCAAGGAATATCTGATTAAAGTCGGGAATCTGAGCCGAGGAGCTGTGCAGATGATCGGAGATTT : 139 
FWD    : TTCTCACCAAGGAATATCTGATTAAAGTCGGGAATCTGAGCCGAGGAGCTGTGCAGATGATCGGAGATTT :  88 
                                                                                                                                                   
IL4I1   : GCTGAACGAGGACTCG. : 155 




IL17REL: CTTTGCATTGAGGGTTGGCTGGCAATTCCAGATGCCAGGAGGTTACAACTTTGTCCCTTTGAAAATGATA :  70 
FWD    : ................................................CTTTGTCCTTT..GAAATGATA :  20                                                                                                                                                                  
                                                                            
IL17REL : CAAAGGCATTATGGGATAATATTGTTTATAATCCAGTGACACAAACCCTAGCTTGGGAA : 129 
FWD     : CGAAGG.ATTATGGGATAATATTGTTTATAATCCAGTGAC.CAAACCCTAGCTTGGGAA :  77 
 
 
IL18_________________________________________________________________                                                                           
IL18  : GTGAAATCTGGCAGTGGAATGTACTTCGACATTCACTGTTACAAAACCACCGCGCCTTCAGCAGGGATGC :  70 
FWD   : .............................................................CAGGGATGC :   9 
                                                                                                                                                                                                                                                   
IL18  : CTGTTGCATTCAGCGTCCAGGTAGAAGATAAGAGTTACTACATGTGTTGTGAGAAAGAGCATG.. : 133 
FWD   : CTGTTGCATTCAGCGTCCAGGTAGAAGATAAGAGTT.CTACATGTGTTGTGAGAAAGAGCATGAG :  73 
                                
 
IRF1________________________________________________________________ 
IRF1  : GATCTGGATCAACAAGGATAAGATGATATTTCAGATCCCATGGAAACATGCAGCTAAGCATGGCTGGGAC :  70 
FWD   : .....................................................................C :   1 
                                                                                                                                                                                                                                         
IRF1  : ATGGAGAAGGACGCCTGCCTCTTCCGGAGCTGGGCCATCCATACAGGAAGATATAAAGT. : 129 
FWD   : ATGGAGAAGGACGCCTGCCTCTTCCGGAGCTGGGCCATCCATACAGGAAGATATAAAGTA :  61 
                                                                           
 
UPP1_______________________________________________________________ 
UPP1  : TCAGTCAGTCACGGTATGGGCATTCCTTCTATTTCAATCATGTTGCACGAGCTGATCAAACTGTTGTATC :  70 
FWD   : .......................TCCTTCTATTTCA.TCATGTTGCACGAGCTGATCAAACTGTTGTATC :  46 
                                                                                                                                                                                                                                                             
UPP1  : ATGCCAAGTGTTCCAACATAACCATTATTCGCATTGGCACCTCGGGTGGAATAGGTCTGGAACCAGGCTC : 140 
FWD   : ATGCCAAGTGTTCCAACATAACCATTATTCGCATTGGCACCTCGAA........................ :  92 
                                                                                                                               
UPP1  : AGTGGTT : 147 
FWD   : ....... :   - 
                                                                               
Figure 6.3. Sequence alignments of selected qPCR products. 
 
 Optimisation of the 96.96 qPCR Dynamic Array via pilot studies 6.3.2
For the first test run, cDNA samples were generated using SuperScript III 
reverse transcription kit where 2 μg of RNA was used. Complementary cDNA was 
diluted 1:5 prior to preamplification. A reaction volume of 5 μl was prepared 
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comprising 2.5 μl of PreAmp Mix and 2.5 μl 200 nM primer mix stock which included 
primers for r28S and ENSGALG00000015395 genes. The thermal reaction consisted 
of 16 cycles. Preamplified cDNA was diluted 1:4 in low EDTA-TE buffer without 
Exonuclease I treatment. Results are presented as a heat map in Figure 6.4. 
  
Figure 6.4. Heat map view of qPCR results from first optimisation of 96.96 Dynamic Array. Reactions 
were performed with 95 genes including 6 reference genes, in columns and 40 samples from Aviagen 
broilers in rows (technical duplicates). Each square represents one of the 9,216 chambers with 
contained qPCR reactions with colour-coded level of Cq values.  
Examination of amplification curves for all genes indicated that many target 
transcripts were only detected very late in the qPCR cycling programme, (around 
26-27 cycles, which is near the completion of qPCR reaction), as indicated by navy 
blue colour on the heat map. In case of genes that were amplified early in the qPCR 
reaction (e.g. r28S, ENSGALG00000015395) the melting curve examination showed 
specific amplification. For most of the genes with an amplification signal, melting 
Cq value 
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curve analysis showed non-specific products caused by residual primers. The first 
96.96 Dynamic Array run using preamplified cDNA did not produce positive results 
in the case of most of the genes tested, as it was not properly optimised. Although 
the preamplification step was performed as described in Rødgaard et al. (2012), 
where PreAmp mix volume was 5 μl and DNA used was diluted 1:5, not many genes 
were expressed.  
Several changes in sample preparation were applied to resolve the problems 
encountered during first run. In the next pilot study, the complementary DNA was 
reversely transcribed from not more than 100 ng/μl of total RNA. Newly made cDNA 
was not diluted before preamplification. The primer mix (200 nM) did not contain 
primers for r28S and ENSGALG00000015395 transcripts, as these genes proved to 
be highly abundant and could bias the efficiency of the preamplification reaction. 
The crucial step in multiplex PCR is the removal of unincorporated primers. In this 
study exonuclease I, from Escherichia coli (Lehman and Nussbaum, 1964) was used 
to digest primers that were not incorporated into newly made amplicons. The 
changes in sample preparation in this second pilot study did not result in useable 
qPCR data. Only r28S and ENSGALG00000015395 transcripts were amplified, 
despite absence of their primer pairs in the preamplification mix (data not shown). 
To test the hypothesis of preamplification inhibition, a third test run was performed 
where cDNA without preamplification was used. The cDNA from samples predicted 
to have high levels of the target transcripts was selected to make serial dilutions, 
specifically from the HD11 cell line stimulated with LPS and CD40 ligand, heterophils 
stimulated with Salmonella Enteritidis, or spleens from IBDV and MDV infected 
birds and splenocytes stimulated with LPS. The results of the third pilot trial are 
presented in Figure 6.5. Non-preamplified cDNA qPCR resulted in stronger 
fluorescence signals than preamplified samples in previous tests. Although this third 
pilot experiment confirmed that the RNA is reverse transcribed there was a need to 
confirm if different samples from infection studies would yield similar results with 




Figure 6.5.Heat map view of the third pilot study using serial dilutions of samples predicted to have 
high levels of the target cDNA. Samples were not preamplified prior the use in 96.96 Dynamic Array 
chip. Chambers containing higher concentrations of cDNA have detectable levels of fluorescence.  
The fourth test run was performed using archived samples (cDNA and 
preamplified cDNA), specifically spleen and thymus from MDV infected birds; spleen 
and bursa from IBDV infected birds; spleen and caecal tonsils from Campylobacter 
colonisation studies; duodenum infected with Clostridium perfringens (CP4 virulent 
strain); spleen and Harderian gland from IBV infected line N birds; HD11 cell line 
stimulated with LPS and CD40 ligand; jejunum infected with Eimeria maxima and 
caeca infected with Eimeria tenella. RNA samples were reverse transcribed as 
previously described. The preamplification protocol was modified where 2.5 μl of 
PreAmp master mix was combined with 1.25 μl of cDNA or preamp cDNA (not 
diluted) and 1.25 μl primer mix (200 nM). Archived preamplified cDNA samples 
were not amplified in the qPCR. Neither archived samples results in positive qPCR, 
apart from r28S and ENSGALG00000015395 cDNA. The majority of the tested genes 
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were not amplified in selected samples from infection studies and most of the 
fluorescence signal recovered was very weak (data not shown). 
The preamplification step is claimed to be crucial for use of 96.96 chip as the 
volumes of the reactions are very small (6 nl) and low expressed genes may not be 
detected. The qPCR performed on cDNA returned positive results but only in case of 
genes with high mRNA levels. Preamplified cDNA produced positive outcomes only 
for genes that were not included in preamplification primer mix. Therefore, there is 
a need to optimise the protocol for preamplification, as the recommended 
guidelines did not yield positive results.  
 Preamplification optimisation 6.3.3
The preamplification or specific target amplification is a multiplex PCR with a 
limited number of cycles where simultaneous gene expression of many targets 
occurs (Mengual et al., 2008). As only primers for genes of interest are used in the 
PCR, no other target is amplified and the relationship between targets is preserved 
(Korenkova et al., 2015). Although is it the essential part of the workflow in these 
type of applications it is the least studied step in qPCR. Preamplification should 
increase the yield of qPCR and highly expressed samples should have Cq ~ 5-15 
cycles, where low expressed targets are characterised by Cq values around cycle 20. 
The cDNA for two samples – caecal tonsils and bursa from Aviagen broilers were 
prepared using 500 ng of total RNA and the SuperScript III kit. β-actin (ACTB) mRNA 
gene expression was examined in selected samples. Three preamplification mixes 
ranging from 2.5 μl (Mix 1), 5 μl (Mix 2) to 7.5 μl (Mix 3) of PreAmp master mix and 
different concentrations of cDNA were tested in conventional qPCR machine. Two 
cycle numbers for thermal cycling were tested and preamplified cDNA was diluted 
ten times after exonuclease I treatment. Results are shown in Figure 6.6. Non-
preamplified cDNA was amplified earlier in reaction cycle compared to preamplified 
cDNA. Both caecal tonsils and bursa samples preamplified in three different 
reactions resulted in Cq values higher than 25 for 15-cycle PreAmp and Cq equal or 
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higher than 30 for 18-cycle PreAmp. The lowest Cq values was observed for 15-cycle 





Figure 6.6. Preamplification test in 5 μl performed using a standard qPCR machine ; expression of 
ACTB in a) cDNA of caecal tonsils and b) cDNA of bursa. Three master mixes tested in two reactions 
using bursa and caecal tissues. Non-preamplified cDNA (1/5 dilution) used as a control in qPCR. The 
error bars represent SD from three technical replicates. 
The next optimisation attempt involved increasing the volume of PreAmp Master 
mix to 20 μl and decreasing cycle numbers to 10. Samples were treated with 
exonuclease I. Different concentrations of RNA were used in reverse transcription 
reaction. Results are shown in Figure 6.7. Increasing the reaction volume to 20 μl 
resulted in positive preamplification despite the lower number of thermal cycling. 
Preamplified samples, reverse transcribed from 250 ng of total RNA and both neat 
and diluted 1/10 were amplified earlier than non-preamplified cDNA. Only bursa 
cDNA made from 125 ng of total RNA, preamplified and diluted 10 times resulted in 
a Cq value being higher than non-preamplified cDNA.  
According to the manufacturer’s description the PreAmp Master Mix was 
optimised on total RNA reverse transcribed using a High Capacity Reverse 
Transcription Kit. The next step was to use the same RT kit and test newly made 
preamplified cDNA and diluted 10 times in qPCR. The test was performed using 
cDNA made from 100 ng/μl RNA, as recommended by the manufacturer. Two RT 














































Preamplification mix consisted of 2.5 μl PreAmp Master Mix, 1.25 μl of primer mix 
(200 nM) and 1.25 μl of neat cDNA. Samples were treated with exonuclease I. 





Figure 6.7. Preamplification test in 20 μl reaction volume and 10-cycle PCR ; expression of ACTB in 
a) caecal tonsils cDNA; b) bursa cDNA. Two concentrations, 250 ng and 125 ng, of RNA were used to 
make cDNA. Non-preamplified cDNA (1/5 dilution) was used as a control in the qPCR. The error bars 
represent SD from three technical replicates. 
There was no difference observed in Cq values between different volumes of RT 
reactions. Both, 10 μl and 20 μl reactions resulted in similar Cq values and 
concentrations of cDNA (~2400 ng/μl). The mRNA expression of ACTB in both 
samples was at similar levels when cDNA and preamplified cDNA was used as 
template in qPCR. Preamplified cDNA had higher Cq values than non-preamplified 
cDNA but lower than previously reversely transcribed samples using SuperScript III 
kit, as shown in Figure 6.6 (Mix 1). Therefore, the High Capacity Reverse 








































































Figure 6.8. Preamplification test of cDNA made using a High Capacity Reverse Transcription Kit and 
100 ng/μl total RNA in 10 ul and 20 ul reactions. Ceacal tonsils (CT) and bursa (B) tissue RNA was 
tested. Non-preamplified cDNA was diluted 1/5. The error bars represent SD from replicates (n=3). 
The next step was to examine if standard RNA isolated from COS-7 cells 
transfected with plasmids containing IL-1β, IL-6, IL-8, IL-12β, IL-18 and CXCLi2 
inserts will produce positive signals with and without preamplification when tested 
using 96.96 Dynamic Array. To make cDNA, High Capacity Reverse Transcription in 
10 μl reaction, using 100 ng/μl was performed. Newly synthesised cDNA, in final 
concentration of 5 ng/μl of reaction, was used in 5 μl preamplification reaction. 
Preamplified cDNA was then serially diluted (1:2) and used as a template in 96.96 

























Figure 6.9. Heat map view of a) non-preamplified cDNA and b) preamplified cDNA corresponding to 
control transcripts. Samples were reverse transcribed from standard IL-1β, IL-6, IL-8, IL-12β, IL-18 
and CXCLi2 RNA, serially diluted 1:2. Increase in dilution caused decrease in detected fluoresce of 
qPCR reaction in non-preamplified samples (a). Preamplified samples did not resulted in positive 
qPCR for most of the genes, apart from IL-12β (b). 
As shown in Figure 6.9a, serial dilutions of cDNA without preamplification resulted 
in specific and efficient detection of the target cDNAs with decreasing fluorescence 
signal in qPCRs with each two fold serial dilution, which is characterised by change 
in colour that corresponded with higher cycle number. Amplification of 
preamplified cDNA in 96.96 Dynamic Array qPCR was unsuccessful, as shown in 
Figure 6.9b. For most of the samples tested the concentration of cDNA after 
preamplification was too low due to possible inhibition of reaction. It can be 
therefore concluded that use of higher concentrations of cDNA in higher than 
recommended volumes of PreAmp master mix would give positive results. 
 A very important aspect of PCR setup is a dilution of the original sample. 
Lowering the concentration of a template is common practice in single-template 
assays but in the case of mixed templates, dilutions may lead to loss of low or 
Cq values 
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moderately concentrated targets. Another test of the preamplification reaction was 
performed using final concentration of cDNA in the preamplification reaction 185 
ng/μl in 20 μl volume. Ten samples from two chickens, each representing a different 
farm, were selected and pooled for cDNA synthesis using High Capacity Reverse 
Transcription Kit where 100 ng/μl of total RNA was used. As the RT reaction 
produces ~2500 – 3500 ng/μl of cDNA, samples were diluted 1:5 before the 
preamplification reaction. Results are shown in Figure 6.10. The increase in volume 
of the reaction and concentration of cDNA resulted in successful preamplification. 
In the preamplification optimisation, both template dilutions and concentration of 
PreAmp master mix were changed in order to eliminate inhibition. The greater 
reaction volume with appropriate cDNA concentration worked but the reason for 
inhibition of reaction in previous optimisation attempts is unknown.  Having 
optimised the reaction, the next step involved testing the same settings in 96.96 
Dynamic Array chip. 
 
Figure 6.10. Preamplification test with the use of higher cDNA concentration and higher reaction 
volume.  The mRNA expression of ACTB in ten samples from sibling test and pedigree farms was 
tested. Higher concentrations of cDNA (185 ng/μl) were used in 20 μl preamplification reactions. 
Non-preamplified cDNA used as a control. The error bars represent SD from four replicates. 
 
136 
 Application of the optimised qPCR protocol to RNA from tissues 6.3.4
from Aviagen broilers on pedigree and sibling test farms 
Having optimised the preamplification protocol (Figure 6.10), samples from 
the remaining Aviagen broilers were prepared in the same manner to be used as a 
template in 96.96 Dynamic Array qPCR. Samples were treated with exonuclease I 
before qPCR in 96.96 Dynamic Array. Results are shown in Figure 6.11. The 
expression of 89 genes related to immune responses, as well as 6 reference genes 
was detected, as shown in the heat map based on colour coding of the expression 
level before pre-processing. The majority of the data fell in the of range about Cq = 
5 – 23. Melting curves for all the primer pair were examined. Melting curves for ‘no 
template’ controls, for reference genes, for genes where primers did not span exon-
intron boundaries are shown in Appendix 1, Figure 2-5. The same reaction settings 
were implemented in an additional 96.96 Dynamic Array to confirm whether all 
steps, from RNA extraction, reverse transcription to preamplification, results in 
reproducible data. RNA from eight tissues (four per farm) was isolated and reversely 
transcribed as previously described. Newly synthesised cDNA was preamplified in 
20 μl reactions using 185 ng/μl of the template.  
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Figure 6.11. Heat map view of 96.96 Dynamic Array qPCR for immune-related genes in broilers on 
pedigree and sibling test farms.  cDNA (185 ng/μl) preamplified in 20 μl was used as a template. 
Samples (blood, spleen, bursa, caecal tonsils and ileum) were collected from 8 chickens (4 per farm). 
40 samples were used in a duplicate as the templates for amplification of 89 genes of interest and 6 
reference genes. The bottom part of the heat map corresponds to serial dilutions for standard curve 
calculation, no template control (NTC) and positive control chambers. 
PBL samples were not available for RNA extraction. Whole PBL samples were used 
in RNA extraction for the first run in Figure 6.11. Preamplified cDNA from eight 
tissues was tested in quadruplicates on the 96.96 Dynamic Array chip. Results of 
this experiment are shown in Figure 6.12. Most of the genes were amplified 
similarly to the previous run (Figure 6.11). Only the column designated for IL-12β 
did not show amplification as the primer pair for this gene was missed in 
preparation of assay mixes. All replicates of the same sample showed Cq values 
reaching the same level with minimal differences (~0.5 Cq) between individual 
repeats. Missing data were likely to be a result of the genes being expressed at very 
Cq values 
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low levels, which can be seen as lack of fluorescence detection in most of the 
replicates. The last column of the chip did not produce results as water, instead of 
primers, was added to the assay mix as a negative control. Overall the data from 
this repeated study show that the optimised protocol and qPCR platform is capable 
of reliably reporting transcript levels across repeated studies.  
 
Figure 6.12. Heat map view of 89 genes mRNA expression detected by 96.96 Dynamic Array qPCR in 
8 tissue samples tested in quadruplicates. The test established the reproducibility of the settings 
used. The maximum difference between quadruplicate Cq values did not exceed ~0.5 Cq confirming 
accuracy of measured mRNA gene expression within the chip. 
 
 Data pre-processing  6.3.5
Data that did not give rise to any Cq value was represented by 999 which 
was then translated to NAN (not a number) by GenEx software. Missing data were 
rare, as evident from the reliable repetition of values across Figure 6.11 and Figure 
6.12, however rarely failed reactions were detected, possibly owing to the nano-
scale volumes handled, bubbles in microfluidic channels or issues with the quantity 
or integrity of the samples or reagents loaded. Missing data due to PCR failure were 
restored based on replicate information. Out of 9,216 reactions, 84 were filled in 
with replicate mean value. The rest of the missing (54 reactions) data were filled in 
with values calculated by imputation. 
Cq values 
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 The analysis of tissue gene expression from Aviagen broilers 6.3.6
raised in two hygienic settings 
The normalised data were analysed in GenEx software using principal 
component analysis and t-test statistical methods to explore the differences in gene 
expression between two housing environments (pedigree and sibling test farms) 
and within farms based on gene expression between organs. 
Principal Components Analysis (PCA) is a useful, explanatory technique for 
simplifying complex and multivariable data sets (Basilevsky, 1994; Pearson, 1901). 
The whole data set from both farms was analysed using PCA statistical test in GenEx 
Enterprise to compare the global gene expression profiles of five chicken tissues. 
The preliminary PCA plot indicated broad differences between the PBL samples and 
the rest of the tissues (Figure 6.13). 
 
Figure 6.13. Principal component analysis indicating broad similarities and differences in 
transcription of immune-related genes in analysed tissues.  Data points represent individual samples 
of sibling test and pedigree farms; A – bursa (circles), caecal tonsils (diamonds), spleen (squares), 
ileum (up-pointing triangles) from sibling test and pedigree farms; B – PBL (down-pointing triangles) 
collected from chickens raised on sibling test farm; C – PBL collected from chickens raised on 
pedigree farm. 
The PCA results of the whole data showed the difference between PBL 
samples from two farms (zones B and C in Figure 6.13). The rest of the samples 
were clustered together and there were no clear sets consisting of tissues from a 
particular farm but there was visible grouping of samples depending on the tissue 
type. PCA was also performed on the same data set with PBL samples removed. This 





samples grouped together and caecal tonsils group slightly overlapped with ileum 
group but there was no separation based on the farm type (Figure 6.14).  
 
Figure 6.14. Principal component analysis of qPCR data for immune-related genes across tissues of 
birds reared on the pedigree and sibling test farms without PBL samples ; bursa (dark blue), spleen 
(orange), caecal tonsils (green), ileum (red). Circles represent samples from sibling test farm and 
squares represents samples from pedigree farm. 
Differences in gene expression between and within the farms 
The data from the 96.96 dynamic array was analysed in GenEx to explore the 
differences in expression of the selected immune-related genes between farms. 
When comparing the levels of gene expression between the farms where all tissues 
were taken under consideration, only 13 genes out of 92 tested proved to be 
significantly differentially expressed (P ≤ 0.05). The expression levels of all genes 
tested at both farms are shown in Figure 6.15.
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Figure 6.15. Relative expression (mean ± SEM) of genes expressed in tissues collected from pedigree (green) and sibling test (blue) farms. The significantly 
differentially expressed genes are indicated with * P ≤ 0.05 or ** P ≤ 0.0005; the data point represents all 20 tissue samples per farm type. 
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To explore the differences between farms, individual tissues were analysed and 
compared. As PCA results previously showed, the biggest differences between the 
two farms were observed in PBL samples. When PBL samples from pedigree (n = 4) 
and sibling test (n = 4) farms were compared, 51 genes were shown to be 
significantly differentially expressed (DE) with 10 genes highly significantly DE 
(P ≤ 0.0005) and 41 significantly DE (p ≤ 0.05) (Figure 6.16).  
 
Figure 6.16. Volcano plot of genes expressed in chicken blood (PBL) collected from pedigree and 
sibling test farms.  Scattered points represent genes; the x-axis is the log2 fold change for the ratio 
sibling test vs pedigree farm, whereas y-axis is the log10 p-value. Green colour represents genes that 
are highly significantly DE (p value ≤ 0.0005) and yellow colour represents gene that are significantly 
DE (p value ≤ 0.05). 
The number of differentially expressed genes was substantially lower in other 
tissues tested. The same analysis which compared gene expression between the 
two farms resulted in 19 genes significantly DE with 2 highly significantly DE in the 
bursa (Figure 6.17a), 12 genes significantly DE with 1 highly significantly DE in the 
spleen (Figure 6.17b), 9 genes significantly DE in the caecal tonsils (Figure 6.17c) and 
23 genes significantly DE with 1 highly significantly DE in the ileum (Figure 6.17d). 
Based on the number of genes that are differentially expressed at different levels of 
biosecurity in housing environment, PBL could potentially be used as the indicator 





Figure 6.17. Volcano plot of immune-related genes expressed in tissues collected from chickens raised on pedigree and sibling test farms ; a) bursa, b) spleen, c) 
caecal tonsils, d) ileum. Scattered points represent genes; the x-axis is the log2 fold change for the ratio sibling test vs pedigree farm, whereas y-axis is the log10 p-
value. Green colour represents genes that are highly significantly DE (p value ≤ 0.0005) and yellow colour represents gene that are significantly DE (p value ≤ 0.05). 
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The analysis of tissues from different farms showed that samples of bursa, spleen, 
caecal tonsils and ileum (Figure 6.18 a-d) were highly positively correlated between 






Figure 6.18. Correlation of the magnitude and direction of gene expression in tissues from chickens 
raised on pedigree (y axis) and sibling test (x axis) farms  a) bursa, b) spleen, c) caecal tonsils, d) 






The variation between birds within an organ was analysed to determine whether 
the differences seen in an organ originates from particular bird being higher 
responder to pathogens present in the environment. Out of 92 genes expressed at 
different levels, 25 were significantly DE with five of them being highly significant 
(Figure 6.19). The significance of gene expression was due to the differential 
response of just one or two of birds regardless of farm type they were housed in. In 
many cases the level of expression of a particular gene varied significantly between 
the birds from the same farm, for example expression of DTX2 gene was very high 
in birds 7 and 8, both from pedigree farm whereas bird 5 and 6 showed a level of 
expression similar to their siblings raised on sibling test farm (birds 1-4). Another 
example is the CD80 gene, which was expressed on higher levels in birds 2, 3, 4, 6, 7 
and 8 but not in birds 1 and 5 which were housed in different environments. The 
three reference genes that were not selected as normalisers (ribosomal r28S, B2M 
and GUSB), had levels of mRNA expression that were significantly different across 
birds, confirming that they were not a good control of gene expression in this 
sample set. For the bird vs bird analysis all tissues were combined therefore the 
differences seen between birds stem from differential responses detected in 
particular tissues.  
Overall, the sample group (four birds per farm) is not enough to overcome 
variance within the group (environment). There was no clear variation in gene 
expression observed between birds. The gene expression resulted is small number 




Figure 6.19. Relative expression (mean ± SEM) of significantly DE genes between birds from the sibling test farm (1-4) and pedigree farm (5-8) ; ** p ≤ 0.0005.  
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PBL gene expression analysis 
The PBL proved to have the highest number of differentially expressed genes 
and differed between farms (Figure 6.20). Among the 51 genes with expression 
significantly different between farms, 46 had higher mRNA levels in PBL samples 
collected from birds from the sibling test farm. The lower level of biosecurity at the 
sibling test farm may be associated with the observed upregulation of genes 
involved in immune responses: e.g. toll-like receptors (TLR4, TLR15), cytokines (IL-
1β, IL-6,IL-12β, IL-18), and chemokines (CCLi4, CXCLi2, CCL20). Other genes that 




Figure 6.20. Relative expression (mean ± SEM) of genes expressed in PBL collected from pedigree (blue) and sibling test (green) farms.  Genes expressed significantly 
different (* p ≤ 0.05; ** - p ≤ 0.0005)
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 Validation of differentially expressed genes by qPCR 6.4
To validate the 96.96 Dynamic Array results, three transcripts (DTX2, IRG1, SAAL1) 
were analysed by qPCR in a conventional 96 well format. These genes were selected 
because of their significantly different regulation (DTX2 downregulated and IRG1 
upregulated) and no change in expression (SAAL1) when gene expression in all 
tissues from both farms was compared. Results showed that SAAL1 and IRG1 
exhibited a similar transcriptional profile to that of 96.96 array. The down-
regulation of DTX2 was not detected, as it was observed in data generated using the 
96.96 Dynamic Array. Comparison of both 96.96 array and qPCR statistical test is 






Figure 6.21. Validation of 96.96 Dynamic Array qPCR results for selected 3 transcripts : DTX2, SAAL1, 
IRG1; a) fold change in expression of three genes tested between sibling test and pedigree farm in 
96.96 Dynamic Array, b) results of fold change calculation for three genes of interest, as measured in 
conventional 96 well format; each bar represent average of 40 biological replicates ± SEM * - level of 








































Poultry breeders have to overcome many challenges caused by diseases that 
lead to decreased yield and bird welfare. Chickens with improved innate resistance 
could be introduced in breeding programs to minimise the losses but there are no 
methods available that would select the chickens with superior immune 
responsiveness to pathogens. Therefore, the idea to develop a cost-effective and 
rapid technique to select birds characterised with higher level of immune 
performance seemed reasonable. The work presented in this chapter was 
performed in order to develop and validate a new diagnostic tool for immune gene 
expression in the chicken. The 96.96 Dynamic Array from Fluidigm was selected as 
the platform of choice.  
As with any qPCR method, each step for the BioMark System had to be 
optimised. Without intensive quality control, several steps in qPCR workflow could 
influence the accuracy of the results. The use of a dye-based technique of DNA 
detection required extensive primer design and optimisation. Although the design 
of primers to span intron-exon boundaries is recommended (Wang and Seed, 2003) 
it does not guarantee that pseudogenes as intronless copies will not be amplified. In 
this study, contamination with DNA was avoided by applying the DNase treatment 
during the RNA extraction process. This is the most efficient strategy to remove or 
decrease the number of gDNA copies (Derveaux et al., 2010) to the level where 
abundance of gDNA does not interfere significantly with quantification of mRNA 
(Bustin and Nolan, 2013). Melting curve analysis was performed at the end of the 
PCR cycles and confirmed the specificity of primer annealing with perfect melting 
curves having a single sharp peak (Taylor et al., 2010). All of the primers used in this 
study were successfully validated. The stability of reference genes selected in 
Chapter 5 was also confirmed based on the Cq values generated during high-
throughput qPCR. 
The use of the Fluidigm platform requires a preamplification step. The 
samples need to be highly concentrated to ensure the template DNA for 
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amplification is present in the mix. This method of enrichment of samples has been 
used in many studies (Noutsias et al., 2008; Sindelka et al., 2010). The process of 
preamplification should be optimised before the main experiment using high 
throughput qPCR platforms (Rusnakova et al., 2013). In experiments presented in 
this chapter, samples were tested with and without preamplification where 
different concentrations of cDNA were used with various volumes of TaqMan 
PreAmp master mix. Three cycle numbers of PCR reactions were tested to 
determine if the length of reaction changes the amount of amplification. As 
described in Korenkova et al. (2015), different concentrations of RNA, number of 
cycles and dilutions of cDNA were all very crucial for the preamplification reaction. 
These studies using various combinations showed that for the BioMark System 
preamplification works most efficiently in 15-18 reaction cycles and with higher 
concentrations of cDNA samples diluted either 20x or 40x. In experiments 
presented in this chapter, neither higher number of cycles of PCR reaction nor the 
different concentrations of cDNA used resulted in preamplified samples having 
lower Cq values that non-preamplified cDNA. Korenkova et al. (2015) observed that 
increase of number of cycles (21 and 24) caused exhaustion of primers and reagents 
by high abundant templates and lower level of success of reaction, therefore it is 
not recommended, especially if the targets have unknown level of abundance.  
To validate the utility of 96.96 Dynamic Array chip as a diagnostic tool a 
number of samples from Aviagen broilers were used. In this study, the differences 
in immune responses between chickens raised on two farms with high and low 
levels of biosecurity were analysed. Detection of differences in immune 
performance between birds within and between the farms, were performed to 
establish which tissue delivers the most informative data.  
The study consisted of two different farms, where four birds were random 
selected from the population and five tissues were sampled. PCA analysis of the 
qPCR results transformed the data into easily visualised two-dimensional plots. 
Although birds were not infected with any particular pathogen, they were 
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vaccinated, the hygiene levels differed between farms with presence of common 
pathogens such as Campylobacter, Eimeria species and E. coli was known at the 
sibling test farm. The difference in gene expression profiles were most obvious in 
blood samples when the complete data sets, including all tissues from both farms, 
was analysed in PCA. The lists of genes that were significantly differentially 
expressed in individual tissues were not common for all tissues. Most of the genes 
DE in blood were also DE in other tissues but there was no pattern characterised by 
the same profile of expression with any particular tissue. That is the reason why 
blood samples were separated from other tissues when visualised in the PCA. The 
analysis of the data set with exclusion of the blood samples revealed the similarities 
between the gene expression profiles in bursa and spleen and between caecal 
tonsils and ileum. Surprisingly a stronger concordance was observed between bursa 
and spleen. The caecal tonsils and ileum are closely related and are part of the gut-
associated lymphoid tissue (GALT) system together with the bursa of Fabricius 
(Befus et al., 1980). Nevertheless, gene expression profiles in caecal tonsils and 
ileum separated from bursa samples that were assembled in cluster with the 
spleen. All tissues were equally exposed to the same biotic stimuli, yet there in no 
indication that any of the tissues showed significant changes in the transcription of 
immune-related genes. 
The birds used in this experiment were three-weeks of age and their 
immunological responses were coordinated by a nearly mature immune system. As 
the birds were sampled at only one timepoint it is difficult to speculate if the gene 
expression observed at this particular level was triggered by matured cells and 
organs involved and if the response would differ if the birds were sampled earlier 
and later in their life. The cytokine expression in the caecum was studied 
throughout the chicken’s life span in the experiments done by Crhanova et al. 
(2011) which revealed that IL-8, IL-17 and partially IFN-γ expression changed with 
gut flora development. The relative expression of other genes tested IL-1β, IL-18 
and iNOS was unstable up to day 25 after which the low levels of expression 
continued to be unchanged. The same study involved infections with Salmonella 
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Enteritidis and showed that the level of response to the pathogenic bacteria was 
dependent on the age of the birds infected. The stimulation of younger chickens 
caused higher levels of cytokine gene expression and although those levels 
continued to decrease they were higher at day 42 compared to the gene expression 
in birds infected later in their life. The patterns of immune response to gut 
microflora and pathogenic microorganisms may include overlapping pathways, 
therefore it is difficult to say whether the responses observed in sibling test farm 
birds were activated by only commensal microbes. The levels of the gene 
expression may not give the clear answer as the microflora of the environment is 
unknown but it could be speculated that the responses triggered at the sibling test 
farm reached higher levels compared to pedigree farm owing to presence of 
common pathogenic microorganisms.  
It could be expected that PBL and spleen tissue gene expression would have 
more genes in common, as the spleen is very rich in blood. Spleen accumulates 
leukocytes and is the main site of antigen presentation and processing. However in 
the present study principal component analysis reliably found differences in the 
profile of expression of the immune-related genes expressed at these sites. A 
microarray study by Nie et al. (2010) on basal expression of genes in eight tissues, 
including bursa and small intestine, found that nearly half of the genes were 
expressed in all tissues and small percentage were tissue-specific. 
It is difficult to establish if the blood is the best estimator of immune vigour 
compared to other tissues, based on the initial data. The PBL showed the highest 
number of the DE genes that included genes with proinflammatory functions. In the 
same samples, many significantly DE genes were involved in diminishing the 
inflammation by regulating the overexpression of the proinflammatory genes. The 
PBL consist of many cells programmed to confer microorganisms as the first line of 
innate defence, where cell populations in other tissues are also involved in later 
stages. It would be preferential to select the PBL for developing a diagnostic test for 
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immune robustness in chickens as the circulating cells detect inflammatory state in 
whole organism.  
The test of mRNA gene expression in samples from both farms was not 
performed using whole transcriptome gene expression platform and only eighty-
nine genes were included. Many of the immune-related genes, listed in Chapter 4, 
were selected based on upregulation during infection or stimulation with 
constituents of pathogens. Therefore, it is difficult to differentiate between immune 
responsiveness of healthy chickens and chickens responding to infection using the 
selected genes, as the phenotype of immune robustness at mRNA level are not 
known. It could be assumed that the selected panel of genes was not appropriate to 
detect differences in immune responses in other tissues, apart from blood 
leukocytes. It would be feasible to test the same hypotheses in additional 
timepoints and examine the outcomes from different immune/colonisation stages. 
The low numbers of significantly expressed genes between individual birds from 
both farms could suggest that the level of variation did not depend on the level of 
biosecurity. This could be explained by the individual ability of bird to detect the 
invading microbes but also by the unequal level of immune responses within the 
bird, between organs. Another obstacle in interpretation of the results is the 
differences in the vaccination schemes used at the two farms. The differences in the 
gene expression in PBL may plausibly be due to different vaccines and times of 
administration. Therefore, the farm settings are not adequately controlled for 
measuring the innate immune robustness of healthy birds.  
The results showed that there are differences in immune responses between 
farms but the number of birds used in this experiment was too low to select the 
birds characterised by improved immunity. The PBL isolated from the blood showed 
to be promising indicator of immune gene expression differences between farms 
but the variation between birds, based on only the blood samples, was impossible 
to estimate. Nevertheless, the Fluidigm chip with the proposed set of genes could 
be a convenient diagnostic tool for measuring the differential responses in the 
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future experiments. It has been optimised and verified in the field experiment but 
the experimental setup needs to be adjusted to avoid future problems with the data 
interpretation.  
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 General discussion Chapter 7
 Overview of this study 7.1
The main aim of this project was to design and optimise a diagnostic tool for 
assessing innate immune responses in commercial chickens. All objectives stated in 
Chapter 1 were met and the tool has been optimised and validated. The 96.96 
Dynamic Array IFC within the BioMark system (Fluidigm Corporation) was used in 
preliminary experiments involving 89 innate immune-related genes. Lymphoid 
tissues and blood were isolated from an Aviagen broiler line housed on their 
pedigree and sibling test farms that differ in levels of hygiene. The test validated the 
usability of the chip and evaluated immune performance based on expression of 
selected genes. Crucial steps in the workflow were also optimised. The optimisation 
of preamplification reaction was the first major challenge, as the recommended 
and/or published protocols did not produce useable data. Reference gene 
normalisation was also performed before the final high-throughput qPCR analysis 
and the data from the Fluidigm chip confirmed the stability of transcription of the 
selected reference genes across animals and tissues. The importance of proper 
selection and validation of reference genes has been underlined several times in 
Chapter 5 and supported with numerous published examples.  
Supplementary to the studies presented, a first author manuscript has been 
accepted for publication in the Journal of Veterinary Immunology and 
Immunopathology to select reference genes for qPCR analysis of chicken gene 
expression, this time using lymphoid tissue isolated from the RI-J line. This study 
confirmed that TBP is the most stable gene in bursal cells, thymocytes and 
splenocytes, consistent with findings presented in Chapters 5 and 6. The selection 
of genes used in Chapter 6 was performed based on published studies and the RNA-
seq analysis of chicken effector cells stimulated with LPS. The cloning and 
sequencing of selected candidate genes confirmed their presence in the chicken 
genome and made the design of assays more accurate. The design and validation of 
a new diagnostic tool has been performed successfully and according to the MIQE 
guidelines for qPCR analysis. 
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 Challenges and limitations of the study 7.2
The project started by evaluating effector cell phenotypes and their mRNA 
gene expression as screening methods for innate immune function to be used in 
breeding programmes. The techniques presented in this work involved weeklong 
cell cultures. These methods were confirmed to be time-consuming and together 
with the requirement for greater number of birds to perform heterophil 
experiments, they were not considered as viable future diagnostic tools. Although 
previous studies on commercial and inbred lines showed that resistance to one 
pathogen could be associated with resistance to other pathogens, the birds used in 
the experiments presented in this thesis were not challenged with multiple 
pathogens simultaneously as occurs in commercial settings. The mRNA levels of 
only a few cytokines and chemokines is unlikely to be sufficient to select birds with 
higher immune responsiveness. Therefore, the decision was made to select genes 
that are involved in innate immune responses to a plethora of infections and 
implement them in new high-throughput qPCR diagnostic tool. 
The selection of genes to be used in the qPCR platform was based on 
published experiments with widely different design. Most of the studies used to 
generate the list utilised microarray platforms to distinguish the genes significantly 
differentially expressed in infected cells or tissues. The comparison of the data from 
different platforms is difficult as they are based on diverse protocols, from 
manufacturing, hybridisation and final analysis (Brazma et al., 2001). Therefore, 
direction, magnitude and significance of gene expression in a particular infection 
study may differ when analysed using different platforms. 
The current study design did not result in detection of birds characterised 
with overall greater responses in any of the farms tested. The intensity of immune 
responses differed between farms as shown in Figure 6.15, which is not surprising 
as the level of hygiene varied greatly. The analysis of all datasets showed that the 
greatest difference between farms is visible in blood samples (Figure 6.13). The 
analysis of immune responses based on lymphoid tissues did not show any of the 
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organs to be more responsive to the environmental challenges. Therefore, it 
suggests that the blood would yield the most information about the immune state 
of each bird sampled. That hypothesis needs to be tested in future experiments 
with larger numbers of birds and more defined challenge at a given timepoint.  
The genes used to characterise immune function in this study were selected 
based on their activation upon infection or stimulation of effector cells with 
pathogen-associated molecular patterns. This makes the analysis of results 
problematic. The elevated expression of particular genes may not be a result of a 
high state of innate immune readiness in healthy birds, but rather could be a 
reflection of disease. Moreover, it is not possible to fully interpret the meaning of 
responses detected when the nature of pathogen challenge, time of measurement 
relative to time of infection and the relative exposure (pathogen load) is not 
precisely controlled.  
A further challenge in evaluating immune responses is interpretation of gene 
expression as a being indicative of robustness, resistance or tolerance. The 
definition of robustness in farm animals was explained by Knap (2005) as “the 
ability to combine high production potential with resilience to stressors, allowing 
for unproblematic expression of high production potential in wide variety of 
environmental conditions”. Disease resistance could be defined as the ability to 
reduce the pathogen occurrence by inhibiting infection and pathogen growth (Best 
et al., 2008). Tolerance to pathogen may be described as the ability to limit the 
damage by counteracting the detrimental impact (Rohr et al., 2010). The tolerant 
animal would be able to maintain productivity despite increasing load of pathogens. 
For breeders, both, maintenance of productivity and ability to reduce pathogen 
burden, are equally important. Previous studies on lines selected for higher 
heterophils mRNA gene expression showed that the parental and F1 progeny with 
higher resistance resulted in fewer Campylobacter jejuni colonies from cloacal 
swabs (Li et al., 2008c). This could suggest that selection based on mRNA gene 
expression levels may lead to generation of a line that is robust, as it not only 
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maintains the expected phenotype but also reduces the prevalence of pathogens. 
The use of gene expression data simultaneously with information about other traits, 
for example weight gain and feed conversion ratio, could help to refine the 
phenotype of robustness and ensure it does not come at the expense of other 
production-relevant traits.  
 Future applications 7.3
In addition to previously used pro-inflammatory cytokines and chemokines to 
evaluate innate immune responses of inbred and commercial lines (Wigley et al., 
2006; Swaggerty et al., 2008) the panel of immune-related genes selected for this 
project includes various genes involved in downstream signalling after 
pathogen/agonist recognition. The additional carefully selected genes in the panel 
could result in more precise selection of chickens based on their immune responses, 
once the immune robustness phenotype is better understood. Collection of samples 
at different timepoints would be practical to examine different maturity stages of 
immune system and changes in responses. This approach could clarify if the 
expression of the selected panel of genes is dependent on the age of the birds. In 
the future, when the chip is used as a diagnostic tool, only one appropriate time-
point may be necessary to predict the robustness. Apart from additional time-
points, vaccination schedules would have to be standardised. Birds used in the 
preliminary chip test, housed on the pedigree farm or sibling test farm received 
different vaccines at hatch and on different days throughout their lives, which had 
the potential to change the nature and magnitude of immune responses and 
explain some of the differences detected.  
The chip could also be used as a tool to study immune readiness at the point 
of hatch or even during late stages of embryo development. Mortality in the first 
week post-hatch is an important aspect of chicken breeding and is used as an 
indicator of the occurrence of welfare problems. The transitional period from 
embryonic stage to the post-hatch chick and further to the broiler farm is a major 
challenge to the digestive, immune and thermoregulatory systems. The 
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performance of the newly hatched chickens in the first days is indicative of the 
performance during rearing weeks at the farm (Yassin et al., 2009). Therefore, the 
gene expression screening of newly-hatched chicks, yet to have significant contact 
with pathogens or acquired microbiota could help to predict how the flock will 
perform in later stages.  
The value of the multiplex PCR platform for immune-related genes could also 
be tested in a wider range of environmental settings, for example on test farms 
using birds of the same genotype but reared in cold and hot environments, at 
different stocking densities, intensive indoor vs. outdoor free-range systems and so 
on. This will be important to improving the performance of poultry to meet fast 
increasing demand owing to growth of the human population and rising affluence 
and urbanisation in developing countries. Expansion of breeding under hot 
temperatures is also very important because of global climate change. Heat stress is 
known to result in decreased productivity and increased mortality (Turnpenny et al., 
2001). It has been shown that diverse lines demonstrate different, heritable 
responses to chronic heat exposure (Lu et al., 2007). Several heat shock proteins 
and genes responsible for glucose transportation have been shown to be involved in 
responses to heat stress (Garriga et al., 2006; Lei et al., 2009; Yan et al., 2009). 
These, and many other expression quantitative trait loci (eQTL) associated with 
heritable resistance to other production-relevant phenotypes, could be added to 
the qPCR panel to test differences in transcript expression between farms as a guide 
to selection.  
Apart from commercial lines tests, the optimised diagnostic tool could be 
applied in studies of inbred lines when challenged with pathogens. That could help 
to select genes that carry the information about resistance or susceptibility to 
disease, for example in the inbred lines housed by the National Avian Research 
Facility that differ in resistance to Eimeria, Salmonella, Campylobacter and other 
agents. Results could narrow down the list of candidate genes associated with 
differential resistance. The limited number of genes tested, compared to whole 
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transcriptome analysis, would lower the costs of experiments even further. 
However, it would not allow for the discovery of novel genes or transcript variants 
associated with resistance, as happens in RNA-seq differential expression studies. 
Projects involving a vaccine challenge or infection could also benefit from applying 
this platform by adding to knowledge of the nature, magnitude and timing of 
responses to vaccination and pathogen challenge. Gene expression studies offer 
very exciting avenues for solving the problems of existing and emerging diseases. 
Blood transcriptome analysis as a diagnostic tool has been successfully used to 
profile human patients with sepsis, where candidate transcriptional signatures of 
differential diagnosis were identified (Pankla et al., 2009). Microarrays and other 
gene expression platforms that measure host responses to infections could serve as 
a disease progression monitoring systems. It has become obvious that genomic and 
transcriptomics approaches cannot elucidate all the problems but play a part in 
selection programs. The complexity of biology and host interaction with the 
environment make the selection for immune robustness difficult. In-depth 
information of fields such as epigenetics, alternative splicing, miRNA regulation 
would add to knowledge of candidate biomarkers at multiple levels. The Chicken 
genome is still in draft version and lacks much genetic and functional annotation, 
therefore it would be advantageous to annotate the genome at similar levels to that 
of human (Cheng et al., 2013).  
 Future challenges of poultry breeding 7.4
Breeding for disease resistance in farmed animals has made remarkable 
progress. Despite the advances, difficulties still exist (Jie et al., 2011). The costs of 
breeding for disease resistance are still high as challenging chicken flocks with 
pathogens to select resistant individuals leads to death of susceptible birds and the 
number of birds used need to be very high. Identification of the disease resistance 
phenotype can also be problematic, as the disease may not affect each bird to the 
same level. Therefore, susceptible animals may not have been identified as they are 
not exposed to the pathogen, resistant birds may have sub-clinical infections and 
play a role of pathogen reservoir/carrier. In addition, the interaction between 
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pathogens makes the breeding of multi-resistant lines difficult and secondary 
infections can cause higher mortality than the primary infection (Jie et al., 2011).  
Knowledge of genes involved in disease resistance can be implemented in 
creating transgenic chickens, e.g. inactivating viral receptors or introducing or 
upregulating resistance-associated genes. Recently, genetically modified chickens 
able to suppress avian influenza A virus transmission have been generated by 
constitutive expression of a decoy RNA resembling a viral vRNA segement to 
interfere with virus replication (Lyall et al., 2011). The creation of birds resistant to 
AI could lead to reduced costs of production caused by AI outbreaks and lower risk 
of transmission of the virus to human population. The chickens resistant to AI 
phenotypes do not show significant differences in hatching weights. Future 
transgenic chicken lines overexpressing particular immune-related genes, or indeed 
birds given immuno-modulatory substances to boost immune function,  could be 
screened using the qPCR panel with Fluidigm chip to understand the basis of any 
beneficial phenotypes. For decades it has proved challenge to introduce disease 
resistance by selection without affecting other production traits, therefore 
transgenesis may aid the fight against the diseases (Whitelaw and Sang, 2005).  
 Conclusions 7.5
The research described here could potentially aid the selection for improved 
immune robustness. The technical optimisation and validation of a new tool to 
simultaneously quantify expression of tens of relevant immune-related genes will 
prime research in many areas of avian biology, especially to define baseline immune 
gene expression for selection, the basis of differential resistance, and host 
responses to infection, vaccination or immuno-modulatory substances. The chip 
with the selected panel of genes now needs to be tested at different time-points in 
experiments where genotypically identical chickens are placed in different 
environments in which more variables are defined and controlled. Results from 
mRNA gene expression studies, together with information about other phenotypes  
could help to distinguish birds that are more robust.  
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Table 1. Primers for sequencing cDNA inserts in pGEM-T. 
 







Primer name Plasmid name Sequence (5'-3') 
T7 (forward) pGEM T-Easy TAATACGACTCACTATAGG  
Sp6 (reverse) pGEM T-Easy ATTTAGGTGACACTATAG 









































Figure 1. RNA-seq differential expression pipeline (Trapnell et al., 2012) 
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Table 3. Primers designed to clone genes of interest 
Gene Forward Tm [°C] Reverse Tm [°C] length (bp) 
ABCG2 ATGGGAACTGCTCAAAACAACAG 56.1 TTATGTGAACTTCCTCATAAACCGGAG 56.6 2106 
ATF3 GAGGAACTTAGATTCGCCATC 53 TTAACCTTGTAATGTTCCTTCTTTGATC 53.8 419 
BATF3 GAGCCACGAAGAAGACGATAAGAAGG 58.8 TCATCTGGGCAGGCAGC 58.2 292 
BCL2A1  ATGGAAACTGCTGAGTTCTATTACG 54.9 TCAGTGGTACTCTCTGAACAAG 53.9 524 
C3ORF52 ATGAGCTGGCTCCGTGC 58.4 CATGTTGATGTGAGAGAAACTGGGTC 57.6 700 
CD40 ATGGGGCGGCTCGGGC 65 TCACAGCTGCTCCTGCTCGGC 64.5 831 
CD72 ATGGCCCAGAGCGTGCTCTAC 61.8 TCACCCTTCGGCCAGCAGA 61.6 972 
CD80 ATGAAGATGGGGTGCCTGAAGAG     58 TCATAGAGATGACATTTCACATGTCAATTTACAGC 58 950 
CD83 ATGGCTTCAGCAGCCTAC 53 TTAGATAGAACTTGAAGTAAGTCCAC 52 648 
CXORF21  ATGCTGTCAGAAGGTTACCTTTACAG 56.7 CTATGCATTAGTGTTGCTATACTGAGAAATATG 57 870 
DTX2 ATGGCAGCAGCTCAGGGAGCAG 64.2 CTGTTCCAGGCCACCTTCAGGAGCTC 64.7 1475 
EAF2 ATGAACGGGATGGCCCCG 60.8 TCAGTCATCACTATCGCTTCCAGATTCAC 59.6 795 
EDN1 ATGGATTGCAGCCGCCTG 58.9 CTAGAATGTTTTCAGGCTTTTCCAGATGC 58.2 618 
EGR1  ATGGCTGCGGCCAAG 56.5 TTAGCAAATCTCAATTGTCCTTGGAGA 56.5 1532 
ENSGALG00000002955 ATGAAGATGTTCAGGTGGAGGTG 56.8 CAAGTCTATCCTTTCCCTGGAGATC 56.4 1167 
ENSGALG00000005747 ATGACTCGCTGCCAGGTG 57.8 TCATTCATTCTGGCAGCTTTTATAGTCC 57 1056 
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Gene Forward Tm [°C] Reverse Tm [°C] length (bp) 
ENSGALG00000011172 ATGCACCAGAGCAGCATCAATGG 60.2 GGTCCAGGCACTCCGC 59.3 1315 
ENSGALG00000015395 ATGCTTCTGCTTCAGGCCTGC 60.6 TCAGTGTTCCTCTGGACTTGTAGAGACAG 60.5 1056 
ENSGALG00000022324 ATGAGGATGCCGCTTCC 55.1 TTAAACATTCACTGTGCTTTCTTGTGG 56.4 1008 
ENSGALG00000025905 ATGAAGATGGAGACAGGGGAT 55.3 TTAAATTTGTGATATCATTCTCAGTGCAGG 55.9 933 
ENSGALG00000027419 ATGATGGTTACTTGCCTGCTCCTCTC 60.3 TCACGTGTTGGGCACTGCAG 60.7 918 
ETS2 ATGAGTGAATTTGCGATCAGAAACATG 56.3 TCAGTCCTCGGTGTCAGG 56.2 1440 
G0S2 ATGGAAACCATGCACGAGCTG 58.3 TTAGGATGCATGCTGCCTGG 57.8 299 
GCH1 TACGCACGGCGGGAGGG 63.5 TCAGCTCCTGATGAGCGTCAAGAACTCTTC 62.6 711 
GLUL ATGGCCACCTCGGC 55.5 TTAGTTCTTGTACTCAAAAGGCTCGTC 56.8 1122 
HPS5 ATGAGGCTCTGTATCTGCTTCGTG 58.6 TCAGTATTTGTTAGGAAGTCCTGCGG 58.4 384 
IFIT5 ATGAGTACCATTTCCAAGAATTCC  53 TCAGCTTGAGAGGGAAAGTCG  52 1440 
IL10RA  ATGGCCCTCTGCGCTGC 61.9 CTTCTGGCACAGGAACAGCTGCT 61.8 900 
IL17REL ATGATAAGTGTTCATGTTCTGATTCTTC 53.7 GTGGAACTGAATAATCTACATCTGTC 53.3 1266 
IL1R2 ATTTCAAGACACTTTCCCTCGCTCTTC 58.9 CCTGCCAGGATGACACAGG 58.1 1149 
IL4I1  ATGGCTGCGATGGTTCTCTTCC 59.7 TCAGAGCTCTCCCTTCTCCACG 60.1 1572 
IRAK2 GTGTGGTCTTAGCAGAGATA  51 TTATCTACATTTACCTTGGGATG  50 803 
IRF1 ATGCCCGTCTCAAGGATGCG  65 TTACAAGCTGCAGGAGATGGC  60 942 
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Gene Forward Tm [°C] Reverse Tm [°C] length (bp) 
IRF10 ATGGCGGAGCCGGGGTC  63 GCCAGCAGTCTGAGTGATTGACATCCTCA  63 620 
JUN (AP1) ATGGAGCCTACTTTCTACGAGGATG  58 TCAAAACGTTTGCAACTGTTGTGTTAG  58 932 
LYG2 GAACATAGCAAATGTTGAAACAACTGG 55.5 TCAGTATCCATTTCTCTGAAAGAACTTG 55 541 
LYZ ATGGGTCTTTGCTAATCTTGGTGCTTTGC 62 TCACAGCCGGCAGCCTCTG  63 444 
MADPRT ATGGAGCACGCCATTCTGG 58.1 CACGGAAGACATTGTGGCATCG 58.2 481 
MAFA ATGGCCTCGGAGTTGGCC 60.7 TCACATGAAGAAGTCAGCGGCAGTAG 60.4 861 
MAFF ATGGCTGCGGATGGGCTG 61.4 CTAGGAGTAGGCGGCCTGGTTG 61.5 450 
MYD88 ATGGCTACGGTACCCGTGGGTG  64 TCACCAAGTGCTGGATGCTATTGCTCGC  64 1131 
NDNF ATGCAGAAGCTGCCTACC 55.1 CTAACAGAACTTCCTCGTTTTCACC 55.7 1651 
NFKB2 ATGGTGGAGCAGAAGGAGCC 59.6 GCTTGTCGCTGACGTCCC 59.1 2646 
NFKBIZ ATGGGGGGAGGAAAGCAGCACA  58 TCAAAACAGCGACGCTCTCTGC  65 1192 
NLRC5 CTGGCAGAACTAGATCTCTCCAGGAATCAG 60.8 TCACTCAATCTTCCGGAGGTGCTC  60.5 1263 
NOS2 ATGCTGTGCCCATGGCAG  59 TTATATTCTTTTGACTTCATGTGGGAACACAG  57 3411 
NR4A3 ATGCCCTGTGTGCAAGCGCAG 63.6 TCAGAAGGGCAAGGTGTCCAGAAACAGC 64 1829 
PFKFB3 GCCAATTCCCCCACTGTGATAG 57.9 CGGCAGCCATAAGCCACTG 59.2 1189 
PKD2L1 ATGGAGGGGAAGTGCTGCTTCTAC 60.7 GCTGCAGCTCATCCTTCTGGC 61 1558 
PLA2G5 ATGAATGCTCTCCTTGCATTGGC 58.3 TCACCTGCACTTGCACCTG 58.2 417 
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Gene Forward Tm [°C] Reverse Tm [°C] length (bp) 
PLK3 ATGACGGACCTCTCCAGCAACAAAAC 61.1 CTAGGCATCAGCCCACTCCTGG 61.6 1734 
PPARG ATGGTTGACACAGAAATGC  51 CGCCATTAATATAAGTCTTTATAGATTTC  51 1433 
PTGS2 ATGACAACAGGATTTGATCGGTATG 55.2 CCTGGATACAGTTCCATAGCATCTAT 55.8 1379 
RASD1  ATGAAACTGGCAGCGATGATCAAGAAG 59.4 CTAGCTGATCACACAGCGGTCC 59.7 836 
SAAL1 ATGGATCGCAACCCCTCGC 60.6 TTAGGTAGGGACCTTCAGGCTCGG 61.7 1407 
SDC4 ATGCCGCTGCCCCGC 63.6 CCAAGGTCGTAGCTGCCCTCGTC 63.6 545 
SELE ATGGTGAATTGTTGGACATACC 53.2 TTAGACATTCTGGCATTCAGTAGT 53.8 1562 
SERPINE2 ATGAACTGGCACTTCTCGC 55.5 TCAAGGTTTGTTTATTTGTCCCATAAAC 54.6 1329 
SLCO6A1 ATGAAGGGCAACGACGGTAT 56.6 TTACGCATGTATAGCAGATACCATTTCTG 56.7 2037 
SNX10 ATGACACCAAAACACGAA 49.5 TCACGATTCTTCAGAAGC 49.4 606 
SOCS1 ATGGTAGCGCACAGCAAGGTGTCAGC  61 TTAGATCTGAAACGGGAAGGATT  59 624 
SOCS3 ATGGTCACCCACAGCAAGTTCC  63 TTAGAGGGGGGCATCGTACTG  61 626 
STEAP1 ATGGAGAAGAGAGAAGGTGATAGTC 55.3 GAACTCTCTCCAGGTCAAAGAG 54.5 759 
STEAP4 ATGAATAAAAATTCTTCCAACATAATGGC 53.4 TTACACAGCAGACTTGTTGATAAC 53.3 1418 
TGM4 ATGAGCCAAGACAGCGACCTGAAAG 61.1 CTAGTGGGTGACCGTGATGGCC 61.9 2129 
TIRAP ATGGCCGGATGGTTTAGGCGG  62 CTACTGCATTCCACTCGTGGAGCTCC  62.5 666 
TNFAIP3 ATGGCTGGCCAACACATCCT 59.7 CTAGCCGTAGATCTGGGGGAACTG 60.4 2421 
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Gene Forward Tm [°C] Reverse Tm [°C] length (bp) 
TNIP2 ATGCACCTGGCCGG 55.8 TCATACAGTGAGGACATCTAAGTTCAC 55.9 1506 
TOLLIP ATGGCGACCACCGTCAGTAC  59 CTATGATTCTTCAGTCATCTGAAGCAAGGAG  58 824 
TRAF3IP2 ATGGCTTCTGTGTCAGGCACTTTTGTG  61.5 TCATAACGGCACAACCTGGAGTGTTG  61 1598 
UPP1 ATGGCTCCTGGTGTCT 52.8 TTATACTTTCCCAAGACTTTTCTTAATG 51.9 942 
WDR24 ATGGATGAGAACCTGCTGGCC 59.8 TCAGGTGTACTCGCAGAGGTGG 60.6 2118 
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Table 4. Gene symbols and transcripts accession numbers for the final 89 genes. 
 
Gene symbol Database number 
1 ABCG2 ENSGALT00000009304 
2 ATF3 XM_004935334.1(X1) XM_419429.4 (X2)  
3 BATF3 XM_004935335.1; XM_419428.4 
4 BCL2A1  ENSGALG00000006511 
5 C3ORF52 XM_004938298.1 (x4); XM_416636.4 (x3); XM_004938299.1 (x5) 
6 CCL19 XM_424980.4 
7 CCL20 NM_204438.2 
8 CCL4 (CCLi3) NM_204720 
9 CCL5 (CCLi4; ah294) NM_001045832.1 
10 CD40 ENSGALT00000039105 NM_204665.2 
11 CD72 ENSGALT00000003752 
12 CD80 NM_001079739 
13 CD83 XM_418929.3 
14 CSF1 NM_001193295.1 
15 
CXCL13L2 
XM_420474.4 (X3); XM_004941025.1 (X5); XM_004941024.1 (X4); 
ENSGALT00000016832 
16 CXCLi1 ENSGALT00000019072; NM_205018 
17 CXORF21  ENSGALG00000016286 
18 DTX2 XM_415763.4 
19 EAF2 NM_001006525.1 
20 EDN1 XM_418943.4 
21 EGR1  ENSGALG00000007669 
22 ENSGALG00000002955 ENSGALT00000004669 
23 ENSGALG00000005747 ENSGALT00000009229 
24 ENSGALG00000011172 ENSGALT00000018214 
25 ENSGALG00000015395 ENSGALT00000030421 
26 ENSGALG00000022324 ENSGALT00000035899 
27 ENSGALG00000025905 ENSGALT00000042716 
28 ENSGALG00000027419 ENSGALT00000046220 
29 ETS2 NM_205312.1 
30 G0S2 ENSGALG00000023933  NM_001190924.3 
31 GCH1 NM_205223.1 
32 GLUL NM_205493.1 
33 HPS5 XM_004941433.1 (X4); XM_421011.4 (X3); ENSGALT00000010127 
34 IFIT5 XM_421662.3 
35 IL10RA NM_001039597.1 
36 IL12B NM_213571.1 
37 IL13RA2 ENSGALT00000032399 
38 IL17REL XM_001232492.3 (X1); XM_004937501.1 (X2)  
39 IL18 ENSGALG00000007874 
40 IL1B ENSGALG00000000534 
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Gene symbol Database number 
41 IL1R2 XM_416914.4 
42 IL4I1  ENSGALG00000000081 
43 IL6 ENSGALG00000010915 
44 IL8 (IL8L2; CXCLi2) ENSGALG00000026098 
45 IRAK2 NM_001030605.1 
46 IRF1 NM_205415.1 
47 IRF10 NM_204558.1 
48 IRF7 ENSGALG00000014297 
49 IRG1 ENSGALG00000016919 
50 JUN (AP1) NM_001031289.1 
51 LYG2 ENSGALT00000027062; XM_416896.4 
52 LYZ NM_205281.1 
53 MADPRT NM_001033646.1 
54 MAFA NM_205025.1 
55 MAFF ENSGALT00000020063 
56 MYD88 NM_001030962.1 
57 
NDNF 
ENSGALT00000019508; XM_004941227.1; XM_004941228.1; 
XM_004941225.1; XM_420627.4; XM_004941226.1 
58 NFKB2 ENSGALT00000009068 
59 NFKBIZ NM_001006254 
60 NLRC5 XM_003641889 
61 NOS2 NM_204961.1 
62 NR4A3 XM_419081.4 
63 
PFKFB3 
XM_004937473.1 (x11); XM_416472.4 (x7); XM_004937470.1 (x8); 
XM_004937472.1 (x10); XM_004937471.1 (x9) 
64 PKD2L1 ENSGALT00000009261 
65 PLK3 ENSGALG00000010129 
66 PPARG NM_001001460.1 
67 PTGS2 NM_001167718.1; ENSGALT00000008125; ENSGALT00000044290 
68 RASD1  ENSGALG00000004860; NM_001044636.1 
69 SAAL1 ENSGALT00000045705 
70 SDC4 NM_001007869.1 
71 SELE NCBI XM_422246.4 
72 SERPINE2 NM_001083920.1 
73 SLCO6A1 ENSGALT00000044226 
74 SNX10 NM_001030986.1  
75 SOCS1 NM_001137648.1 
76 SOCS3 NM_204600.1 
77 STEAP1 XM_418642.3 (X4); XM_004939274.1 (X6); XM_004939273.1 (X5 
78 STEAP4 ENSGALG00000008997; XM_001235256.3 
79 TGM4 ENSGALG00000011888 
80 TIMD4 NM_001006149.1 
81 TIRAP NM_001024829.1 
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Gene symbol Database number 
82 TLR15 NM_001037835.1 
83 TLR4 NM_001030693.1 
84 TNFAIP3 XM_003640919.2 
85 TNIP2 NM_001031166.1 
86 TOLLIP NM_001006471.1 
87 TRAF3IP2 XM_419782.2 
88 UPP1 ENSGALT00000031003 
89 WDR24 ENSGALT00000003862; NM_001030628.1 
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Table 5. Primers, alignment site and amplicon length for qPCR detection of transcripts of genes of interest using the 96.96 Dynamic Array in BioMark System 
(Fluidigm). 
Gene Forward Reverse exon-intron 
amplicon 
length (bp) 
ABCG2 GGAGTAAGGTGCTCTGGTGAAGA TCTCCCACATTGCCATGTTAGT fwd 13-14 ex 73 
ATF3 CATGAAAACGGAGTTTTCTCCTG GTCTCCAGCTTTTCTGATTCTTTCTG fwd 1-2 ex 141 
BATF3 GGACAAACTTCACGAGGAATATGAAT CCTTGGTATGGTCACAAAGTTCAT fwd 1-2 ex 169 
BCL2A1  ACCATATTTACTTTTGGAGGTCTTCTCA ACCGTTTTCCCAGCCACC fwd 1-2 ex 159 
C3ORF52 GCAACGAGCAAGGAGAGAGATC AGAGCTAGACTGATGAGAATGACCAG fwd 1-2 ex 128 
CCL19 TGAGATGTGTCCTGCATGTGTATG GCCATGGGATGGGCTTCT not ex-in 80 
CCL20 AGCTGTCTGGTGAAGTCTGTGATATT AGGATTTACGCAGGCTTTCAGT rev 1-2 ex 77 
CCL4 (CCLi3) CTCTGCCCCAGTGGGACC GACTTCGCGCTCCTTCTTTGT fwd 1-2 ex 151 
CCL5 (CCLi4; ah294) CTCCGTTTGGGGCTGATACA TGCTGCCTGTGGGCATTT rev 2-3 ex 113 
CD40 AAAACTGAGCCATGCCACTTCT CCGGCTTGACTCACAGATCAC fwd 1-2 ex 102 
CD72 GCATGTCTGTCTGAACGGAGACT AAGATGCACTTGCCATGGTAGA fwd 4-5 ex 66 
CD80 CCCTCTTTGTTACCGCTGACTT CACACGTTCGTCGTTGAGGA fwd 1-2 ex 152 
CD83 ACCTGAGTGGCATCATCACATTAA CACGTACAGGTAAAGAAGATGAGCAG rev 3-4 ex 142 
CSF1 TCGTCTGCAGCATCCATGAG GTGCCGCTCGGTGATGAT not ex-in 65 
CXCL13L2 CCAACGGCAACCTGAACTG CATATTTCCGCAAGGGAATGA not ex-in 66 
CXCLI1 AAGAGATCATCCTCACCCTGAAGA GCTTCTTTTTTGCTGACATCCG fwd 2-3 ex 115 
CXORF21  CGCAGATATCACGAGAGAGGAA TGCAAGAAGCGGCTGATG one exon gene 70 
DTX2 AATGGAGTCAGTGCTCTAAACCTCC CCTCATCCACAGGAGTACCCTTC fwd 2-3 ex 138 
EAF2 AGGAGACCTTGAAGTTGGCA GTGGAGTCGAGCCCTCAATA not ex-in 71 
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Gene Forward Reverse exon-intron 
amplicon 
length (bp) 
EDN1 CGTGTATTTCTGCCACCTGGAT AGGGCCTCCAAGACCATAGG not ex-in 76 
EGR1  CCTTGCGGCAGACACTTTTC CTACCATTTGGGGCTGGCT fwd 1-2 ex 141 
ENSGALG00000002955 GGAAACGCTCATCTGGGCTAT TTTTTTCCGTTCCACTATCTGGAT fwd 6-7 ex 81 
ENSGALG00000005747 TGGATCCGGAGCCTCAAC GGTCTGCGCAGCTCCAAA one exon gene 65 
ENSGALG00000011172 GGGAGACCTGCACGAAGCT GCCAATGTTGGTGTAGATGTTACC rev 1-2 ex 79 
ENSGALG00000015395 GGAGACAACTGCAGAAACACAGAG GAAGATCCTGGTGTCTGCCTCT fwd 4-5 ex 148 
ENSGALG00000022324 TCTCCCCACCGATGCTAGTG GGCTAAACCAGAGAGAATGAGGAT one exon gene 77 
ENSGALG00000025905 TGACACTGCTTGTTCATCATTTCTT GCCTCACAGTCTCCTGATTTAATTG rev 4-5 ex 75 
ENSGALG00000027419 GCATCAGGCTCTGTGCAGG GTTGTCTTCAGCCCCATCCAT fwd 1-2 ex 144 
ETS2 GGAATGCTCAAGCGGCAA TTCACAGTTGTTGGACTCGTAAGAAG fwd 1-2 ex 150 
G0S2 GAAGGGAATATAGAGGAGGAGAAGAGA CTCCCGCTTCCGAGGAA one exon gene 69 
GCH1 GACTACAAGTCCAGGAACGCCT TACCCCACGCATTACCATACAC not ex-in 122 
GLUL GCCAGTCTGCAGACACAAATCT GCCAGCCAAACGGATGAC fwd 2-3 ex 132 
HPS5 TCTGTATCTGCTTCGTGTTGCTCT GCGCCTCCAGCTGCAT fwd 1-2 ex 100 
IFIT5 ATGAGTACCATTTCCAAGAATTCCTT CAATCTGATCCTCTATTGATTCTTCCA fwd 1-2 ex 127 
IL10RA CACAAAATCTATGGCACCAACAG GTGCCCGTGGATCTTCATG fwd 1-2 ex 66 
IL12B TGGGCAAATGATACGGTCAA CAGAGTAGTTCTTTGCCTCACATTTT not ex-in 83 
IL13RA2 CTGCAAGGGAAACTGGAATCC CGTGTGCTCCAGACCCTCATA fwd 2-3 ex 150 
IL17REL  CTTTGCATTGAGGGTTGGCT TTCCCAAGCTAGGGTTTGTGTC fwd 7-8 ex 129 
IL18 GTGAAATCTGGCAGTGGAATGTACT CATGCTCTTTCTCACAACACATGTAG fwd 2-3 ex 133 
IL1B CAGCAGCCTCAGCGAAGAG CTGTGGTGTGCTCAGAATCCA fwd 1-2 ex 86 
IL1R2 CCAAGAATCTGGGCAAAAGG CTGGTACAGATATACACTCCTGAGTCTTC rev 6-7 ex 69 
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Gene Forward Reverse exon-intron 
amplicon 
length (bp) 
IL4I1  GCCCTGCAGTCGGCTGT CGAGTCCTCGTTCAGCAAATCT fwd 3-4 ex 155 
IL6 GCTTCGACGAGGAGAAATGC TGAATTCCAGGTAGGTCTGAAAGG fwd 2-3 ex 72 
IL8 (IL8L2; CXCLi2) CTGTCGCAAGGTAGGACGCT GCTATGATTTCAACATTCTTGCAGTG fwd 1-2 ex 149 
IRAK2 TGGAAGAGGTTGCCATTGATT TGTTTCCATAATTTCCAGTACCTCTGT rev 2-3 ex 95 
IRF1 GATCTGGATCAACAAGGATAAGATGATAT ACTTTATATCTTCCTGTATGGATGGCC fwd 1-2 ex 129 
IRF10 GGGATGCAGAGAAGGATGAGAA GCTCTCCTCGGCCACATG fwd 2-3 ex 83 
IRF7 GCCTGAAGAAGTGCAAGGTCTT TGCAAAACACCCTGAAGTCG not ex-in 123 
IRG1 AGTGGCTGTGCACTCAATGG CACATTGAAAGCTAAGAGCAGGTC fwd 2-3 ex 151 
JUN (AP1) CGAGCCCCCGGTGTATG TTGTAGTTGGGTGCAGAGTTGAG one exon gene 69 
LYG2 GTTTAATGCAGGTTGACAAACGG TGCTGTTCCTTACTCCATGTTGG fwd 2-3 ex 142 
LYZ TACAGCCTGGGAAACTGGGT TTCCTGGAGCCTGGGGTC fwd 1-2 ex 155 
MADPRT ATAAAGGAGGTGGCGATGGA GTGGATGCAGCCCTGGTACT one exon gene 66 
MAFA GCAGAACAGGAGGACCTTGAAG TCTGCTGGACCCGCTTGTAG one exon gene 68 
MAFF AGCAGAAGATGGAGCTGGAATG CTGCAGGGCCTCGTACTTG fwd 1-2 ex 150 
MYD88 GGCAGCGTGGAGGAGGA TCCATGCCCATACGGATCAT fwd 1-2 ex 150 
NDNF CACCCTGTGATGCTCCCCT GTTCTCCTGAACCTTCTCCACTG rev 2-3 ex 81 
NFKB2 TGAGGTGCGGTTCTATGAGGAT GGACGGTCAATTTTGGGCTT not ex-in 132 
NFKBIZ GGAGCTCATCCGTCTCTTCTTG GTTGCCATTGTAAGCCTTTGC rev 9-10 ex 74 
NLRC5 AGAGCCCTGGGTATGTAAGTTGAG TTGCATATCATGATCGCAGTGA rev 6-7 ex 90 
NOS2 CAGCGGAAGGAGACAAACAGAG AACTCTTCCAGGACCTCCAGG not ex-in 109 
NR4A3 CCAGCTTCAGCACCTTCATG GAGGCGGATTGCATTTGG not ex-in 82 
PFKFB3 AACAAAAGTTTTCAATGTAGGGGAGT CATCCCTCAGGGCAGCC fwd 1-2 ex 134 
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Gene Forward Reverse exon-intron 
amplicon 
length (bp) 
PKD2L1 GTTCTGAGGTTAGTGGTTGAGTTTCC CGTATAAGCTTGACTGTCCGGATT fwd 5-6 ex 80 
PLK3 AAGGCCAAGAAGGGCTCTCT CGGCAGATGGACGTCTTCA fwd 7-8 ex 80 
PPARG TTTCAAGCATTTCTTCACCACACT TGATTGCACTTTGGCAATCCT fwd 1-2 ex 111 
PTGS2 CTGTACAACACCGGAATTCTTCAC GGAAATGTTGTTGATGATGTTCCA fwd 1-2 ex 118 
RASD1  TCACAGGTGACGTTTTCATCCT GACCAGCGGCACCTCG fwd 1-2 ex 143 
SAAL1 GCAGCCAAACAAGTCCGC GGAGCCTGCACAATAGCCTG fwd 7-8 ex; rev 8-9 110 
SDC4 AAACCTGTCCAACAAGATCTCCAT CTGCAATGAGAGCTGTAAGAACTTCT rev 4-5 ex 86 
SELE GCCGGGTTGTGAATTTGTTGA CATTGAGCTGTGCATGACGA fwd 1-2 ex 117 
SERPINE2 ACACAACACCGCTCTCTGCTATC ACCTGCACTCTTTTGGCTACCAT not ex-in 91 
SLCO6A1 TGGAACAGGCATGCTACATAACTT ATCTCTGCCACAAACAGGGTAGTAT fwd 8-9 ex 91 
SNX10 GGTACGAGACCCCAGAACACA ACAAATTCTCGGAAGCGTCG not ex-in 132 
SOCS1 GCACGCACTTCCGAACCTT AAGCCGCAGGCATCCA one exon gene 82 
SOCS3 ACCCCAAACGCACCTACTACA TGCCCGTTGACAGTCTTACG one exon gene 121 
STEAP1 GTCGCCAATCCACCAGAAGTA CACCTGGGGAACAAATCCTG not ex-in 113 
STEAP4 GGATGCAAGTCGGCAGGT CAGCCAAGAGAGATCCTTGATCTAA fwd 1-2 ex 116 
TGM4 GTCAAGGTACTTTCCAGTGTGGC GCGTTCACTTCCGCGTACA fwd 8-9 ex 103 
TIMD4 CCTTCATAGTGCACACCATGTCA TGCACTTGGAGTTTGGGCA fwd 1-2 ex 147 
TIRAP CTGAAGGACATTGACAGGAAGGAT TCTTCCAGGTAGCGCAGCA rev 2-3 ex 122 
TLR15 TTCAGACAAAGAAGAACAGAGGAAAA TCGGTGCTCCACACAAGTCA one exon gene 79 
TLR4 GTCCGTGCCTGGAGGTCAT CAATTTCAGACTGTTGAAACTGAGGT fwd 1-2 ex 125 
TNFAIP3 CAGATCCCACAGAGCCTCCTT GGCGGCTCATTGCAGTTG fwd 1-2 ex 157 
TNIP2 GTAGCTCATGTGGAAGACTTAAATGC GTGCTGAAGGTATGCTGTGCTG fwd 3-4 ex 136 
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Gene Forward Reverse exon-intron 
amplicon 
length (bp) 
TOLLIP TGATGAGCGAGCCTTTTCAAT CCTTCTTTGTCATCACCCTGC fwd 3-4 ex 132 
TRAF3IP2 ATTTGCCGGAAGAGTTGCG GCAGGAAGTTCACAAATTTCATGAC not ex-in 84 
UPP1 CATGTACAAAGTGGGACCCGT CGAGGTGCCAATGCGAATA not ex-in 139 
WDR24 CTCTGGCCAGTCGGAGAGTG GCCGTTGTGGGCTGTGA fwd 1-2 ex 148 
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Table 6. Primers designed for seven reference genes used in BioMark System (Fluidigm). 
 
 











































RNA 62 FM165415 
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Table 7. Slope and reaction efficiencies for reference genes tested in tissue samples from birds reared on the pedigree farm. 
 Mean quantification cycle (Cq) values 
ACTB Bursa Spleen CT I leum Blood  Dilution factor Cq Log10 (dilution factor) Slope Efficiency 
Bird 1 19.9 16.2 18.3 19.6 23.6  1 19.5 0 -3.92 1.80 
Bird 2 18.1 16.4 18.9 19.4 22.4  0.1 23.4 -1 
  Bird 3 17.4 16.6 18.1 18.8 21.7  0.01 26.5 -2 
  Bird 4 19.8 18.8 18.4 20.1 22.0  0.001 30.2 -3 
  Bird 5 19.3 17.0 18.4 19.9 22.1  0.0001 35.8 -4 
  B2M Bursa Spleen CT Ileum Blood  Dilution factor Cq Log10 (dilution factor) Slope Efficiency 
Bird 1 22.4 20.0 18.9 21.0 26.0  1 21.3 0 -3.58 1.90 
Bird 2 20.8 19.4 21.0 21.4 24.8  0.1 24.9 -1 
  Bird 3 19.4 19.5 20.4 20.3 25.0  0.01 28.7 -2 
  Bird 4 20.7 21.5 20.6 22.2 24.8  0.001 32.3 -3 
  Bird 5 21.4 20.3 21.0 21.8 25.5  0.0001 35.5 -4 
  GAPDH Bursa Spleen CT Ileum Blood  Dilution factor Cq Log10 (dilution factor) Slope Efficiency 
Bird 1 24.0 21.0 22.6 22.4 28.1  1 23.5 0 -3.60 1.89 
Bird 2 22.7 21.5 22.7 22.4 27.5  0.1 27.4 -1 
  Bird 3 22.5 21.8 22.4 21.8 26.9  0.01 30.8 -2 
  Bird 4 23.7 23.8 22.7 23.5 26.9  0.001 34.4 -3 
  Bird 5 23.8 21.9 23.1 23.0 27.4  
     GUSB Bursa Spleen CT Ileum Blood  Dilution factor Cq Log10 (dilution factor) Slope Efficiency 
Bird 1 23.0 26.2 27.7 28.3 31.9  1 27.2 0 -3.36 1.98 
Bird 2 23.1 27.3 27.7 28.0 34.0  0.1 30.6 -1 
  Bird 3 24.0 27.1 27.0 28.2 32.7  0.01 34.0 -2 
  Bird 4 25.5 28.4 27.5 28.8 32.6  0.001 
 
-3 
  Bird 5 22.9 27.7 28.1 28.5 35.5  



































TBP Bursa Spleen CT Ileum Blood Dilution factor Cq Log10 (dilution factor) Slope Efficiency 
Bird 1 28.7 25.7 28.0 28.9 33.3  1 28.9 0 -3.83 1.82 
Bird 2 27.3 26.3 28.2 29.0 32.6  0.1 32.8 -1 
  Bird 3 27.1 26.7 27.9 28.1 31.5  
     Bird 4 28.4 28.7 28.0 29.5 31.7  
     Bird 5 28.4 26.7 28.5 29.2 32.1  
     TUBAT Bursa Spleen CT Ileum Blood  Dilution factor Cq Log10 (dilution factor) Slope Efficiency 
Bird 1 24.7 28.6 33.0 34.2 36.5  1 28.5 0 -3.23 2.04 
Bird 2 23.9 31.5 33.9 34.2 38.1  0.1 31.8 -1 
  Bird 3 25.2 31.3 33.7 33.8 35.3  0.01 35.0 -2 
  Bird 4 27.0 32.6 31.9 35.2 36.0  
     Bird 5 23.7 31.7 33.6 34.2 38.2  
     r28S Bursa Spleen CT Ileum Blood  Dilution factor Cq Log10 (dilution factor) Slope Efficiency 
Bird 1 11.9 9.8 10.8 10.5 16.6  1 11.7 0 -3.67 1.87 
Bird 2 10.8 9.8 10.9 10.9 15.5  0.1 15.5 -1 
  Bird 3 10.7 10.0 10.8 10.4 14.6  0.01 18.9 -2 
  Bird 4 11.7 11.2 11.0 12.2 15.3  0.001 22.9 -3 
  Bird 5 11.8 10.3 11.1 10.7 14.5  
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Table 8. Slope and efficiencies for reference genes tested in tissue samples from birds reared on the sibling test farm. 
 
Mean quantification cycle (Cq) values      




factor) Slope Efficiency 
Bird 1 18.4 17.7 18.3 20.4 17.6  1 19.4 0 -3.29 2.01 
Bird 2 17.7 18.2 18.5 18.0 16.2  0.1 22.5 -1 
  Bird 3 18.7 18.7 18.0 18.6 19.9  0.01 26.2 -2 
  Bird 4 18.5 16.9 16.6 19.5 16.8  0.001 29.9 -3 
  Bird 5 19.7 19.3 20.1 21.2 18.7  0.0001 32.6 -4 
  
      
 0.00001 35.6 -5 
  




factor) Slope Efficiency 
Bird 1 18.9 18.9 19.2 21.3 19.3  1 20.9 0 -3.96 1.79 
Bird 2 19.7 20.7 20.0 19.1 18.7  0.1 24.5 -1 
  Bird 3 19.4 19.6 18.5 19.9 21.6  0.01 28.3 -2 
  Bird 4 19.4 19.6 18.0 19.3 19.3  0.001 32.9 -3 
  Bird 5 22.1 22.9 23.8 25.3 22.9  
     




factor) Slope Efficiency 
Bird 1 22.5 23.2 22.3 22.9 21.9  1 23.6 0 -3.07 2.11 
Bird 2 22.7 22.7 21.7 35.4 22.0  0.1 27.1 -1 
  Bird 3 22.6 21.8 22.8 24.3 23.9  0.01 35.9 -2 
  Bird 4 21.9 21.9 22.3 23.2 21.1  0.001 33.4 -3 
  Bird 5 24.7 24.7 25.3 25.7 24.6  0.0001 35.9 -4 
  




factor) Slope Efficiency 
Bird 1 27.9 27.3 26.9 27.2 26.4  1 26.9 0 -3.26 2.03 
Bird 2 26.4 26.2 27.0 27.7 26.7  0.1 30.5 -1 
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Bird 3 27.1 26.8 28.2 28.2 28.7  0.01 33.6 -2 
  Bird 4 27.4 27.6 26.6 26.5 27.0  0.001 36.7 -3 
  Bird 5 30.1 30.3 30.8 31.4 29.2  
     




factor) Slope Efficiency 
Bird 1 27.1 27.9 27.8 29.8 26.6  1 29.1 0 -3.24 2.03 
Bird 2 27.3 28.4 28.1 26.9 26.7  0.1 32.1 -1 
  Bird 3 27.7 27.5 26.9 28.3 29.3  0.01 35.5 -2 
  Bird 4 27.5 27.0 26.9 29.3 27.4  
     Bird 5 30.3 30.1 31.3 32.6 31.3  
     




factor) Slope Efficiency 
Bird 1 32.5 32.5 30.1 27.3 27.7  1 28.4 0 -3.68 1.87 
Bird 2 26.9 27.0 27.7 30.2 31.2  0.1 31.8 -1 
  Bird 3 30.2 26.9 33.5 33.3 33.9  0.01 35.7 -2 
  Bird 4 33.2 30.1 32.8 29.6 30.0  
     Bird 5 35.5 36.4 35.4 36.6 34.4  
     




factor) Slope Efficiency 
Bird 1 10.7 10.7 10.9 13.4 11.0  1 11.7 0 -3.67 1.87 
Bird 2 10.8 12.7 11.2 10.6 10.4  0.1 15.5 -1 
  Bird 3 10.8 11.0 10.5 10.8 12.8  0.01 18.9 -2 
  Bird 4 10.6 10.1 10.0 13.4 10.7  0.001 22.8 -3 
  Bird 5 10.8 11.2 13.4 13.8 10.3  
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Table 9. Transformation of Cq values into quantities by ΔCt method - samples from pedigree farm.  
ACTB   Bursa Spleen CT Ileum Blood 
 
Bursa Spleen CT Ileum Blood 
ΔCq Bird 1 -2.52 0 -0.16 -0.86 -1.84 E-ΔCq 0.23 1 0.91 0.60 0.34 
 
Bird 2 -0.69 -0.23 -0.81 -0.62 -0.63 
 
0.67 0.87 0.62 0.69 0.69 
 
Bird 3 0 -0.39 0 0 0 
 
1 0.79 1 1 1 
 
Bird 4 -2.34 -2.62 -0.30 -1.32 -0.31 
 
0.25 0.22 0.84 0.46 0.84 
 
Bird 5 -1.90 -0.88 -0.33 -1.17 -0.37 
 
0.33 0.60 0.83 0.50 0.80 
B2M   Bursa Spleen CT Ileum Blood 
 
Bursa Spleen CT Ileum Blood 
ΔCq Bird 1 -2.92 -0.64 0 -0.62 -1.15 E-ΔCq 0.15 0.66 1 0.67 0.48 
 
Bird 2 -1.39 0 -2.11 -1.02 0 
 
0.41 1 0.26 0.52 1 
 
Bird 3 0 -0.15 -1.48 0 -0.17 
 
1 0.91 0.39 1 0.89 
 
Bird 4 -1.23 -2.12 -1.66 -1.82 -0.01 
 
0.45 0.25 0.34 0.31 0.99 
 
Bird 5 -1.99 -0.91 -2.03 -1.46 -0.67 
 
0.28 0.56 0.27 0.39 0.65 
GAPDH   Bursa Spleen CT Ileum Blood 
 
Bursa Spleen CT Ileum Blood 
ΔCq Bird 1 -1.46 0 -0.22 -0.63 -1.21 E-ΔCq 0.39 1 0.87 0.67 0.46 
 
Bird 2 -0.17 -0.58 -0.32 -0.63 -0.59 
 
0.90 0.69 0.82 0.67 0.69 
 
Bird 3 0 -0.81 0 0 0 
 
1 0.59 1 1 1 
 
Bird 4 -1.19 -2.81 -0.30 -1.69 -0.04 
 
0.47 0.17 0.83 0.34 0.97 
 
Bird 5 -1.30 -0.91 -0.76 -1.17 -0.51 
 
0.44 0.56 0.62 0.47 0.72 
GUSB   Bursa Spleen CT Ileum Blood 
 
Bursa Spleen CT Ileum Blood 
ΔCq Bird 1 -0.13 0 -0.71 -0.27 0 E-ΔCq 0.92 1 0.62 0.83 1 
 
Bird 2 -0.18 -1.15 -0.69 0 -2.03 
 
0.88 0.46 0.62 1 0.25 
 
Bird 3 -1.06 -0.90 0 -0.19 -0.76 
 
0.48 0.54 1 0.88 0.59 
 
Bird 4 -2.63 -2.27 -0.48 -0.80 -0.63 
 
0.16 0.21 0.72 0.58 0.65 
 
Bird 5 0 -1.48 -1.14 -0.45 -3.54 
 
1 0.36 0.46 0.74 0.09 
TBP   Bursa Spleen CT Ileum Blood 
 
Bursa Spleen CT Ileum Blood 
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ΔCq Bird 1 -1.66 0 -0.13 -0.79 -1.76 E-ΔCq 0.37 1 0.92 0.62 0.35 
 
Bird 2 -0.17 -0.65 -0.33 -0.93 -1.04 
 
0.90 0.68 0.82 0.57 0.54 
 
Bird 3 0 -0.95 0 0 0 
 
1 0.56 1 1 1 
 
Bird 4 -1.28 -3.03 -0.10 -1.45 -0.20 
 
0.46 0.16 0.94 0.42 0.88 
 
Bird 5 -1.31 -1.02 -0.64 -1.13 -0.60 
 
0.45 0.54 0.68 0.51 0.70 
TUBAT   Bursa Spleen CT Ileum Blood 
 
Bursa Spleen CT Ileum Blood 
ΔCq Bird 1 -1.08 0 -1.13 -0.41 -1.23 E-ΔCq 0.46 1 0.45 0.75 0.42 
 
Bird 2 -0.26 -2.88 -1.95 -0.39 -2.89 
 
0.83 0.13 0.25 0.76 0.13 
 
Bird 3 -1.56 -2.65 -1.76 0 0 
 
0.33 0.15 0.29 1 1 
 
Bird 4 -3.35 -3.92 0 -1.41 -0.74 
 
0.09 0.06 1 0.37 0.59 
 
Bird 5 0 -3.02 -1.68 -0.33 -2.98 
 
1 0.12 0.30 0.79 0.12 
r28S   Bursa Spleen CT Ileum Blood 
 
Bursa Spleen CT Ileum Blood 
ΔCq Bird 1 -1.20 -0.01 -0.05 -0.10 -2.08 E-ΔCq 0.47 0.995 0.97 0.94 0.27 
 
Bird 2 -0.13 0 -0.17 -0.53 -0.99 
 
0.92 1 0.90 0.72 0.54 
 
Bird 3 0 -0.19 0 0 -0.07 
 
1 0.89 1 1 0.96 
 
Bird 4 -1.00 -1.40 -0.22 -1.77 -0.76 
 
0.54 0.41 0.87 0.33 0.62 
 
Bird 5 -1.08 -0.58 -0.34 -0.24 0 
 
0.51 0.70 0.81 0.86 1 
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Table 10. Transformation of Cq values into quantities by ΔCt method - samples from sibling test farm. 
ACTB   Bursa Spleen CT Ileum Blood 
 
Bursa Spleen CT Ileum Blood 
ΔCq Bird 1 -0.63 -0.87 -1.69 -2.40 -1.39 E-ΔCq 0.65 0.545 0.31 0.19 0.38 
 
Bird 2 0 -1.27 -1.93 0 0 
 
1 0.41 0.26 1 1 
 
Bird 3 -0.83 -1.87 -1.43 -0.56 -3.72 
 
0.56 0.27 0.37 0.68 0.07 
 
Bird 4 -0.73 0 0 -1.51 -0.60 
 
0.60 1 1 0.35 0.66 
 
Bird 5 -1.94 -2.38 -3.50 -3.12 -2.49 
 
0.26 0.19 0.09 0.11 0.18 
B2M   Bursa Spleen CT Ileum Blood 
 
Bursa Spleen CT Ileum Blood 
ΔCq Bird 1 0 0 -1.19 -2.21 -0.61 E-ΔCq 1 1 0.50 0.28 0.70 
 
Bird 2 -0.82 -1.79 -1.94 0 0 
 
0.62 0.35 0.32 1 1 
 
Bird 3 -0.43 -0.69 -0.44 -0.87 -2.88 
 
0.78 0.67 0.78 0.60 0.19 
 
Bird 4 -0.44 -0.76 0 -0.29 -0.60 
 
0.77 0.64 1 0.85 0.70 
 
Bird 5 -3.16 -4.01 -5.80 -6.30 -4.23 
 
0.16 0.10 0.03 0.03 0.09 
GAPDH   Bursa Spleen CT Ileum Blood 
 
Bursa Spleen CT Ileum Blood 
ΔCq Bird 1 -0.62 -1.44 -0.58 0 -0.88 E-ΔCq 0.69 0.42 0.70 1 0.59 
 
Bird 2 -0.75 -0.91 0 -1.11 -0.90 
 
0.63 0.58 1 0.51 0.58 
 
Bird 3 -0.72 0 -1.09 -1.46 -2.84 
 
0.65 1 0.52 0.41 0.18 
 
Bird 4 0 -0.15 -0.58 -0.31 0 
 
1 0.91 0.70 0.83 1 
 
Bird 5 -2.77 -2.90 -3.59 -2.80 -3.56 
 
0.19 0.17 0.11 0.18 0.12 
GUSB   Bursa Spleen CT Ileum Blood 
 
Bursa Spleen CT Ileum Blood 
ΔCq Bird 1 -1.51 -1.09 -0.29 -0.74 0 E-ΔCq 0.34 0.46 0.81 0.59 1 
 
Bird 2 0 0 -0.39 -1.24 -0.28 
 
1 1 0.76 0.42 0.82 
 
Bird 3 -0.68 -0.61 -1.66 -1.72 -2.23 
 
0.62 0.65 0.31 0.30 0.21 
 
Bird 4 -0.97 -1.46 0 0 -0.57 
 
0.50 0.36 1 1 0.67 
 
Bird 5 -3.69 -4.08 -4.25 -4.88 -2.75 
 
0.07 0.06 0.05 0.03 0.14 
TBP   Bursa Spleen CT Ileum Blood 
 
Bursa Spleen CT Ileum Blood 
ΔCq Bird 1 0 -0.80 -0.93 -2.83 0 E-ΔCq 1 0.57 0.52 0.13 1 
 
Bird 2 -0.22 -1.38 -1.18 0 -0.19 
 
0.86 0.37 0.43 1 0.87 
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Bird 3 -0.65 -0.50 -0.06 -1.31 -2.72 
 
0.63 0.70 0.96 0.39 0.14 
 
Bird 4 -0.40 0 0 -2.38 -0.84 
 
0.76 1 1 0.18 0.55 
 
Bird 5 -3.24 -3.09 -4.40 -5.63 -4.76 
 
0.10 0.11 0.04 0.02 0.03 
TUBAT   Bursa Spleen CT Ileum Blood 
 
Bursa Spleen CT Ileum Blood 
ΔCq Bird 1 -5.61 -5.56 -2.38 0 0 E-ΔCq 0.03 0.03 0.23 1 1 
 
Bird 2 0 -0.07 0 -2.89 -3.58 
 
1 0.96 1 0.16 0.11 
 
Bird 3 -3.24 0 -5.81 -5.95 -6.19 
 
0.13 1 0.03 0.02 0.02 
 
Bird 4 -6.26 -3.23 -5.08 -2.31 -2.29 
 
0.02 0.13 0.04 0.24 0.24 
 
Bird 5 -8.63 -9.44 -7.68 -9.24 -6.77 
 
0.00 0.00 0.01 0.00 0.01 
r28S   Bursa Spleen CT Ileum Blood 
 
Bursa Spleen CT Ileum Blood 
ΔCq Bird 1 -0.07 -0.59 -0.87 -2.81 -0.67 E-ΔCq 0.96 0.69 0.58 0.17 0.66 
 
Bird 2 -0.14 -2.57 -1.14 0 -0.09 
 
0.92 0.20 0.49 1 0.94 
 
Bird 3 -0.20 -0.87 -0.52 -2.39 -2.43 
 
0.88 0.58 0.72 0.22 0.22 
 
Bird 4 0 0 0 -2.75 -0.36 
 
1 1 1 0.18 0.80 
 
Bird 5 -0.13 -1.10 -3.35 -3.14 0 
 
0.92 0.50 0.12 0.14 1 
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All test genes NTC 
Figure 2. Melting curves for No Template Control (NTC) samples from qPCR analysis using 96.96 
Dynamic Array platform; a) for reference genes, b) all genes tested. 
 
 








Figure 3. Melting curves for all reference genes for all conditions from analysis using 96.96 Dynamic 
Array. 








Figure 4. Melting curves for genes where primers do not span exon/exon boundaries and with 
introns < 500 bp. 
 








Figure 4 continued 








Figure 4 continued 








Figure 4 continued 




















Figure 5. Unusual melting curves with additional peaks at lower temperatures from qPCR analysis 
using 96.96 Dynamic Array. 
 






Figure 5 continued 
 
